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Protein-protein interactions (PPI) play a vital role in almost every cellular process. 
Although many methodologies exist to probe PPIs, one of the most successful 
and widely employed is tandem affinity purification coupled with liquid 
chromatography and tandem mass spectrometry (LC-MS/MS). Although best 
demonstrated in yeast, TAP has encountered significant hurdles in its application 
to mammalian systems, especially the observed low yield of bait protein and its 
interacting partners after two consecutive purifications.  
 
To address these issues, a novel dual-tag affinity purification (DAP) system was 
developed that not only enhances bait protein recovery, but also allows for rapid 
evaluation of dual-tag compatibility with a protein of interest based on its known 
subcellular localization. In addition, several tags of varying composition were 
constructed to allow for maximal bait protein compatibility. With this system, 
mammalian bait protein yield was improved by more than 200% relative to 
previously published results.  
 
Capitalizing on this success, DAP was applied to human telomere binding 
proteins TRF1, TRF2, and POT1 to garner a greater understanding of the protein 
networks that involve the telomere. Expectedly, all the members of the telosome 
complex were identified at frequencies that lend evidence towards the currently 
accepted architecture. Also identified were several other novel proteins and 
subcomplexes that may enhance our understanding of telomere maintenance / 
length regulation. For instance, members of the classical nuclear import system 
co-purified with both TRF1 and TRF2. Although previously documented for 
TRF1, TRF2’s association with importin alpha (KPNA2) and beta (KPNB1) has 
not been demonstrated till now. Interestingly, further study revealed that KPNA2 
acts as a negative regulator of TRF2 nuclear localization.  
 
This observation could have far-reaching implications as TRF2 is thought to be 
also heavily involved in the DNA damage response. Along these lines, a more in-
depth MS analysis revealed several putative phosphorylation sites along TRF2’s 
sequence. One site, pS380, seems to be phosphorylated by the DNA-damage 
kinase ATM and plays a role in a cell’s proliferative capacity, possibly affecting 
telomere length regulation. The studies contained here within demonstrate the 
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The Study of Protein-Protein Interactions 




1.1: Molecular Biology to Systems Biology 
The 20th century witnessed the transformation of the biological sciences 
from a soft, observation-based study of whole organisms to one based on 
hypothesis, experimentation, and empirical evidence. This rapid progression 
included the merger of biology with several other scientific disciplines such as 
chemistry and physics. The discovery of DNA, its structure and role as a 
hereditary unit as well as the link between DNA, RNA, and protein (the central 
dogma) marks the unofficial birth of the field of molecular biology [1]. Molecular 
biology can be simply defined as the study of the macromolecules that give rise 
to life and life processes. Although the studies that formed the foundation of 
molecular biology took place in a relatively short period, roughly 25 years, the 
area’s continued salience has proven remarkable gains into the study of 
medicine, evolution, and, in general, the understanding of and appreciation for 
the intricacies of life. Aside from the great strides made in its earliest years, 
perhaps the hallmark of molecular biology research, especially regarding human 
health and advances in medicine, was the sequencing of the human genome 
completed in the early 21st century. Genomics, as it was coined, is simply the 
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study of an organism’s genome, including its sequencing, mapping, and 
annotation. The Sanger method [2], established by the Nobel Laureate Fred 
Sanger, allowed for the eventual development of modern high-throughput 
sequencing instruments that were instrumental in both the human genome 
sequencing effort, as well as the sequencing of other organisms. As of June 
2008, our genomic databases contain the complete genome sequences of 2010 
viruses, 724 prokaryotes, and 22 eukaryotes with more than 1400 additional 
sequencing efforts underway 
(http://www.ncbi.nlm.nih.gov/genomes/VIRUSES/virostat.html and 
http://www.ncbi.nlm.nih.gov/genomes/static/gpstat.html). This transition from the 
targeted field of molecular biology to the data-driven concepts intrinsic to 
genomics marked a shift from hypothesis-driven to hypothesis-generating 
research. Although one field spawned the other, both are inextricably linked as 
the newly generated hypotheses must still be tested by tried and true molecular 
biology-specific methodologies. 
 
The maturation of genomics embodied a general evolution in the approach to 
experimentation aimed at deciphering complex biological systems, pathways, 
and mechanisms. Rather than continue down the path of “reductionism”, the 
deep, focused, and discrete experimentation that had formed the basis of both 
early and modern molecular biology, the area of genomics introduced 
researchers to a different, potentially complementary approach, one based on 
“integration” [3, 4]. This integrative model forms the basis for the emerging field 
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of systems biology, in which entire pathways and cellular subsystems are 
analyzed, both in their regulation and in their interaction with other systems and 
pathways [5]. This global perspective can often provide a better understanding of 
the roles different macromolecules play in the everyday functioning of an 
organism. The term systems biology is itself integrative; amassing several 
subfields playfully termed the “omics” which include genomics, transcriptomics, 
proteomics, metabolomics, gylcomics, lipidomics, and interactomics [6]. Of these, 
proteomics is perhaps one of the most highly developed and important 
components of systems biology. 
 
1.2: Proteomics 
As its name implies, proteomics is the comprehensive study of proteins 
and their functional roles. Compared to genes which hold information, proteins 
are the actual tangible components of the cellular machinery, carrying out the 
multitude of functions that support life, whether biochemical or structural. The 
proteome is therefore the entire complement of proteins within an organism or 
cell at any given time. The latter is important to understand as protein expression 
profiles are extremely dynamic, allowing for organisms/cells to adapt to various 
environments and situations [7, 8]. The dynamic nature of the proteome is in 
stark contrast to the static genome and because of this, the proteome is often 
considered to be much more complex and thus more informative, compared with 
its omic progenitor. This complexity is even more pronounced considering 
proteins are often post-translationally modified (PTM) by the addition of usually 
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smaller, chemically functional groups (Figure 1.1 ), drastically altering structure 
and/or function [9]. However complex, understanding the interplay between 
proteins and other macromolecules remains vital to systems biology research. 
 
The field of proteomics can be loosely broken down into several major focus 
areas: (i) general proteomics: the characterization of the protein complement of 
tissues, cells, single-celled organisms, and/or subcellular compartments; (ii) 
comparative proteomics: the assessment of the changes in protein expression 
between related samples in different life stages, disease states, or environments 
to identify state-related proteins and pathways [10]; (iii) community proteomics: 
the identification of the major species and protein products of a community of 
microbes to learn about the population and interdependence of each member 
[11]; (iv) structural proteomics: the acquisition of information regarding the three-
dimensional structures of proteins on a genome-wide scale [12]; (v) PTM 
proteomics such as phosphoproteomics: the identification of potential sites of 
protein modification in a large-scale, high-throughput manner [13]; and (vi) 
interactomics: the elucidation of proteins that potentially interact with specific bait 
protein [14]. Each focus area described above is capable of providing vast 
amounts of data that provide seemingly limitless avenues of further research. 
 
1.3: Protein-Protein Interactions 
Out all the proteomic subfields, interactomics perhaps has the greatest 




Figure 1.1: A depiction of the various post-translational modifications (PTM)s that can be applied 
to each amino acid residue. Image courtesy of: Gramatikoff K. in Abgent Catalog (2004-5) p.263. 
 
 5
exquisite interaction between seemingly distinct cellular processes. Protein-
protein interactions play a vital role in almost every cellular process including 
DNA replication, transcription, translation, signal transduction, cell cycle 
regulation, DNA damage repair, and general metabolism [15]. Protein-protein 
interactions can vary in their interaction affinities either assembling into large, 
moderately stable protein complexes such as the mammalian ribosome, which 
consists of around 80 different proteins [16] or they can be more transient in 
nature, as demonstrated by the brief interaction between a protein kinase and its 
substrate protein [15]. In fact, it is estimated that the average protein in a human 
cell will purposefully interact with at least 5 to 15 other proteins [9] throughout the 
course of its cellular lifespan. 
 
The interaction of one protein with another can have many different outcomes: 
the binding of one protein can lead to a subtle change in the three-dimensional 
structure of another, allowing the enhanced binding and catalysis of a particular 
substrate [15, 17]; the formation of a ligand binding site at the interaction 
interface [18]; the channeling the metabolism of substrate to product through the 
concerted action of bound enzymes, each contributing to the overall stepwise 
progression of the reaction [19]; the modulation of activity through steric 
hindrance [20, 21], proteolytic targeting [22-24], and/or proper localization to the 
cell compartment in which the protein functions [25]. Although not an exhaustive 
list, these outcomes substantiate the importance of protein-protein interactions 
and the necessity to understand them in greater detail. 
6
 
The benefits of protein-protein interactions are loosely based on the principle of 
modularity. The assembly of various multi-component protein machines using 
parts that are often readily interchangeable and/or available in the cell allows for 
the conservation of both resources and energy. Also, the general idea of building 
a larger protein machine based on modular subunits lends benefits to the proper 
localization of the complex (diffusion of smaller parts is easier than diffusion of a 
large megacomplex), the robustness of the complex (error in encoding one 
component does not lead to total complex disruption or failure; just replace the 
offending part), and/or the ability to increase or decrease function or processivity 
by varying the complex composition [15].  
 
Protein-protein interactions play a vital role in almost every aspect of cellular 
metabolism. As follows, the identification of interacting components as well as 
researching the functional significance of the resulting complexes would provide 
enormous insights into the manifestation of disease, the identification of potential 
therapeutic targets, as well as enhancing the overall understanding of basic life 
processes. With this in mind, several strategies have been developed over the 
recent years aimed at identifying the plenitude of interacting partners associated 




• Co-immunoprecipitation (Co-IP) – Considered the gold standard assay for 
probing interacting partners, Co-IP utilizes antibodies to identify 
associated proteins. The methodology entails the antibody-based 
purification of a “bait” protein followed by the identification of co-purifying 
interacting partners via western blot. As antibodies are required for this 
technique, some preliminary knowledge regarding the existence of the 
interaction is required. Though not high-throughput, this technique is often 
used to verify potential interacting partners identified through other 
screening-type approaches (reviewed in [15]). 
 
• Fluorescence Energy Resonance Transfer (FRET) – A binary approach to 
confirming the interaction between two proteins, FRET utilizes the 
quantum transfer of light energy between two spectrally overlapping 
fluorescent molecules or proteins. In FRET, the emission wavelength of 
one excited fluorophore (attached to protein X) overlaps with the excitation 
wavelength of the second fluorophore (attached to protein Y). If X and Y 
interact, the excitation of X would translate to the emission of Y, visually 
confirming the interaction [26, 27]. 
 
• Bimolecular Fluorescence Complementation (BiFC) – Another binary 
approach to confirming protein-protein interactions, this technique is a play 
on FRET but instead is based on the assembly of a fully functional 
fluorescent protein such as green fluorescent protein (GFP) during the 
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interaction of two proteins, one tagged with the N-terminal domain of the 
fluorophore, the other with the C-terminal domain. Fluorescence can only 
occur when the two domains are close to one another, i.e. when the two 
tagged proteins interact [28]. 
 
• Yeast Two-Hybrid (Y2H) – A discovery-based method to identify binary 
protein-protein interactions. Y2H is based on the expression of a reporter 
gene if and when an interaction between two proteins occurs. In this 
technique, each protein is fused to one specific part of a transcription 
factor, a binding domain (BD) or an activating domain (AD). If the two 
proteins in question interact, the BD and AD come close enough together 
to initiate transcription of the reporter gene, confirming the interaction [29].  
 
• Tandem Affinity Purification (TAP) – A natural extension of Co-IP, TAP 
was designed specifically to be high-throughput. TAP is designed around 
two separate and independent purification events reduce non-specific, co-
purifying proteins. In this methodology, a “bait” protein is tagged with two 
affinity purification domains, separated by a TEV protease cleavage site. 
In contrast to Y2H and the other binary methodologies, TAP can 
theoretically identify both interacting proteins and interacting complexes of 
proteins, which may be of more use to systems biology [30]. 
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In contrast to the other above described techniques, TAP is not an in vitro-based 
probe of binary interactions; it is more of a brute-force co-purification of bait-
associated proteins within the confines of the natural system in which the 
proteins function, i.e. purifying human interacting proteins from human cells. This 
difference alone suggests that TAP is more consistent with systems biology 
analysis for several reasons: (i) TAP is able to sample the gamut of interacting 
partners for a particular protein in one simple experiment; (ii) both direct and 
indirect proteins can be purified, which suggests the ability to identify interacting 
complexes, many of which could provide novel functional information about the 
bait protein; and (iii) changes in the interaction profile for a given bait can be 
probed in different conditions and scenarios, providing further information 
regarding bait protein function and/or cellular response mechanisms. Although 
seemingly more powerful than the other techniques described above, not 
mentioned is the means by which co-purifying proteins are detected. Unlike the 
other techniques, there is no signal or reporter system built-in to suggest the 
existence of an interaction. 
 
The identification of co-purifying partners using the TAP strategy is contingent 
upon the technique’s output; a doubly purified eluate that contains the bait 
protein and any number of known or unknown associated proteins. This open-
endedness is both a strength and weakness. On one hand, TAP can be applied 
to any protein that is readily available to the researcher without any prior 
knowledge of the protein’s interacting partners or participation in a particular 
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complex. Thus, TAP is very much of a discovery-based technique. On the other 
hand, the resulting co-purifying proteins must be identified by some general 
methodology as targeted identification, i.e. antibody-based detection for example, 
is precluded by this same virtue. Therefore the detection of co-purifying proteins 
is often accomplished through the coupling of a separation methodology like 
1D/2D-PAGE or liquid chromatography (LC) with an analytical technology, the 
most common being mass spectrometry (MS). In fact, the developmental strides 
made in the field of biological MS, starting with the advent of electrospray and 
MALDI in the late 1980’s / early 1990’s [31-33], have permanently coupled the 
technology with the study protein mixtures. 
 
1.4: Shotgun mass spectrometry, affinity purificati on and the development 
of TAP to study protein-protein interactions. 
 
As described above, a popular strategy used in the proteomic subfield of 
interactomics involves the purification of an affinity tagged protein of interest 
(bait) along with its interacting partners. The resultant set of proteins is then 
characterized by MS. The most robust and highly developed methodology with 
regards to the MS-based identification of proteins is termed “shotgun” or bottom-
up MS. Shotgun MS is based on the proteolytic digestion of an unseparated 
mixture of proteins to peptides which are then separated by high performance 
liquid chromatography (HPLC or LC), usually via peptide hydrophobicity and/or 
charge. In the case of electrospray ionization, the LC is coupled to the MS, 
leading to the direct analysis of the LC-separated peptides by tandem mass 
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spectrometry (MS/MS) over a given time. The general idea behind MS/MS is the 
predictable, collision-induced dissociation of a peptide along the peptide bonds 
that link each amino acid residue to one another. The resultant fragment ions 
yield peptide-specific sequence information in the form of b- and y-ions, thus 
making it possible for database search algorithms to identify a particular peptide 
and, in turn, the protein(s) from which it was derived (see schema in Figure 1.2  
and MS/MS spectral analysis examples in Figures 5.3 and 6.4 ). 
 
While seemingly counterintuitive, this alternative to 1D/2D-PAGE for high-
sensitivity analysis consistently outperforms other strategies in speed, dynamic 
range, and sensitivity. The power and practicality of this strategy has been 
demonstrated extensively in the literature, and has an excellent track record in 
the large-scale, rapid, and robust analyses of proteins from complex biological 
samples [34]. Nevertheless, the coupling of single-tiered affinity purification with 
LC-MS/MS is prone to generating false-positives due, in part, to the non-specific 
binding of proteins to the bait, affinity tag, and/or resin beads used in the 
purification. In addition to issues with specificity, single-step purification 
methodologies often lead to the suboptimal enrichment of the bait protein and its 
partners over background and can lead to their escaping detection. Yet, 
improvements to MS instrumentation may yield unsatisfactory results. Although 
increased sensitivity and/or dynamic range would better detect low abundant, 
transient interactions, and may compensate for the enrichment issue identified 




Figure 1.2: Peptide tandem mass spectrometry involves the selection and accumulation of a 
parent ion (514.64 m/z) and its fragmentation by collision induced dissociation via a collision gas 
such as argon. The resultant ion fragments represent mostly b- and y-ions which can be used to 









“correctly” identifying additional non-specific interactions, leading to further 
complications during data analysis. Taken together, the limiting step in the 
successful, high-throughput detection of specific, bait-associated proteins is very 
much dependent on the purification itself.  
 
Headway into this area has been made with the introduction of the Tandem 
Affinity Purification (TAP) tag. In contrast to single-tiered purification, the TAP tag 
was designed to incorporate two separate affinity tags onto a protein of interest, 
thus dictating two separate purification events. The original TAP tag consists of 
two protein A domains and one calmodulin binding peptide domain separated by 
a tobacco etch virus (TEV) protease cleavage site [30, 35]. TAP is essentially a 
technology built around compromise, decreased yield versus increased 
enrichment. The specificity issue described above is generally a product of the 
purification conditions. Stringent buffers, which are the mainstay in general 
protein purification, are not recommended for protein complex determination as 
many loosely bound or transient partners will be lost. However, decreasing the 
stringency of purification negatively impacts the purity of the captured complex. 
This disparity is partially addressed by TAP, which allows for the isolation of a 
decently pure complex in close-to-native conditions.  
 
The decrease in sample complexity due to a reduction in non-specific 
interactions is accomplished via the two separate and independent purification 
events, the first of which is facilitated by TEV-based proteolytic cleavage. This is 
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essentially an elution step specific to the tagged bait protein containing the 
cleavage site. In contrast to most elution buffers, only those bound species with 
the specific protease recognition site should be liberated from the beads, leaving 
behind much of the non-specifically bound contamination (see Figure 1.3 ). This 
feature is key to the TAP strategy. Not only does it allow for the native elution of 
tightly bound, affinity captured bait proteins, i.e. ProA-IgG [35], it also reduces the 
elution of non-specific proteins. The latter note is especially relevant considering 
the development of TAP-based systems that utilize other affinity tags. For 
example, the purification of His-tagged proteins is notorious for capturing other 
proteins with naturally occurring stretches of histidine, as occurs often in 
eukaryotic systems [36]. With the standard imidazole-based elution buffer, these 
natural but non-specific components would elute along with the bait protein. This 
would not occur with TEV-based elution. Whatever the case, this reduction in 
non-specific proteins that would otherwise move on to the second purification 
essentially enriches the bait and its associated proteins, allowing for their 
improved detection. Interestingly, the overall reduction in sample contamination 
would also indirectly benefit the MS/MS analysis as well. As there are less 
contaminating proteins entering the MS at any given time, the instrument would 
essentially spend more of its resources analyzing peptide ions that are relevant 
to the bait protein. Assuming optimal separation, the identification of transient 
interacting proteins thus becomes more probable as the instrument is able to dig 
deeper into the spectrum of parent ions (dynamic range) instead of wasting 






Figure 1.3: Tandem affinity purification. The general idea behind TAP is the general reduction in 
non-specific contaminants (C) with a concomitant enrichment of the tagged bait protein (blue). 
There are two separate purification events with a mid purification elution using TEV protease. 
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1.5: The application of TAP to mammalian systems  
The TAP method was originally developed in yeast and has best 
demonstrated its utility in the systematic identification of numerous multiprotein 
complexes in the yeast interactome [37]. In addition, there are over 40 papers 
describing the technique’s successful application to other yeast strains. However, 
the use of TAP to examine the protein complexes and networks of higher 
eukaryotes is not as straightforward. Although several groups have had success 
in applying it to their system, D. melanogaster [38, 39] and mammalian cell 
culture [40-45], the TAP method affords more luxuries to and is easier to 
implement in yeast. For example, the ease in which yeast undergo homologous 
recombination can be exploited to easily replace an endogenous version of a 
gene with its TAP-tagged counterpart. This is a huge advantage over other 
systems as expression of the tagged bait protein is essentially regulated by the 
endogenous promoter, leading to true physiological expression. Additionally, 
competition between endogenous and exogenous versions of the bait protein is 
eliminated. In higher eukaryotes, homologous recombination gives way to 
transient or stable transfection, which, without tedious optimization, often leads to 
exogenous overexpression of the tagged bait protein. This can lead to the 
formation of non-physiological complexes that co-purify and complicate the 
analysis. In addition, without knocking out or knocking down the endogenous 
version of the bait protein, there would be competition for complex components, 
effectively perturbing stoichiometric ratios and reducing the number of interacting 
proteins available for subsequent capture and identification. One final advantage 
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of yeast-based TAP is the ability to grow bait-expressing cells in bulk, which 
makes up for the relatively low yield (~40%) of the tagged bait protein after two 
successive rounds of purification [35]. This feat is not so easily accomplished 
with eukaryotic cells and is an especially pressing issue for certain cell types that 
are not amenable to bulk growth or suspension culture, i.e. primary or monolayer 
specific cells.  
 
In order to adapt the TAP technique for successful use in mammalian cell lines, 
several groups have modified Rigaut’s original tag or methodology to enhance 
TAP’s compatibility to more complicated systems. The modifications range from 
creating affinity tag combinations that are more “mammalian friendly” [46-48], 
increasing the pull down efficiency and yield [49], stabilizing tagged bait protein 
expression at or close to endogenous levels [46] or reducing endogenous 
competition, and subsequently increasing interacting protein yield, through the 




 The elucidation of protein-protein interactions is one of the current goals of 
systems biology. Many methodologies exist to probe protein-protein interactions. 
One of the most successful strategies entails the use of tandem affinity 
purification coupled with LC-MS/MS. Through the double purification of a bait 
protein of interest and the subsequent identification of its co-purifying partners by 
mass spectrometry, detailed interacting protein networks can be constructed. As 
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virtually all cellular processes are regulated by the interactions between proteins, 
a better understanding of which proteins interact and when would benefit both 
basic and applied biological research.  
 
The ensuing chapters describe the development of a novel dual-tag affinity 
purification system that addresses several of the issues relevant to applying 
TAP-based strategies to mammalian cell lines. This system, once validated, was 
applied to garner information about the protein network surrounding the human 
telomere through the dual-tag affinity purification of three telomere binding 
proteins: TRF1, TRF2, and POT1. Although several interesting candidate 
interactions were identified for all three proteins, further focus was placed on 
TRF2; specifically, the identification of novel sites of phosphorylation and the 












Introduction to the Human Telomere 
 
2.1: Functional Significance of the Telomere 
Most linear eukaryotic chromosome ends terminate in a 
proteinaceous/DNA structure called the telomere. Telomeres are composed of 
both repetitive DNA sequences, i.e. (TTAGGG)n in humans, and proteins that 
bind to and/or act upon these tandem-repeat sequences (Figure 2.1a ). The first 
pieces of evidence that suggested the existence of the telomere in eukaryotic 
organisms were provided synonymously by McClintock and Muller. McClintock 
made the observation that although normal chromosome ends (the telomere) 
should theoretically resemble the ends resulting from intrachromosomal breaks, 
they do not behave similarly in that they do not fuse together with other available 
broken chromosomes. Muller, on the other hand, provided corroborating data in 
his inability to obtain chromosomal terminal deletion mutants, which suggested 
an important protective mechanism for this region of DNA (as reviewed in [50]). 
Further work by McClintock on the importance of the telomere showed that 
inappropriate fusion of chromosomes lead to abnormalities in chromosome 
segregation due to the existence of two centromeres on the fusion. As the 
centromere is essentially the anchor point for chromatid separation via 
microtubules during mitosis (anaphase), a chromosome with two or more 




Figure 2.1: The human telomere, structure and function. (A) A diagram depicting the physical 
structure of the human telomere which exists at the end of each linear chromosome. The 3’ 
overhang, a result of the “end replication problem” loops back on itself and invades the duplex 
telomeric DNA forming a cap like structure. (B) A schematic depicting the semi-conservative DNA 
replication and the mechanism behind the formation of the 3’ overhang; the end replication 
























This shearing creates a new chromosomal break point and leads to an uneven 
genetic distribution (via fragmented chromosomes) into the resultant daughter 
cells, both of which lead to an increase genomic instability (as reviewed in [50]). 
 
Recent work studying the importance of the telomere has shed more light onto its 
important function of helping to maintain overall genomic stability. As the 
telomere theoretically resembles the break point of a normally occurring double 
strand break, there must have been enormous evolutionary pressure to devise a 
system in which naturally occurring chromosome ends do not elicit a similar 
cellular response mechanism, which can involve erroneous repair of the non-
broken DNA and/or senescence or apoptosis of the offending cell. Rightly so, the 
specialized proteinaceous/DNA complex of the telomere does in fact shield the 
region from being recognized as damaged DNA, both subverting the DNA 
damage response and preventing excessive loss of generic material via 
nonspecific nucleolytic attack that could occur if the ends were not protected (as 
reviewed in [50]). 
 
Aside from the DNA damage response cloaking aspect of the telomere, one of its 
most important functions is to provide a buffered region of non-coding DNA that 
obviates the loss of viable genetic information upon every passage of the cell 
cycle. This loss of genetic material, which is inherent to the replication of linear 
chromosomes, is aptly coined the “end replication problem”. During S-phase, 
chromosomal DNA is replicated in a semi-conservative fashion by DNA 
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polymerase in only the 5’ 3’ direction. This directional limitation creates two 
different mechanisms by which DNA is copied, leading strand synthesis and 
lagging strand synthesis. In the former mechanism, the DNA polymerase has no 
trouble replicating DNA, effortlessly following the replication fork until the very 
end of the chromosome. The latter mechanism, however, generates the “end 
replication problem” [51] (Figure 2.1b ). In lagging strand synthesis, RNA primers 
must first bind to the newly accessible DNA (via fork progression) before 
synthesis by DNA polymerase in the reverse direction (relative to the replication 
fork) can occur. However, once the polymerase reaches a previously synthesized 
region, it disengages, leaving behind the characteristic Okazaki fragments 
specific to lagging strand replication [9]. For all internal fragments, DNA 
polymerase and ligase convert the RNA to DNA and seal the gaps. However, 
there is a problem with the last RNA primer (binding to the terminal 3’ end of the 
mother strand); it cannot be converted to DNA as the polymerase has no where 
to bind downstream [51]. Thus, the RNA primer gets degraded and a section of 
the telomere is lost, leaving behind the characteristic 3’ single stranded 
overhang. As mentioned above, this loss of genetic material occurs upon every 
cell division. Therefore, by providing a buffered region of non-coding DNA that 
can be progressively lost without much consequence, the telomere allows the 





2.2: Telomere Extension via Telomerase 
In somatic cells, the progressive shortening of the telomere via both the 
“end replication problem” and nucleolytic degradation [52] dictates the replicative 
lifespan of that specific cell type. As telomere attrition eventually reaches a level 
where they are critically short, these cells usually undergo an unresolvable DNA 
damage response that leads to cellular senescence [53]. However, several cell 
types such as stem cells, germ cells, and other cells that divide frequently, i.e. 
immune cells, require that their telomere length is fully maintained. The 
lengthening of eukaryotic chromosomes is accomplished through telomerase, a 
ribonucleoprotein complex that functions primarily as a reverse transcriptase, 
making DNA from an RNA template. The primary target of telomerase is the 3’ g-
rich overhang. Utilizing the attached RNA moiety as a 3’  5’ template, the 
complex synthesizes nucleotides in the 5’  3’ direction, extending the 3’ 
overhang [54-56]. Synthesis of the complementary strand of DNA is thought to 
occur via lagging strand synthesis by the DNA replication machinery. The actions 
of both telomerase and DNA polymerase thus increase the length of the tandem 
repeat telomeric DNA tract providing a larger binding area for specific telomere 
binding proteins and the protective telosome complex (see below) [50]. As 
mentioned above, telomerase’s main function is to address the progressive loss 
of DNA after each cell cycle. Telomerase appeared early in eukaryotic evolution 
as a strategy to deal with the problems associated with linear DNA [57-60]. Thus, 




The core components of the telomerase enzyme are the protein telomerase 
reverse transcriptase (TERT) and the telomerase RNA component (TERC). The 
quaternary structure of the human holoenzyme suggests the inclusion of two 
copies each of TERT and TERC, though it is still unclear whether this 
dimerization is required for functionality [50]. The general mechanism of telomere 
elongation by telomerase is shown in Figure 2.2 . Once granted access to the 
DNA (see “telosome” below), the distal few nucleotides of the 3’ overhang bind 
the complementary bases in the TERC-derived RNA template. The TERT 
component of the enzyme then adds dNTPs specified by the remaining bases in 
the template. Once complete, the extended 3’ overhang is released by 
telomerase and is either extended again or converted to double strand DNA via 
primase and DNA polymerase [50]. 
  
A functional telomere requires a minimal length of tandem repeat sequence in 
order to effectively cap the telomere (described below). Therefore, in cells that 
utilize telomerase, there is an intricate homeostasis employed which maintains 
telomere length within the limits dictated for that particular cell type, preventing 
both the formation of critically short or over-extended telomeres [62]. In fact, 
telomerase function is not clockwork in that it is not a basic routine linked to 
cellular events such as the cell cycle. It more so functions independently, 
lengthening the telomere on an as needed basis [63]. This homeostasis implies a 
degree of regulation imparted upon telomerase by the telomere. This signal is 
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Figure 2.2: The lengthening of the 3’ G-rich overhang by telomerase in human cells. The 
telomerase holoenzyme utilizes a reverse transcriptase (TERT) and a RNA molecule (TERC) that 
provides the template for RNA  DNA polymerization. Once the 3’ end has been lengthened by 
telomerase, DNA polymerase and primase are able to synthesize more double stranded telomere 
DNA via lagging strand synthesis. Image courtesy of Blackburn and Seidel. 2006. “Telomere 


















thought to be conveyed through the actions and components of the telosome 
complex [50].  
 
2.3: Safeguarding the Telomere: the Telosome 
 Lining the telomeric tract is a six-member complex called the telosome or 
shelterin. The telosome is composed of three DNA binding proteins: telomere 
repeat binding factors 1 and 2 (TRF1 and TRF2 respectively) and protection of 
telomeres 1 (POT1), and three other accessory / linking proteins, repressor / 
activator protein (RAP1), TRF interacting protein 2 (TIN2), and POT1 and TIN2 
organizing protein / adrenocortical dysplasia homolog (TPP1) [64]. The general 
assembly of the telosome is depicted in Figure 2.3 and described below [65]. 
TRF1 and TRF2 bind to duplex telomeric DNA and function to anchor the 
telosome along the tandem TTAGGGn repeats [66-69]. Both telomere-binding 
proteins are linked by and able to recruit TIN2, which links POT1 to the complex 
through TPP1 [70-74]. Interestingly, POT1 localizes to both the single strand 
DNA overhang, binding the DNA directly, and also to the telosome complex 
through its association with both TPP1 and TRF2 [74, 75]. RAP1, a telomere 
repeat binding factor ortholog, interacts directly through TRF2 [76]. Telosome-like 
complexes and protein components are also found in other organisms, including 
yeast, demonstrating the importance of telomere protection and regulation by 
specific proteins. For example, POT1-like proteins have been identified in nearly 
all eukaryotes while TRF-like proteins, including RAP1, have been found in both 











Figure 2.3: The Telosome. Top panel shows the domain structure of each participating member 
as well as the connectivity of the complex. Bottom panel demonstrates the proposed architecture 
of the complex when bound to telomeric DNA. Image courtesy of de Lange T. 2005. Shelterin: the 













The major function of the mammalian telosome, as well as the telosome-like 
structures in lower eukaryotes, is to essentially prevent telomere DNA access by 
other proteins such as those involved in DNA damage surveillance and repair 
and even telomerase. In fact, the negative regulation of telomerase by the 
telosome is one of the complex’s most important functions. This negative 
regulation is brought upon by several of the components of the telosome, mainly 
those that bind the telomere DNA directly, TRF1, TRF2, and POT1 (reviewed in 
[64, 65]). Interestingly, the negative regulation imposed by the telosome seems 
to be dependent on telomere length. It has been shown previously that longer 
telomeres generate a stronger inhibitory effect on telomerase [77]. As follows, 
telosome loading on the telomere is also dependent on tract length where the 
shorter the telomere, the less area the telosome has to bind. This progressive 
decrease in the amount of telosome loaded on the telomere leads to a relaxation 
of telomerase inhibition and, subsequently, telomerase-dependent telomere 
elongation [65].  
 
Regarding the human telomere, the major telosome component thought to be 
responsible for this inhibition is POT1 [73, 78]. Several studies have 
demonstrated that POT1’s association with the single stranded 3’ overhang 
precludes telomerase access to the telomere. This has been shown in 
overexpression studies with POT1-DNA binding mutants that demonstrated an 
increase in telomere elongation [78] as well as in vitro studies where POT1 
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loading onto telomere-mimicking oligonucleotides prevented telomerase binding 
[79, 80]. Although POT1 may be the major inhibitory factor, other evidence 
linking TRF1, TRF2, TRF telomere-binding stability through TIN2, and RAP1 to 
telomerase regulation suggests added levels of telomerase suppression. These 
observations suggest that, on top of POT1’s direct inhibition, perhaps the 
association of accessory factors with the other telosome components and/or their 
involvement in t-loop formation. 
 
T-loops, or telomeric loops, are phenomena that occurs at the ends of linear 
chromosomes to protect the free 3’ telomeric overhang from DNA processing 
mechanisms. Very simply, the 3’ G-rich overhang folds back on itself and invades 
the upstream duplex telomeric DNA, base pairing with 3’  5’ strand while locally 
displacing the 5’  3’ strand (displacement loop or d-loop; see Figure 2.1a  
bottom panel). T-loop size appears to be variable and dependent on the size of 
the local telomeric tract. As follows, t-loops as large as 25 kb and as small as 1 
kb have been observed in human cells [64]. The discovery of t-loops was the 
result of an electron microscopy-based investigation of telomeric DNA. In the 
initial in vitro studies, it was found that the only substrates required for t-loop 
formation were telomere-mimicking oligonucleotides with 3’ overhangs and the 
telomere binding protein TRF2. TRF2 was discovered to substantially enhance t-
loop formations and localize to the base of the loop, perhaps directing strand 
invasion. These observations were corroborated in vivo with telomeric DNA that 
had been extracted from live cells [81, 82]. T-loop formation by TRF2 alone, 
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however, is not remarkably efficient and probably requires the help of accessory 
factors [64]. Interestingly, several telosome components have been shown to 
associate with proteins involved in HR-based DNA repair which, conceivably, 
could aid TRF2 in this effort [64, 83]. Interestingly, other telosome components 
have been implicated in t-loop formation. TRF1, for example, is able to loop and 
bend telomeric tandem repeats in vitro and TIN2 seems to be able to enhance 
this ability [84-86]. Perhaps all of these factors, TRF2, HR-based accessory 
proteins, and TRF1, work in concert to direct t-loop formation in vivo.  
 
In addition to the negative regulation of telomerase, the telosome has also been 
implicated in the protection of the telomere from components of the DNA damage 
response. As mentioned above, the telomere suspiciously resembles broken 
DNA. It has been shown that telomeres that stripped of their protective telosomes 
trigger a DNA damage response that often results in the erroneous repair via 
homologous recombination (HR) or non-homologous end joining mechanisms 
(NHEJ). This observation is true regardless of the eukaryotic species, from yeast 
to human [65]. This situation is also relevant to telomeres that are or become 
critically short through natural means such as aging; a DNA damage response is 
triggered and the cells either senesce or die [64, 87]. Regarding mammals, the 
major contributor to this telosome-based shielding from the cellular DNA damage 
response is TRF2. TRF2 is able to suppress both HR and NHEJ as evident by 
both an increase in telomere sister chromatid exchange (via HR) in the absence 
of TRF2 [88] and a substantial increase in chromosome end-to-end fusions (via 
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NHEJ) in TRF2 knockout cells or with cells expressing a dominant-negative 
version of the telomere binding protein [89, 90]. Accordingly, the loss or 
repression of TRF2 induces that ATM-dependent DNA damage response, 
involving p53-dependent cell cycle arrest [89, 91] as well as the localization of 
several DSB response factors to the telomere, including γH2AX, 53BP1, 
Mre11/Rad50/NBS1, and phosphorylated ATM; together, these collectively form 
a telomere-dysfunction induced foci (TIF) [92]. 
 
This necessary repression of the DNA damage response at the telomere by 
TRF2 is thought to be through its propensity to direct t-loop formation, creating a 
capped DNA structure that prevents telomeric recognition as damaged DNA [81, 
88]. However, this observation does not preclude the importance of other 
telosome or telosome-associate factors in fending off an erroneous damage 
response. It has been previously shown that loss of the t-loop by itself does not 
immediately induce chromosome end-to-end fusions [93]. Also, the formation of 
TIF were evident upon the inhibition of TIN2 or POT1 as well [86, 94]. Whatever 
the case, there is little debate regarding the importance of the telosome in the 
protection and overall length regulation of telomeric DNA.  
 
2.4: Telomere Replication in Mammals 
There are examples of a telomere / telomerase based replication origin in 
ciliates and some yeast, mostly brought upon by the observation that primase 
binds to the telomeres. For mammals however, there is little information 
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regarding telomeric replication. Like ciliates, there are suggestions that the 
mammalian telomere can in fact serve as a replication origin. For example, TRF2 
has been linked to replication initiation by directly recruiting the origin recognition 
complex to the telomere [95]. This is especially relevant considering both a 
recent report [96] suggesting TRF2's ability to unwind the double helix and 
TRF2's known interacting partners such as helicases. In fact, One of TRF2's 
major functions is to facilitate protective cap formation at the telomere via its 
ability to direct d-loop formation [96, 97] and strand invasion. The formation of 
this displacement loop may in fact act as a single stranded RNA priming site for 
general DNA synthesis. 
 
There seems to be conflicting data concerning exactly when telomeres are 
replicated in human cells. Although several older studies have shown that 
telomere replication occurs arbitrarily throughout S-phase [98-100], a recent 
analysis observing BrdU incorporation rates suggested that the replication of 
telomeres occurs in two spurts, one in late S, the other in G2/M [97]. This data 
corroborates another study which used FISH to observe replication of 
subtelomeric DNA in late S phase while also fitting quite nicely with telomeric 
replication timing in yeast which also occurs in late S [101]. 
 
Although this protective t-loop structure at the telomere may be beneficial for 
prevent erroneous DDR, problems may arise when replication forks enter this 
relatively abnormal structured region. Supporting this logical deduction are 
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several recent studies in both yeast and human cell systems that show stalled 
replication forks in the telomeric region [97, 102-104]. As the telomeres are the 
distal most regions of the chromosomes, natural resolution of the stalled fork via 
another fork approaching in the opposite direction is not possible. This stalled 
fork can induce a transient ATM/ATR-dependent DNA damage response at the 
telomere during the DNA replication phase of the cell cycle [102]. However, as 
telomeric replication does in fact occur in normal dividing cells without much 
consequence, nature must have devised a way to deal with this somewhat 
specialized region. A recent report in fission yeast found that telomere binding 
proteins play an important role in the replication of telomeric DNA. When Taz1, a 
telomere binding protein and ortholog of mammalian telomere binding proteins 
TRF1 and TRF2 [67-69], was mutated, replication fork progression through the 
telomeric region was impeded, leading to substantial loss of telomeric DNA [104]. 
This data suggests that perhaps telomere binding proteins, in addition to 
protecting the telomere from being recognized as damaged DNA, may also 
regulate replication fork progression through this structurally difficult region and 
ensure that replication proceeds without consequence to genomic stability [105]. 
 
The question remains, however, as to how exactly these telomere binding 
proteins contribute to the replication of this sterically hindered region of DNA. 
When considering the telomeric structure and the general mechanism of DNA 
synthesis, the progression of the replication fork towards the t-loop is thought to 
induce a large amount of local helical stress resulting in positive supercoiling of 
34
the DNA. Normally topoisomerases, enzymes involved in relieving superhelical 
stress by nicking one or both strands of double stranded DNA [106], would 
address this accumulation of stress [105]. However, the t-loop is essentially a 
structural anomaly that may preclude topoisomerase activity at the telomere. 
Curiously, TRF2 is both able to induce and bind positive supercoils [96]. This 
may lead to a build up of TRF2 at the interface between the replication fork and 
the t-loop G-rich strand invasion point. As TRF2 is vital for replication fork 
progression through this region, its increased concentration may be important for 
t-loop disassembly [105]. Interestingly, two RecQ ATP-dependent DNA helicases 
named Werner Syndrome protein (WRN) and Bloom's Syndrome protein (BLM) 
are known to associate with TRF2 and the telomere in general [107-109]. Both 
proteins are linked to genomic instability with Werner Syndrome mainly 
characterized by premature aging due to accelerated telomere loss and thus 
reduced proliferative capacity of somatic cells and Bloom Syndrome by a 
increased frequency of chromosomal breakage and rearrangement leading to a 
high risk of cancer amongst other pronounced abnormalities [110-112]. 
 
Several lines of evidence point to the importance of RecQ helicases such as 
WRN and BLM in the replication of telomeric DNA. Helicases are specialized 
enzymes that are involved with the unwinding of duplex DNA while RecQ 
helicases represent a family of conserved helicases that, when mutated, cause a 
hereditary predisposition to cancer. It has been suggested that WRN is the 
principle helicase involved in the removal of the secondary structure at the 
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telomere, due to both its localization to the telomere in S-phase and the observed 
loss of telomeric DNA / increased incidence of genomic instability through 
chromosomal fusion when WRN is mutated [113-115]. Although, it is plausible 
that other unknown/unidentified helicases are also involved, the sheer fact that it 
associates with TRF2, a potential sensor/mediator of topological stress (as 
described above), strengthens its connection to t-loop unwinding and thus the 
reinitiation of DNA replication at the telomere. In fact, it has been shown that 
these helicases are able to remove D-loops, the displacement loop that results 
from G-rich strand invasion, in vitro [116].  
 
Following the successful resolution of the stalled replication for and completion of 
DNA synthesis, the telomeres generated from leading strand synthesis are 
further processed in order to generate the signature G-rich 3’ overhang. 
Theoretically, this could be accomplished by two separate processes, one that 
involves extension of the 3’ tail by the telomerase enzyme or another that 
involves resection of the completely synthesized (via leading strand synthesis) 5’ 
end. However, as telomerase is not required for the proper formation of the 3’ 
overhang, the 5’ resection pathway is hypothesized to be the actual means by 
which the overhang is generated [105, 117, 118]. Supporting this suggestion is 
the fact that human cells activate an ATM-dependent DNA damage response 
following successful replication of telomeric DNA and it is this activation that 
generates the G-rich 3’ tail [97, 119]. As the ATM-dependent damage response 
is intimately linked to normal genomic double strand break repair, which by itself 
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elicits the use of DNA resection via exonucleases [120], it seems even more 
likely that 3’ overhang formation on the leading strand synthesized telomere is a 
function of resection rather than elongation. 
 
Although the 3’ overhang formation on the leading strand generated telomere is 
most likely a product of 5’ resection / exonuclease activity, what about the 
telomere generated by lagging strand synthesis? Based on both observations of 
the general mechanism of lagging strand synthesis and on in vitro studies [121] 
of reconstituted DNA replication, it is hypothesized that the process by which 
lagging strand synthesis occurs, i.e. the generation of Okazaki fragments, is 
enough to generate the overhang. The general idea is that lagging strand 
synthesis is no longer able to occur once the leading strand has been fully 
replicated [105], i.e. the polymerase / replicative complex reaches the end of the 
telomeric DNA (5’ C-rich strand). As the lag time between the synthesis of both 
strands is thought to be around 200 nucleotides in eukaryotes [122], completion 
of the leading strand would lead to an overhang of roughly 200 nucleotides on 
the 3’ end of the telomere processed by lagging strand synthesis. Interestingly, 
this is roughly the length of the observed overhang in human cells [105, 123, 
124].  
 
After the successful generation of the 3’ G-rich overhang in both the leading and 
lagging daughter strands, the hallmark capped structure of the telomere reforms. 
This process, as described in detail above, involves the invasion of the 3’ 
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overhang back into the double stranded region of the telomere. As the telomere 
is composed of a tandem repeat sequence (TTAGGGn), the invading 3’ G-rich 
strand is able to compete for and bind to the tandem repeat sequence of the 
opposing C-rich strand in the double stranded region of the telomere, completely 
displacing a portion of the upstream G-rich strand and creating the characteristic 
displacement (d-loop) and telomeric (t-loop) loops described above. This process 
is thought to be directed by TRF2, POT1 and other accessory factors which, 
interestingly enough belong to the homologous recombination pathway of DNA 
double strand break repair [81, 96, 97, 105]. This makes perfect sense as the 
process of homologous recombination involves an exchange of material between 
two homologous, aligned stretches of DNA via invasion of a single strand of one 
sequence into a double stranded region of complementary sequence in the other 
stretch of DNA [9]. 
 
2.5 Summary 
Telomere integrity in cells thus plays an essential role in the control of 
genomic stability. Loss of genetic material at chromosome ends (“telomere 
shortening”) is often observed in older individuals, cellular senescence, and 
premature aging syndromes [125, 126]. Furthermore, telomere dysfunction 
contributes to overall genomic instability that leads to cell death, defects in cell 
proliferation, and malignant transformation, all of which could contribute to a 
higher incidence of cancer during aging and age related-disorders [127-129]. 
Accumulating evidence suggests that telomere integrity depends on the ability to 
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maintain telomere length and/or the ability to mask the telomeres from DNA 
damage surveillance mechanisms. Telomere-binding or associated proteins, 
such as telomerase and the telosome/shelterin complex, play essential roles in 
telomere length maintenance or telomere protection [130, 131]. Although key 
components in telomerase and other telomeric proteins have been identified, a 
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3.1: Introduction  
One popular method to elucidate protein-protein interactions involves the 
native co-purification of an affinity tagged protein and its interacting partners, 
which are subsequently identified through mass spectrometry (MS) [132]. 
Although straightforward, reproducible, and broadly employed, this strategy is 
hampered by the efficacy of protein recoveries both in terms of sensitivity and 
specificity. This is especially pertinent to methodologies that employ a single-step 
of purification, where suboptimal enrichment of the bait protein and its partners 
over background can lead to masking of their signals. Although improvements to 
MS instrumentation generally increase peptide detection sensitivities, the 
problem of specificity, i.e. distinguishing specific from non-specific interacting 
proteins, remains. Thus ultimately, the limiting factor in the identification of 
specific interacting proteins lies with the purification itself.  
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An effort to resolve this specificity issue has been made with the introduction of 
the Tandem Affinity Purification (TAP) tag. This construct consists of an IgG-
binding domain and calmodulin binding peptide domain separated by a tobacco 
etch virus (TEV) protease cleavage site [35]. The TAP method was originally 
developed in yeast and has best demonstrated its utility in the systematic 
identification of numerous multiprotein complexes in the yeast proteome [37]. 
Although modifications to the original TAP have been successful in examining 
the protein networks of mammalian cells [37, 41, 45, 49, 133], the strategy offers 
a relatively low yield of bait and specific interacting proteins [134], and the 
success rate usually varies on a case-by-case basis. However, problems remain 
that are inherent to any protein tagging strategy: variable exposure of the affinity 
tag, disruption of the bait protein’s ability to fold properly, steric exclusion of 
interacting partners, and ectopic overexpression of the fusion protein, which can 
lead to complications in both the purification and identification of true interactions. 
In this study, we describe an all-in-one dual-tagging system that not only 
enhances bait protein recovery, but also allows for rapid evaluation of dual-tag 
compatibility with a protein of interest based on its known subcellular localization. 
 
3.2: Materials and Methods 
Construction of Dual-affinity Tag Vector  
To assemble the HtS (6His-2tev-2StrepII-CCPGCC) tag element, we 
annealed the HtS sense and antisense oligonucleotides (oligos) followed by PCR 
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amplification with HtS forward and reverse primers. To generate the tetracycline-
inducible p31-N-HtS vector (YW547), the PCR product was digested with 
BbsI/XhoI and ligated into the BbsI/XhoI sites of pTRex-DEST31 (Invitrogen) in 
place of the 6xHis tag. The same strategy was used to create p40-C-StH 
(YW542) vector with StH (CCPGCC-2StrepII-2tev-6His) tag, except that the PCR 
product was digested with BstBI/EcoRV and cloned into BstBI/PmeI sites of 
pDEST40 (Invitrogen) in place of the V5-6xHIS tags. For the assembly of the StP 
(CCPGCC-2StrepII-2tev-2ProA) element, we first generated the center portion of 
the tag by annealing the StP sense and antisense oligos. We then used the 
annealed oligo as a template to obtain a full-length StP element by three rounds 
of PCR amplification with 3 pairs of StP forward and reverse primers. To create 
the p40-C-StP (YW539) vector, the PCR product was digested with BstBI/EcoRV 
and ligated into BstBI/PmeI sites of pDEST40. The same cloning strategy was 
used to create the p31-N-PtS (YW548) vector except that the PCR product was 
digested with BbsI/XhoI, and ligated into the BbsI/XhoI site of pTREx-DEST31 in 
place of the 6xHis tag. To create p40-C-HAtP vector carrying 3HA-2tev-2ProA 
tag, the CCPGCC-StrepII sequences of p40-C-StP was removed by 
BstB1/HindIII and subsequently filled with Klenow and swapped with HA tag 
derived from pcDNA3-HA by blunt ligation. Sequences of the annealing oligos 
and primers used for the dual-affinity tag constructions will be provided upon 
request. Refer to Figure 1A for sequence details. 
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Human TRF2 open reading frame cDNA was amplified by PCR from a pcDNA-
flag-hTRF2 vector with primers specific for the TRF2 coding sequence, flanked 
by either attB1 or attB2 sequences (Gateway-compatible), as previously 




3’. The PCR products were cloned into the Gateway pDONR221 donor vector 
(Invitrogen) through the BP reaction [136] and were compatible for both N'- and 
C'-tagging. To create TRF2 dual affinity tag constructs, TRF2 was subsequently 
transferred from pDONR221-TRF2 into our newly constructed Gateway-
compatible destination vectors (p31-N-HtS, p31-N-PtS, p40-C-StP, p40-C-StH 
and p40-C-HAtP) via an LR reaction as described by the manufacturer. His-
tagged TRF2 bacterial expression vector was created through LR recombination 
between pDONR221-TRF2 and pDEST17 (Invitrogen). 
 
Cell Lines and Transfection 
For transient expression and bait-complex purification, dual-tag TRF2 
fusion constructs (Figure 3.1a ) were transfected into HEK293T cells (ATCC) 
using Lipofectamine PLUS (Invitrogen) or FuGENE 6 (Roche) following the 
manufactures’ protocols. To establish stable cell lines carrying tetracycline-
regulatable N-HtS-TRF2, HEK293T cells were first transfected with 






















Figure 3.1: Features and validation of the dual-tags. (A) Schematics of dual-tags, their relative 
positions in TRF2 fusions, and their amino acid sequence. C, C’-terminal; N, N’-terminal; 
CCPGCC, a tetracysteine motif; S, Strep-Tactin binding peptides (StrepII tag); t, tobacco etch 
virus (TEV) protease cleavage site; P, IgG binding domain of protein A from Staphylococcus 
aureus (ProA tag); H, 6x histidine (His tag); HA, influenza hemagglutin epitope (HA tag). Colors: 
Yellow = tetracysteine motif; Orange = StrepII tag; Purple = ProA tag; Red = TEV cleavage site; 
Blue = His tag; Green = HA tag. (B) Western blot (anti-TRF2) depicting the expression and 
anticipated size of representative fusions 24 h after transfection of respective TRF2 fusion 
constructs into 293T cells. (C) Modulation of fusion protein expression via the Tet-regulatable 
promoter, visualized by western blot (anti-Strep tag, anti-alpha-tubulin). (D) Colocalization of 
transfected TRF2-C-StH with telomeres in U2OS cells after fixation. TRF2-C-StH (green, Lumio), 
telomeres (red, telomeric FISH), DNA (blue, DAPI), and colocalization (yellow, merged panel). (E) 
Live cell image of TRF2-C-StH punctate staining on telomeres revealed by Lumio. (F) Lumio 










with 5 µg/ml Blasticidin-S (Invitrogen). Antibiotic-resistant clones were then 
transfected with the dual-tag construct (N-HtS-TRF2) and pBabe-puro (a kind gift 
from Dr. Gerard Evans), and stable clones were established with further selection 
(3 µg/ml puromycin, 800 µg/ml G418 and 5 µg/ml Blasticidin). Before dual-tag 
purification, N-HtS-TRF2 stable clones were induced with 3 µg/ml tetracycline for 
24-hrs and harvested. For TRF2-C-StH / telomere colocalization experiments 
(Figure 3.1d ), U2OS cells (ATCC) were grown on coverslips to ~30% 
confluency, transfected with TRF2-C-StH by FuGENE 6 (Roche), incubated for 
24 hr, and stained as described below. 
 
Cell Lysis 
Total protein extract was obtained by one of three lysis procedures: 
freeze/thaw-based whole cell lysis (WCL), detergent-based WCL, or nuclear lysis 
(NL); the former of which provides a more concentrated whole cell lysate that 
improves bait capture efficiency. The details for each lysis protocol are as 
follows:  
 
Freeze/thaw WCL. As previously described [137, 138] but modified. Cells were 
pelleted at 200 g and the packed-cell volume (PCV) was noted.  Cells were 
resuspended in 2x PCV of BF3-HisFT (50 mM Tris, 150 mM NaCl, 50 mM 
NaH2PO4, 10 mM Imidazole, 0.1% NP-40, 10% glycerol, pH 8.0, with fresh ß-
mercaptoethanol (10 mM), Roche protease inhibitor cocktail, and 50 µg/ml 
Avidin). Cells were incubated on ice for 10 min, subjected to three freeze/thaw 
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cycles using dry ice/ethanol and 4°C water baths, a nd passed through a 25-
gauge needle between cycles. Lysate was then centrifuged at 21000 g for 30 
min. Supernatant was subsequently placed atop beads specific to the first 
purification (see below). 
 
Detergent-based WCL. Buffer 3 (BF3: 50 mM Tris, 150 mM NaCl, 0.1% NP-40, 1 
mM dithiothreitol (DTT), protease inhibitor cocktail, adjusted to pH 8.0) or BF3-
His (same as above plus 50 mM NaH2PO4, 20 mM Imidazole and 10 mM ß-
mercaptoethanol instead of DTT) was added to the cell pellet (0.5-1 ml per 10 
cm2 plate of 293T cells) and incubated on ice for 30 min. Lysate was then passed 
through a 25-gauge syringe and centrifuged at 4000 g for 5 min. Supernatant 
was transferred to microfuge tubes and centrifuged at 21000 g for 30 min. 
Supernatant was then placed atop beads specific to the first purification (see 
below). 
 
Nuclear Lysis (NL). Two volumes of Buffer A (10 mM HEPES pH 7.9, 10 mM 
KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, a Complete/Mini Protease 
Inhibitor tablet [Roche]) were added to the cell pellet and incubated on ice for 15 
min. Solution was adjusted to 0.6% NP-40, vortexed briefly, and immediately 
centrifuged at 4000 g for 45 s. The supernatant (cytoplasmic fraction) was 
removed and 1 ml of buffer C-His (20 mM HEPES pH 7.9, 400 mM NaCl, 20 mM 
Imidazole, 1 mM DTT, Complete Protease Inhibitor Cocktail) or buffer C (buffer 
C-His minus the imidazole, plus 0.1 mM EDTA and 0.1 mM EGTA) was 
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immediately added to the pelleted nuclei. Nuclei were resuspended and the 
lysates was passed through a 25-gauge syringe needle followed by incubation on 
ice for 30 min. Crude nuclear lysate was then centrifuged at 4000 g for 45 s and 
the supernatant (nuclear fraction) was collected. The nuclear fraction was 
subsequently centrifuged at 21000 g for 30 min at 4°C and the supernatant was 
immediately placed atop beads specific to the first purification (see below).  
 
NOTE: If the dual-affinity tag contained a StrepII component, avidin was added to 
the lysate at a final concentration of 50 µg/mL, which blocks biotinylated proteins 
in the lysate from being non-specifically pulled down by the Strep-Tactin beads. 
 
Dual-Tag Purification and MS Sample Preparation  
Beads specific to the outer affinity tag (Ni-NTA [Qiagen] for His-tag, IgG 
Sepharose™ 6 Fast Flow [GE Healthcare] for ProA-tag) were equilibrated with 
lysis buffer and incubated with lysate (200 µl solid beads per 1.5 ml lysate) for 2-
hrs at 4ºC with agitation. Samples were transferred to an empty Poly-prep 
column (Bio-Rad) and the beads were washed with three 10 ml additions of wash 
buffer (His-tag: 50 mM Tris, 50 mM NaH2PO4, 150 mM NaCl, 20 mM imidazole, 1 
mM DTT, 0.1% NP-40, pH 8; ProA-tag: without imidazole) and one 10 ml addition 
of TEV cleavage buffer (TCB: 50 mM Tris, 150 mM NaCl, 0.5 mM EDTA, 0.1% 
NP-40, 1 mM DTT, pH 8). Beads, resuspended in 1 ml TCB, were then 
transferred to another microfuge tube and treated with 50 U AcTEV™ protease 
(Invitrogen) for 1-hr at RT with agitation. The supernatant was collected, placed 
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atop 200 µl of beads specific to the inner affinity tag (Strep-Tactin beads [IBA] for 
StrepII-tag, HA antibody conjugated to ProA beads for HA-tag), and incubated for 
2-hr at 4ºC with agitation. The supernatant was removed and the beads were 
washed with three 1 ml additions of wash buffer (100 mM Tris pH 8.0, 150 mM 
NaCl, 1 mM EDTA, 1 mM DTT). The doubly purified bait-complex was recovered 
by three 500 µl additions of elution buffer (StrepII-tag: 100 mM Tris pH 8.0, 150 
mM NaCl, 1 mM EDTA, 1 mM DTT, 20 mM Desthiobiotin [IBA]; HA-tag: 80% 
Acetonitrile, 0.025% Formic Acid) with 5 min of agitation between each elution. 
Samples were collected at each step and analyzed by western blot (mouse anti-
Strep-tag [Qiagen]) to monitor purification progress and yield. For MS analysis, 
samples were prepared as originally described by Link et al [139] with 
modifications [140].  
 
2D MudPIT Liquid Chromatography and Tandem MS  
The resultant peptides, acidified to 5% formic acid, were loaded onto the 
back column of a 3-phase MudPIT setup using a pressure cell as previously 
described [139, 141]. Briefly, a 100 micron inner diameter (ID) capillary back 
column containing a C18 reverse phase (RP; Aqua, 5 micron particle, 200 
Angstrom pore [Phenomenex]) behind a strong cation exchange phase (SCX; 
Luna, 5 micron particle, 100 Angstrom pore [Phenomenex]) was attached to a 
100 micron ID resolving front column/nanospray tip packed with C18 RP (Jupiter, 
5 micron particle, 300 Angstrom pore [Phenomenex]). Once situated on the 
nanospray source and equilibrated, five LC-MS/MS cycles were performed per 
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sample. The first cycle consisted of an organic gradient from 100% Solvent A 
(95% H20, 5% acetonitrile, 0.1% formic acid) to 100% Solvent B (30% H20, 70% 
acetonitrile, 0.1% formic acid) over 100 min. In cycles 2-5, a salt pulse of 400 mM 
ammonium acetate (10%, 25%, 60%, 100% respectively) was followed by an 
organic gradient (0% to 100% Solvent B over 100 min). In all cycles, the effluent 
was analyzed by tandem MS. The chromatography was performed using an 
UltiMate™ LC pump (LC Packings) and the data was collected by an LTQ 
(Thermo Finnigan) operating in data dependent mode. 
 
Data Analysis  
MS/MS spectra were analyzed by DBDigger [142] using human IPI 
database version 3.05. The search algorithm was instructed to consider peptides 
containing alkylated cysteines (+57 Da). Enzyme specificity for the search was 
fully tryptic and allowed for missed cleavages.  The search algorithm was 
instructed to allow a precursor mass error of 3.0, and a fragment mass error of 
0.5.  DTASelect was used to filter and organize the search results; Contrast was 
used to control-filter the TRF2 datasets (see below) in order to differentiate 
between putative specific and non-specific interacting proteins [143]. 
Peptide/protein identification acceptance was contingent upon the following 
criteria: XCorr filter levels were required to be ≥23.75832, ≥28.06619, or  
≥43.63964, for singly-, doubly-, and triply-charged ions, respectively, allowing for 
an approximated 5% false discovery rate at the peptide level; DeltCN was 
required to be ≥0.08 and a minimum of 2 peptides per locus was required per 
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protein identification that did not appear in the control dataset (generated by 
performing several control pull downs that identified proteins that non-specifically 
bind to the affinity beads, the tag itself, and to proteins in general).  
 
Lumio Visualization of TRF2 Fusion Proteins 
 U2OS cells (ATCC) were grown on coverslips, transfected with TRF2-C-
StH by FuGENE 6 (Roche), incubated for 24-hr, and stained with Lumio™ 
(Invitrogen) as previously described [144] with slight modifications. Briefly, 1 µl 
Lumio™ Green (2 mM) was preincubated with 1 µl EDT (25 mM) and 1 µl DMSO 
for 15 min in the dark. The labeling solution was then diluted with 200 µl of PBS 
and incubated for 10 min in the dark. Cells were washed with PBS and immersed 
in 1.8 ml of pre-warmed PBS. The labeling solution was then applied and 
incubated for 30 min at 37°C. Cells were washed onc e with PBS and 3 x 10 min 
with PBS containing 350 µM EDT. TRF2-C-StH was visualized in live cells using 
a Zeiss immunofluorescence microscope and acquired with a charge-coupled 
device camera using the Photoshop software. Following live cell imaging, cells 
were fixed with 2% paraformaldehyde and labeled by FISH using a Cy3-labeled 
telomeric probe as previously described [145] and visualized. To visualize the 
TRF2 fusions by SDS-PAGE, 40 µg of lysate was processed using Invitrogen’s 
Lumio Green Detection Kit according to the manufactures’ instructions, 




His-tagged TRF2 Purification and Dot Blotting Analy sis  
For the production of His-tagged human TRF2, BL21 Codon-plus cells 
(Stratagene) carrying pDEST17-TRF2 were grown at 30°C to  ~ 0.6 of OD 600 
and induced for 4.5 hours by 1 mM IPTG. Cells were harvested and resuspended 
in His-binding buffer (20 mM Tris-Hcl pH 7.9, 0.5 M NaCl, 5 mM imidazole, 
Roche protease inhibitor cocktail) and lysed by sonication. The lysate was then 
incubated with Ni-NTA beads (Qiagen) and washed with His-wash buffer (20 mM 
Tris-HCl pH 7.9, 0.5 M NaCl, 60 mM imidazole). Bound His-TRF2 was then 
eluted in His-elution buffer (Tris-HCl pH 7.9, 0.5 M NaCl, 1 M imidazole). Purity of 
the purified His-TRF2 was determined by SDS-PAGE analysis and the 
concentration was obtained using Bradford Assay according to the 
manufacturer’s instruction.  
 
For the dot blot analysis, purified recombinant His-TRF2 and N-HtS-TRF2 whole 
cell lysate from the pull down were serially diluted and spotted on a nitrocellulose 
membrane. The membrane was then probed with rabbit anti-His tag antibody (H-
15 [Upstate]), followed by donkey anti-rabbit-HRP, and developed with ECL 
reagent (Pierce). To obtain the concentration of N-HtS-TRF2, spots were 
analyzed and compared to spots of known concentration of His-TRF2 by 





3.3: Results and Discussion 
 We generated five novel dual-tag purification vectors, each with a different 
combination of affinity tags (two per construct, varying by composition, size, and 
terminal location) and including either a constitutive (CMVp) or tetracycline-
regulatable promoter (Tetp) to allow for controlled expression of the tagged bait 
proteins (Figure 3.1a ). We chose Strep-Tactin-binding peptide (StrepII tag) in 
most of our dual-tag combinations due to both its high binding affinity and its 
small (8-mer) size compared to the original streptavidin-binding peptide (Strep 
tag: 38-mer). Other novel features include a second TEV protease recognition 
site to improve cleavage efficiency (data not shown) and a tetracysteine motif 
(CCPGCC) [146] (except for C-HAtP) to easily monitor bait protein expression, 
purification, and localization. Moreover, all our dual-tags are constructed in 
Invitrogen Gateway-compatible destination vectors, allowing for easy cloning 
through site-specific recombination (see Materials and Methods).  
 
We selected human TRF2 to evaluate our dual-tagging system. TRF2 is a key 
telomere binding protein that functions to stabilize the t-loop configuration, a 
structure that both protects the chromosome end from being recognized as 
damaged DNA and represses telomere elongation by telomerase [64]. Several 
telomere-associated and DNA damage repair proteins are known to interact with 
TRF2 [64, 147] and thus provide both an effective means to assess the efficacy 
of our tagging system and an opportunity to gather potentially novel insight 
regarding TRF2 function.  
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As shown in Figure 3.1b  and 3.1f, all TRF2 fusions produced proteins of 
anticipated size. Moreover, the level of Tetp-driven TRF2 fusion protein 
expression was tetracycline-concentration dependent (Figure 3.1c ). This 
demonstrates the capability to modulate fusion protein expression, potentially 
overcoming problems encountered in over-expression systems. For example, not 
only can expression be adjusted to near physiological level, but also, bait 
proteins that would otherwise impede cellular growth and/or viability can be 
repressed until specific experimental conditions are met. This feature greatly 
expands the tags’ applicability. 
 
The CCPGCC motif featured in 4 out of 5 dual-tags allows for the visualization of 
the fusion protein in both live cells and cellular lysates using Lumio™ 
(Invitrogen), a conditionally fluorescent, membrane-permeable compound based 
on the FIAsH (Fluorescein Arsenical Hairpin) reagent [146, 148]. The expected 
co-localization of TRF2-C-StH with the telomere in fixed cells (Figure 3.1d ) and 
its similar punctate staining pattern in live cells (Figure 3.1e ) indicate that the tag 
does not interfere with TRF2’s subcellular localization. This useful feature 
provides a means to (i) rapidly infer bait protein function following tagging based 
on proper localization, (ii) assess transfection efficiency, (iii) confirm putative 
interacting partners by co-localization, or (iv) monitor the purification progress 
directly by SDS-PAGE (Figure 3.1f ). Interestingly, the tetracysteine motif can 
also function as an affinity tag when paired with FlAsH-conjugated agarose 
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beads [148], providing yet another means by which the bait-complex could be 
purified. 
 
To evaluate the purification efficiency of our tagging system, two plates (10 cm2) 
of 293T cells were transfected with TRF2-C-StH. Cells (~107) were collected 48-
hrs post-transfection, lysed, and tagged TRF2 purified. A western blot was used 
to monitor the recovery at each purification step. Quantitative analysis of the 
density of each band against the percentage of total volumes loaded in each 
sample reveals that the final eluates contain approximately 6% of the TRF2-C-
StH fusion protein present in the lysate (Figure 3.2a ).  
 
To assess bait recovery with regards to downstream MS analysis, each TRF2 
construct was transfected into 293T cells and purified as described above. In 
addition, several controls were included to identify proteins that non-specifically 
bind to the affinity beads, the tag itself, and to proteins in general. Each sample 
eluate was TCA-precipitated, digested, and analyzed by 2D LC-MS/MS. 
Resultant tandem mass spectra were searched against the human IPI database 
v3.05 using DBDigger [142]. Data from multiple pull-downs of each tagged TRF2 
and controls were filtered, organized, and compared using DTASelect and 
Contrast [143]. Expectedly, TRF2 was identified in all pull downs (Search 
parameters and filter criteria in Materials and Methods above; MS data available 

























Figure 3.2: Efficient purification of dual-tagged TRF2. (A) Western blot (anti-Strep tag) depicting 
the complete purification of transiently expressed TRF2-C-StH. Bar graph representing the 
estimated recovery of bait protein relative to input from the lysate. (B) Western blot and graph 
showing the complete purification and estimated recovery of a stably expressing N-HtS-TRF2 
fusion protein using freeze/thaw lysis. NL, nuclear lysate; WCL, whole-cell lysate; FT1, flow-
through of lysate from Ni-NTA resin; TE, TEV protease-mediated elution from Ni-NTA resin; E, 
eluates from Strep-Tactin resin. (C) Dot blot analysis (anti-His tag [H-15, Upstate]) comparing the 
amount of N-HtS-TRF2 in the freeze/thaw processed whole cell lysate to a His-purified TRF2 of 





Using the control-filtered MS data, we identified the major  proteins previously 
shown to associate with the TRF2 complex such as RAP1, TIN2, TPP1, ATM, 
WRN, BLM, Ku70, Ku80, and PARP1 [64, 135, 147] (Table 3.1 ) along with 
potentially novel TRF2-interacting proteins (see Chapter 4 and Appendix A). 
RAP1, a relatively low-abundant protein, was confidently identified in TRF2 pull-
down samples from as little as ~107 adherent cells. In fact, all of the known 
TRF2-associated proteins identified in this study originated from samples 
containing no more than 7x107 cells. Taken together, these data demonstrate the 
efficacy and sensitivity of our dual-tag purification system.  
 
Comparing each of the dual-tags, we found that all five generated sufficient 
recovery for MS analysis, yielding the TRF2 bait protein, known TRF2-interacting 
protein(s), and several new candidate TRF2-associated partners. In this study, 
we mainly focused on the His/StrepII-based tags (Figure 3.1a ) as they produced 
the best TRF2 sequence coverage, the largest number of MS/MS spectra 
assignable to TRF2 peptides, and identified the most known TRF2-interacting 
proteins (Table 3.1). However, this is not to suggest that these tags will always 
outperform the rest.  
 
In an attempt to increase bait protein recovery, we modified a freeze/thaw lysis 
protocol (see Materials and Methods) to keep the cell lysis as concentrated as 
possible and were able to triple the recovery of TRF2 to roughly 16% in the final 











Table 3.1: Peptide Identifications of Known TRF2 Interacting Proteins or Complexes. Each 
confidently identified protein is listed in order of the number of peptides detected across all MS 
runs. Listed are the actual peptides identified for each protein known to interact with the TRF2 
complex with citation. Due to space limitations, only the number of unique peptides from the best 
MS sample run is listed for TRF2 and RAP1. The listed peptides represent the combination of 
multiple pull down experiments. 
 
 
PROTEIN PEPTIDES IDENTIFIED CITATION 
TRF2 
 





45 Peptides Unique to RAP1 
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dot-blot analysis (Figure 3.2c ). In addition, using the freeze/thaw method, a pull 
down experiment (n=4) identified, on average, most (5 out of 9) known TRF2-
interacting proteins listed in Table 3.1 , suggesting a greater enrichment of known 
TRF2-interacting proteins per pull down compared to those not processed by 
freeze/thaw (average 2/9; n=4). Moreover, the total number of proteins found in 
the pull down experiments without freeze/thaw (n=4) was 435±56, compared to 
388±114 with freeze/thaw (n=4). Therefore, the enrichment of specific interacting 
proteins in freeze/thaw samples was not the result of increased total protein 
counts. These data perhaps indicate that keeping the initial lysis concentrated 
may enhance the recovery of specific TRF2 interacting proteins by ensuring 
minimal perturbation of the natural equilibrium that exists between interacting 
partners.  
 
In this study, we have developed a dual-tagging system that offers versatile 
features to address various issues related to the difficulty of identifying interacting 
proteins in mammalian cells. With several available dual-tag constructs, this 
Gateway-compatible system provides enormous flexibility to rapidly modify tag 
composition, terminal location, and bait protein expression, while at the same 







Exploring the Protein Network Surrounding 
the Human Telomere Binding Proteins TRF1, 




 The terminal ends of most linear eukaryotic chromosomes contain 
proteinaceous-DNA structures known as telomeres. These important, 
evolutionarily conserved stretches of repetitive DNA and associated proteins 
function mainly to protect the cell from chromosome attrition, which occurs 
naturally due to the “end replication problem” inherent to semi-conservative DNA 
replication [9, 50]. However as the telomere looks suspiciously like a genomic 
double strand break (DSB), it also serves to prevent the aberrant recognition of 
the chromosome end as damaged DNA, precluding unnecessary and potentially 
hazardous repair [149]. For example, deprotected and/or dysfunctional telomeres 
are often erroneously repaired in the form of chromosome fusions via the non-
homologous end joining pathway (NHEJ, reviewed in [65]). While this usually 
results in cell cycle arrest, cellular senescence or apoptosis, the chromosomal 
fragmentation that occurs can sometimes lead to malignant transformation [127-
129]. In fact, the increased incidence of cancer observed in both elder 
populations and individuals afflicted with pre-mature aging syndromes 
underscore the telomere’s importance to cancer prevention as both groups 
61
exhibit shorter than average telomeres which have lost their protective function 
[125, 126]. Therefore, the integrity of the telomere is a vital component of overall 
genomic stability. 
 
Increasing evidence suggests that telomere integrity, thus in turn genomic 
stability, is dependent on the ability to both maintain telomere length and shield 
the region from recognition as damaged DNA [130, 131]. These two tasks are 
mediated through the interaction of telomerase with shelterin, a six subunit 
complex composed the telomere-associated proteins TRF1, TRF2, POT1, RAP1, 
TPP1, and TIN2 (Reviewed in [64]). Although key components of the shelterin 
complex have been identified, a detailed picture of the interacting protein 
networks surrounding these components has yet to be described. Another aspect 
to consider is that these proteins, aptly named for their association with the 
telomere, may participate in other seemingly unrelated biological processes. For 
example, recent evidence has suggested an alternate but complimentary function 
of telomere repeat binding factor 2 (TRF2): its proposed involvement in general 
DSB repair [150-152]. Intuitively, this makes sense; the telomere both resembles 
a genomic DSB and recruits/maintains associations with several well-
characterized DNA damage response and repair proteins [64, 65].  
 
In this study, we explore the interacting protein network surrounding the core 
components of the human shelterin complex: TRF1, TRF2, and POT1. All three 
proteins bind to and directly interact with the tandem TTAGGG repeats of the 
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telomere and function to maintain telomeric DNA through both structural (t-loop 
formation) and regulatory (telomerase access) mechanisms (as reviewed in 
Chapter 2 and [64, 65]).  To accomplish this task, we employed the use of our 
recently described dual-tag affinity purification system [153] to tag the three 
telomere binding proteins and purify them in native conditions to maintain and co-
purify their interacting partners. Once obtained, co-purified proteins were 
identified via MudPIT liquid chromatography - tandem mass spectrometry 
(MudPIT LC-MS/MS) and the DBDigger search algorithm [142, 154].  
 
After control subtraction and filtering the data with DTASelect [143], we identified 
many putative interacting partners for each of the three core shelterin 
components: 731 total non-redundant proteins for TRF2 (n=8), 275 for TRF1 
(n=5), and 232 for POT1 (n=5). Using Gene Ontology (GO) annotations for 
cellular component filtering, these numbers adjust to 588, 210, and 185 (cell 
component = nucleus or undefined) or 211, 76, and 58 (cell component = 
nucleus) respectively. As an internal control, the three shelterin bait proteins co-
purified all members of the complex, with the exception of TRF1 which identified 
nearly all (five of six) components. To aid in protein network visualization, the 
Osprey software package was utilized [155]. In addition to the telosome/telomere 
protein network, several other candidate networks were enriched such as DNA 
damage repair, ubiquitination, chromosome cohesion, and chromatin 
modification/remodeling. In addition to identifying potential novel interacting 
partners of the telomere binding proteins, our MS results confirm previous 
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studies suggesting the primary architecture of the shelterin complex (reviewed in 
[64]), namely TIN2’s role as the hub of the complex linking two potential 
subcomplexes, one composed of TRF1, the other with TRF2 [156]. Of all the 
shelterin components identified by MS, TRF1 seemed to be the bait with the 
most difficulty precipitating the other shelterin constituents as well as difficulty co-
purifying with the other bait proteins. 
 
As telomere maintenance is an essential component of overall genomic stability, 
the identification of previously uncharacterized telomere-associated proteins 
benefits not only research in the telomere field, but also cancer research in 
general. Likewise, the elucidation of other putative, telomere-associated 
interaction networks may indicate new and exciting avenues of study. 
 
4.2: Materials and Methods 
Gateway Cloning of Telomere Binding Proteins TRF1, TRF2, and POT1 into 
Dual-tag Affinity Purification Vectors 
 
Human TRF2 coding sequence was cloned into an N-terminal His-tev-
Strep-CCPGCC dual-tag affinity purification vector as previously described 
(Chapter 3 and [153]). Human TRF1 coding sequence was PCR-amplified from a 
pET28-hTRF1 expression vector (a generous gift from Dr. David Gilley, 
Department of Medical & Molecular Genetics, Indiana University-Purdue 
University Indianapolis)  using primers specific for the N- and C-terminal region of 
the TRF1 coding sequence, flanked by either attB1 or attB2 sequences 
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(Gateway-compatible, Invitrogen, Carlsbad. CA) and made compatible with the 
incorporation of an N-terminal affinity tag (via deletion of the native start codon). 
The primers used were as follows: (forward primer) 5’ - G GGG ACA AGT TTG 
TAC AAA AAA GCA GGC TTC GCG GAG GAT GTT TCC TCA G - 3’ and 
(reverse primer) 5’ - GGG GAC CAC TTT GTA CAA GAA AGC TGG GTC CTA 
GTC TTC GCT GTC TGA GGA AAT - 3’ (underline denotes start and stop 
codons of the TRF1 coding sequence). The amplified, Gateway-compatible PCR 
product was precipitated and cleaned via PEG purification as described in the 
manufacturer’s protocol (Invitrogen, Carlsbad, CA) and separated on a 1% DNA 
agarose gel to assess its size, purity, and concentration. The PCR product was 
then cloned into the Gateway pDONR221 donor vector (Invitrogen, Carlsbad, 
CA) through the BP recombination reaction as described by the manufacturer 
and the resultant donor vectors were transformed into chemically-competent E. 
coli strain JM109 by heat shock. Positive transformants containing the properly 
recombined pDONR-nt-TRF1 vector were selected by kanamycin (50 µg/ml) and 
the ccdB gene and expanded in liquid culture for plasmid extraction via miniprep 
(Qiagen, Valencia, CA).  Vectors were then sized on a gel and sequenced to 
verify the proper incorporation of the TRF1 coding sequence. TRF1 was 
subsequently transferred from pDONR-nt-TRF1 into one of our novel Gateway-
compatible destination vectors, N-His-tev-Strep-CCPGCC, by an LR 
recombination reaction as described by the manufacturer, transformed (see 
above but with ampicillin [100 µg/ml] selection), extracted via miniprep, and 
verified by gel electrophoresis.  
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Human POT1 coding sequence was obtained from Invitrogen’s Ultimate ORF 
Clones collection already cloned into a Gateway-compatible entry vector 
pENTR221-hPOT1. This vector contained the wild-type POT1 sequence with a 
stop codon and is thus compatible only with N-terminal tag fusions. The POT1 
sequence from the entry vector was then transferred into our N-ProA-tev-Strep-
CCPGCC dual-tag affinity purification vector via an LR recombination reaction 
and obtained / verified as described above. 
 
The resultant telomere binding protein containing, dual-tag expression vectors 
described above were subsequently transfected into U2OS osteosarcoma cells 
(ATCC, Manassas, VA) to assess both expression and proper localization of the 
fusion proteins to the telomere by a combined immunostaining (anti-Strep tag 
antibody) and TEL-FISH approach, as described in Chapter 3. 
 
Cell Culture and Stable Line Creation 
 For all experiments, Human Embryonic Kidney 293T cells (ATCC, 
Manassas, VA) stably expressing both a tetracycline repressor protein (in house 
established 293T-REx cells) and a tetracycline-regulatable, dual-tagged fusion 
protein were utilized. The establishment of these cell lines, each containing one 
of the dual-tagged telomere binding proteins, TRF1, TRF2, or POT1, has been 
previously described for TRF2 (N-HtS-TRF2; see Chapter 3 and [153]). The other 
two fusion proteins, N-HtS-TRF1 and N-PtS-POT1, were similarly established. 
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Briefly, previously established 293T-REx cells were co-transfected with either 
dual-tag constructs, N-HtS-TRF1 or N-PtS-ProA, and pBabe-puro (a generous 
gift from Dr. Gerard Evans), and positive  clones were identified by selection with 
3 µg/ml puromycin, 800 µg/ml G418 and 5 µg/ml Blasticidin-S. The most 
tetracycline responsive clones for each dual-tag fusion proteins were selected 
and used for further experiments. All the stable cell lines were cultured at 37°C in 
Dulbecco’s Minimum Essential Medium (DMEM; Mediatech, Inc., Manassas, VA) 
supplemented with 10% fetal bovine serum (FBS), penicillin/streptomycin, and L-
glutamine. Cells were passaged with trypsin (0.05%) / EDTA (1 mM) according to 
accepted cell culture practices. 
 
Dual-affinity Purification of Telomere Binding Prot eins and Associated 
Partners 
 
For every biological replicate, 293T-REx cells stably expressing one of 
each dual-tagged telomere binding protein were seeded on four 15 cm culture 
dishes, grown to 70% confluence, and induced with 5 µg/ml of tetracycline to 
express the fusion protein. Cells were harvested and proteins extracted by a 
modified freeze/thaw lysis procedure that aims to keep the lysate as 
concentrated as possible (previously described in Chapter 3 and [153]). Once 
obtained, the crude lysate was precleared by centrifugation and the bait proteins 
and their interacting partners were dual-tag affinity purified (as meticulously 
described in Chapter 3 and [153]). Briefly, lysate for each bait protein was loaded 
atop beads specific to the outer affinity tag of each dual-tagged telomere binding 
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protein (Ni-NTA [Qiagen, Valencia, CA] for His-tag purification of N-HtS-TRF1 
and N-HtS-TRF2; IgG Sepharose™ 6 Fast Flow [GE Healthcare, Piscataway, 
NJ] for ProA-tag purification of N-PtS-POT1) and batch affinity purified (i.e. not 
column-based). The bead-bound bait protein and associated proteins were 
washed then eluted from the beads with AcTEV protease (Invitrogen, Carlsbad, 
CA). The supernatant for each bait protein was then placed atop Strep-Tactin 
beads (IBA, Göttingen, Germany) and batch purified a second time. Doubly 
purified bait proteins and associated partners were then washed one final time, 
eluted with desthiobiotin, precipitated with trichloroacetic acid, and prepared for 
mass spectrometry analysis as described below. 
 
MS Sample Preparation and MudPIT 2D-LC-MS/MS Analys is 
For MS analysis, samples were prepared as originally described by Link et 
al. with modifications [139, 141]. Briefly, the TCA precipitated proteins were 
resuspended in and denatured by 8M Urea. Disulfide bonds were reduced with 
Tris (2-carboxyethyl) phosphine (TCEP; Bond-Breaker by Pierce, Rockford, IL) 
and cysteines blocked with iodoacetamide (+57 Da mass shift) to prevent 
reformation of disulfide bonds. The reduced and denatured proteins were then 
digested to peptides with endoproteinase Lys-C followed by overnight trypsin 
digestion. 
 
The resultant peptides were protonated with formic acid, loaded onto the back 
column of a 3-phase MudPIT setup (reverse phase C18 for desalting  strong 
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cation exchange for separation by positive charge  filter union  reverse 
phase C18 resolving column) using a pressure cell as previously described [139, 
141]. As detailed in Chapter 3 and [153], five LC-MS/MS cycles were performed 
per biological replicate with each consisting of a short salt pulse (except for the 
first, step-wise increase per cycle thereafter) followed by a two-hour organic 
gradient to separate peptides for eventual identification via tandem MS. The 
chromatography was performed using an UltiMate™ LC pump (LC Packings) 
online with an LTQ (Thermo Finnigan) outfitted with a nanospray source and 
operating in data dependent mode. 
 
MS Data Analysis 
Tandem mass spectra were analyzed by DBDigger [142] using the 
International Protein Index’s human FASTA protein sequence database, version 
3.25. The search algorithm was instructed to apply a static +57 Da modification 
to cysteine residues to compensate for the action of iodoacetamide used to block 
disulfide bridge reformation during the digestion process. The relevant search 
parameters were as follows: enzyme specificity was fully tryptic, allowing for 
missed cleavages, a precursor mass error of 3.0 Da, a fragment mass error of 
0.5 m/z, and a peptide mass range spanning 400 to 5100 Da.  After data 
extraction from the MS/MS spectra, DTASelect was used to filter and organize 
the search results [143]. Peptide identification was contingent upon the following 
criteria: XCorr filter levels were required to be ≥23, ≥28, or  ≥43, for singly-, 
doubly-, and triply-charged ions, respectively, allowing for an approximated 5% 
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false discovery rate at the peptide level; DeltCN was required to be ≥0.08, and a 
minimum of 2 peptides per locus was required per protein identification that did 
not appear in the control dataset (generated by performing several control pull 
downs that identified proteins that non-specifically bind to the affinity beads used 
in the purification).  
 
Scripting and Database Construction 
 
 To better handle the generated datasets (21 in total: 5 for TRF1, 8 for 
TRF2, 5 for POT1, 3 controls), a Perl scripts were written to extract the data from 
the DTASelect output file (DTASelect-filter.txt) for import into a MySQL database. 
The parameters extracted included: a group id (for ambiguous protein 
identifications), IPI number, peptide count, spectral count, sequence coverage, 
and description of the protein. A new table was created for each sample run, as 
well as a master table that contained the pertinent stats for each run such as: run 
name, date, type of run (sample vs. control), total non-redundant peptides IDs, 
total non-redundant protein IDs, and XCorr filter levels used. With the protein 
identification data in the database, several parameters could be quickly 
accessed.  
 
However, to compare the data between sets, another script was written that is 
loosely based on Contrast written by Tabb et al. (packaged with DTASelect) but 
in this case, database-compatible. Not only does this script compare peptide 
identification data across different sets, but it also narrows down ambiguous 
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protein identifications in cases where other datasets provide more information. 
The general flow of the script is as follows: the first dataset in the group gets 
added to a new database table (each identified protein’s group ID, IPI number, 
peptide count, and spectral count). After the first set is added, each additional set 
is compared to the first in a group by group manner. For example, if a protein 
identification is unambiguous in the initial set (due to identified peptides that 
uniquely belong to the protein called by DBDigger), every other dataset 
containing that protein identification adds its peptide count and spectral count 
information to the table, disregarding any ambiguous protein calls (if they exist) in 
the additional datasets as the first set already unambiguously identified the 
protein (i.e. more peptide information was provided in the first set). Conversely, if 
the first set contains an ambiguous protein call, i.e. the peptide information leads 
to an identification of either Protein A, B, or C, then each additional set 
endeavors to whittle down the list based on its own information. For example, if 
the second dataset contains a group that includes Protein B above, but also 
proteins C and D, then the script assumes that the additional information 
provided by second set has narrowed down the call to be either Protein B or C 
and not A or D as provided by the two sets independently. Following this 
schema, a third set containing a call of B alone or B and X for example, would be 
enough to unambiguously identify the protein. Essentially, the script evaluates 
the union between sets on a group by group basis. Following the dataset 
comparison, the newly built contrast table is control subtracted using a list of IPI 
values that were identified in the control sets.  
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The final, control subtracted contrast table is then exported to a Microsoft Excel 
file via another script that both outputs the contrasted data and queries publicly 
available online databases for additional information, which is appended to each 
row of the table. The additional information includes: Swiss-Prot ID number, the 
official gene symbol, subcellular localization (via local gene ontology database), 
description of the gene, its proposed / known function, and curated keywords, all 
provided by the Swiss-Prot database. The resultant Excel file and all of the 
additional information allowed for a better analysis of what identifications seemed 
to make the most sense. Note: two other scripts were written that performs the 
same queries for adding this additional information to traditionally processed 
Contrast files, i.e. without the database. One script extracts the data from the 
Contrast.txt file to an excel file and the other queries the online databases for 
additional information. This was done to increase the applicability of the script to 
those who do not wish to set up a database of protein identifications.  
 
Protein Network Visualization via Osprey  
 To better visualize the protein network surrounding the telomere binding 
proteins, the control subtracted, contrasted data generated above were imported 
into Osprey network visualization software [155] using the supplied human GRID 
protein database. For each bait proteins, TRF1, TRF2, and POT1, the MS 
identified putative interacting partners were added as nodes and color-coded 
based on the frequency of identification (i.e. TIN2, 7 out of 8) for quick knowledge 
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on the prevalence of the identification. Once added, Osprey was instructed to 
analyze previous interaction data within the imported nodes. To view the bait-
enriched protein complexes / networks, the identified proteins for each bait 




As demonstrated in Chapter 3, the dual-tag affinity purification system was 
successful in co-purifying known TRF2 interacting partners that were identified 
through MudPIT LC-MS/MS. To expand on this, the dual-tag affinity purification 
system was applied to all the telomere binding proteins, TRF1, POT1, and again, 
TRF2. Due to the successful expression modulation via tetracycline, as 
demonstrated in Chapter 3, TRF1 and POT1 were also cloned into N-terminal 
tagging constructs. Although it would have been preferable to clone both into the 
same N-HtS expression construct, as was done for TRF2, the N-HtS-POT1 
fusion protein failed to express in transiently transfected 293T cells while the N-
PtS-POT1 had no trouble being expressed. Therefore, the three bait proteins 
utilized in this study were N-HtS-TRF1, N-HtS-TRF2, and N-PtS-POT1. Before 
stable lines for each fusion protein were created, their expression and proper 
localization to the telomere were verified. As shown, transiently transfected HtS-
TRF2 (Figures 3.1d and 3.1e), HtS-TRF1, and PtS-POT1 (Figure 4.1 ) all were 
successfully expressed and localized to the telomere. This verification was 

















Figure 4.1: Proper telomeric localization of POT1 and TRF1 fusion proteins. Cells were 
transiently transfected with the either construct, fixed, and probed using a combined TEL-FISH / 
immunostaining approach that labels the telomere and Strep-tagged proteins respectively. The 


















our previously generated 293T-REx cells (see Chapter 3). Stable clones that 
exhibited sufficient modulation by tetracycline addition (see Figure 3.1c ) were 
selected and used for the analysis presented in this report. 
 
As described in Chapter 3 and [153], the MS-based identification of bait proteins 
and their known interacting partners after two separate purification events was 
highest using a modified freeze/thaw lysis procedure that aimed to keep the 
lysate concentrated. It was speculated that the increased concentration 
enhanced both the binding of the bait to the purification medium as well as the 
associated proteins to the bait, leading to an overall increase in the amount of 
both bait and interacting partners obtained in the final elution.  
 
As follows, each stable line expressing a dual-tagged telomere binding protein 
was processed by freeze/thaw lysis and put through the dual-tag affinity 
purification procedure. The eluted proteins for each sample were then 
precipitated, digested to peptides, and analyzed by Mud-PIT LC-MS/MS. For 
each dual-tagged bait protein, at least five biological replicates were analyzed by 
mass spectrometry with the exception being TRF2, which had eight total 
replicates. However, three of these replicates involved an additional expression 
of HtS-TRF2 (via transient transfection of the construct on top of expression via 
tetracycline inductions) and exposure to ionizing radiation (2 sets) prior to lysis 
and dual-tag affinity purification. The reasoning for this is discussed below. In 
addition, several negative controls were incorporated into the analysis in which 
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293T-Rex cell lysate was put through the same purification procedure to identify 
proteins that non-specifically co-purify with the beads used for each bait protein 
(Ni-NTA / Strep-Tactin for HtS-TRF1 and HtS-TRF2 or IgG-Sepharose / Strep-
Tactin for PtS-POT1).  
 
The tandem mass spectra for each sample were then searched against the 
human IPI protein database version 3.25 with DBDigger and sorted by 
DTASelect. The number of non-redundant proteins and peptides identified in 
each sample are shown in Table 4.1 . Based on spectral count, the bait protein 
was usually the most highly identified protein in each control-subtracted sample, 
evidence of the success of the purification. To better handle the data, several 
scripts that interfaced with a MySQL database were written (see Materials and 
Methods). Once the identified proteins that passed the filters were imported into 
the database, “on-the-fly” comparisons between datasets could be performed, 
similar to the Contrast program packaged with DTASelect. The difference is that 
this script compares different sample runs in a database, creating its own 
dynamic database table that can be manipulated and queried like any other 
table. This essentially provides a bit more power when comparing complex 
datasets. In addition, a separate script was written that queries online protein 
databases such as Swiss-Prot and appends additional information onto the 
dynamically created comparison table (Microsoft Excel-compatible) such as 
Swiss-Prot IDs, gene symbols, cellular compartment, proposed function, and 
curated keywords. This extra data provides researchers an “at-a-glance” view of 
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Table 4.1: Bulk MudPIT MS/MS data for each dual-tag affinity purified telomere binding protein after searching with DBDigger and filtering with 
DTASelect. Key: HtS = His-tev-Strep, PtS = ProA-tev-Strep, NL = nuclear lysis, IR = exposure to ionizing radiation, xfect = transfection of HtS-
TRF2 on top of tet-regulated expression, and NR = non-redundant.  
 
 
Bait NR Protein Count NR Peptide Count Bait Spectral Count 
HtS-TRF1-01 189 1089 47 
HtS-TRF1-02 113 758 48 
HtS-TRF1-03 102 535 93 
HtS-TRF1-04 178 1021 328 
HtS-TRF1-NL 118 549 88 
HtS-TRF2-01 216 946 413 
HtS-TRF2-02 356 2222 262 
HtS-TRF2-03 376 1849 192 
HtS-TRF2-04 500 2643 182 
HtS-TRF2-NL 123 799 723 
HtS-TRF2-IR1 + xfect 263 848 1239 
HtS-TRF2-IR2 + xfect 293 911 1220 
HtS-TRF2-IRctrl + xfect 328 1054 1236 
PtS-POT1-01 157 606 459 
PtS-POT1-02 139 525 444 
PtS-POT1-03 274 797 171 
PtS-POT1-04 263 622 255 
PtS-POT1-NL 86 334 15 
77
the identified interaction, allowing for assessments such as the frequency of 
identification and whether that identification makes sense based on the additional 
information.  
 
The control-filtered interaction data for each specific bait protein is provided in 
the supplementary table in Appendix A . In short, 731 total non-redundant 
proteins for TRF2 (n=8), 275 for TRF1 (n=5), and 232 for POT1 (n=5) were 
identified as being potential interacting proteins (control-filtered). Using Gene 
Ontology (GO) annotations for cellular component filtering, these numbers adjust 
to 588, 210, and 185 (cell component = nucleus or undefined) or 211, 76, and 58 
(cell component = nucleus) respectively. 
 
As proof of the efficacy of our purification system regarding the telomere binding 
proteins, Table 4.2  lists the identification of all six telosome components via the 
combined data from all the bait proteins. As shown, all six proteins, TRF1, TRF2, 
RAP1, POT1, TPP1, and TIN2, were identified. With regards to the combined 
dataset and the number of times each protein was identified out of 18 total runs, 
five of six components were identified at a rate that ranked them within the top 10 
most frequently observed proteins, while the sixth component, TRF1, was 
observed within the top 15 proteins. The most abundantly identified, non-bait 
proteins were TIN2 (13/18), RAP1 (12/18), NUDT21 (11/18) and TPP1 (11/18), 










Table 4.2: Spectral count data for all identified members of the telosome complex (“Protein” column) organized by bait protein. Bolded rows 
indicate the bait’s appearance in its own MudPIT MS/MS runs. “Count” represents the frequency of the identification for each member of the 
telosome when the data was merged (18 total sets). 
 
Bait = TRF1 Bait = TRF2 Bait = POT1 Count Protein 
   10 6 5 2 5 11 2 3  5 8 20 13 20  13 TIN2 
  5   413 192 1220 723 262 182 1239 1244   30 7 24 12 TRF2 
     175 124 124 335 128 114 117 179  2 4 2 10 12 RAP1 
   8 4 3 7  5  3 3  19 41 16 30  11 TPP1 
   21 3  11  9    3 459 444 171 255 15 10 POT1 















To better visualize the co-purifying, putative interacting partners for each bait 
protein, Osprey network visualization software was utilized. As we are interested 
in both co-purifying proteins as well as co-purifying protein complexes, Osprey is 
able to assemble the MS-identified proteins in terms of a protein network, linking 
together known interactions to better visualize the degree of the interaction. For 
example, TRF2 may co-purify with protein X and protein Y, but it is unknown 
whether the interaction for both is directly through TRF2 or if one is a secondary 
interaction that “hitches a ride”. As mentioned above, the control-filtered 
interaction data for each bait protein was exported to Osprey and linked together 
based on the human BioGRID database (http://www.thebiogrid.org). For each 
specific bait protein, nodes were organized by functional grouping with node 
color indicative of the prevalence / frequency of the interaction (Figures 4.2, 4.3, 
and 4.4 ). For each bait protein, several functional categories were represented: 
TRF2 (DNA damage response, cell cycle/transcription, RNA processing, signal 
transduction, transport, nuclear import, ubiquitin-based protein degradation, and 
DNA replication / nucleotide metabolism); TRF1 (nuclear import machinery, DNA 
replication, ubiquitin-based protein degradation, signaling, cell cycle regulation, 
and chromosome condensation); POT1 (transcription, the cellular response to 
stress, and DNA repair).  
 
Although careful consideration was made towards removing as many false 
positives as possible (biological replicates, controls, and stringent filter criteria), 
























Figure 4.2: The interaction network surrounding human telomere binding protein, TRF2. (A) This 
diagram represents all MS-identified proteins that can be connected back to TRF2 in some way. 
The frequency of identification is listed in the key: Green = 5 to 8 times, yellow = 3 to 4 times, red 
= 2 times, blue = 1 time, out of a total of 8 samples. Identified proteins are grouped by function. 
(B) This diagram represents MS-identified that did not connect back to TRF2, but connected to 
other identified proteins forming subcomplexes. These subcomplexes can tell us more about 



































Figure 4.3: The MS-identified putative interacting proteins of TRF1 that form subcomplexes which can be grouped into several functional 






Figure 4.4: The MS-identified putative interacting proteins of POT1 that form subcomplexes which can be grouped into several functional 






To probe further, several co-immunoprecipitation experiments were performed to 
confirm some of the more abundant and relevant interactions. As our major study 
has utilized TRF2, we chose to focus on these interactions, especially in regards 
to contemporary data suggesting the protein plays a much larger role in overall 
genome maintenance outside its function at the telomere (see Discussion and 
Chapter 5). As shown in Chapter 6, Figure 6.5 , one putative interaction identified 
through this analysis, KPNA2, was confirmed by co-immunoprecipitation.  
 
4.4 Discussion 
 In this study we explored the protein network surrounding the human 
telomere binding proteins TRF1, TRF2, and POT1. Constituents of the protective 
telosome / shelterin complex, these three proteins bind the telomere TTAGGGn 
repeat tracts directly and confer telomere length maintenance regulation and 
overall telomeric stability (see Chapter 2). To accomplish this task, we utilized 
our previously developed dual-tag affinity purification system to purify each 
telomere binding protein along with their associated partners. Bait and interacting 
protein analysis was conducted via MudPIT LC-MS/MS and bioinformatics to 
identify the most relevant interactions over several biological replicates. 
 
As expected, our bait proteins were identified in each replicate and usually 
occupied the top position when proteins were ranked by spectral count. After 
combining the datasets based on bait, a total of 731, 275, and 232 non-
redundant proteins were identified for TRF2 (n=8), TRF1 (n=5), and POT1 (n=5) 
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respectively (Appendix A ). Although these adjust to 211, 76, and 58 when only 
considering known nuclear proteins, we cannot discount the ability for any of 
these baits to interact with cytoplasmic proteins, even though they are 
predominantly nuclear. For example, it was recently discovered that POT1, TIN2, 
and TPP1 can be found as a telosome subcomplex in the cytoplasm [25]. Also, 
novel associations may be identified using this broader dataset. For instance, 
one of the proteins identified in the TRF2 pull down analysis and confirmed as a 
bona fide interaction was KPNA2 / alpha importin 1 (see Chapter 6). This protein 
serves to import proteins into the nucleus and it is hypothesized to only interact 
with its cargo in the cytoplasm, but not in the nucleus [157]. Thus, choosing to 
analyze only the nuclear lysate, although producing generally improved bait and 
known interacting partner capture, would miss some otherwise interesting 
interacting partners. 
 
Combining the datasets all together (i.e. all three bait proteins, control 
subtracted) allowed us to visualize known interacting partners as well as proteins 
that appear to interact with these components and/or the telomere in general. 
The efficacy of our system and current experimental design is demonstrated in 
Table 4.2 . All six telosome components, TRF1, TRF2, POT1, RAP1, TIN2, and 
TPP1, were identified within the top twelve proteins when the dataset was sorted 
by identification frequency (count). When excluding the bait proteins, the other 
three components occupied 3 of the 5 top spots.  
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The frequency of identification also supports the current understanding regarding 
the interconnectedness between the telosome components. According to 
previous studies, TIN2 acts as a general hub, separately interacting with TRF1, 
TRF2, and TPP1/POT1. POT1 also interacts directly with TRF2, which interacts 
directly with RAP1 (see the interaction map in Chapter 2, Figure 2.3 ) [64, 65, 
75]. Our data agrees with the sentiment that TIN2 is the lynchpin of the telosome 
complex [64]. TIN2 was the most abundantly identified protein appearing in 13 of 
18 datasets, co-purifying most frequently with TRF2 (7 of 8) and POT1 (4 of 5) 
and less frequently with TRF1 (2 of 5). Additionally, TPP1 and TIN2 were 
repeatedly found in the POT1 datasets (4 of 5) with significantly more spectra 
obtained compared to the other two bait proteins; another indicator of enrichment 
as the more protein there is in a sample, the more MS/MS spectra obtained in 
general. Although frequently identified in both the TRF2 and POT1 pull downs, 
the identification of RAP1 in the POT1 pull down is most likely through TRF2 as 
evident by the abundance of spectra collected pertaining to RAP1 in the TRF2 
pull down. However, we cannot exclude the possibility that RAP1 interacts 
directly with POT1. Interestingly, these data also indicate that TRF1 is “loosely” 
connected to the telosome complex (or easily lost due to purification conditions) 
compared to the other components. For example, using HtS-TRF1 as bait, 
telosome components were identified at lower frequencies relative to the other 
two telomere binding proteins. The most significant identifications were TIN2 (2 
of 5), POT1 (2 of 5), and TPP1 (2 of 5), corroborating the direct interaction 
between TRF1 and TIN2 [72]. Although this data could indicate that the addition 
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of an HtS dual-affinity purification tag on TRF1’s N-terminus may block its 
association with other members of the complex, this is most likely not the case as 
the co-purification of endogenous TRF1 via HtS-TRF2 or PtS-POT1 was equally 
as low.  
 
The poor enrichment of TRF1 may be explained by the closed interaction 
network formed by TRF2, TIN2, and POT1; each protein directly interacts with 
the other two. This bifurcated association may increase the stability of the 
subcomplex and enhance the capture of all associated components, including 
RAP1 and TPP1 which are direct interacting partners of TRF2 and TIN2 
respectively [76, 78]. TRF1, on the other hand, is thought to interact directly only 
with TIN2. This may affect the capture of TRF1 and/or the rest of the telosome 
depending on which protein is being purified. This observation provides evidence 
that strengthens the idea that the telosome is actually a conglomeration of two 
different subcomplexes [64, 156]. 
 
The identification of telosome components through our analysis also further 
demonstrates the non-direct nature of affinity purification-LC-MS/MS. As 
purifications are mild to retain interacting proteins, it should be understood that 
identified proteins are do not necessarily interact directly. In fact, it is highly 
conceivable that many co-purifying proteins are secondary, tertiary, or even 
quaternary interactions. The capture of these non-directly associating proteins 
most likely depends on both the affinity of the interaction(s) as well as the 
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enhanced stability imparted by multiple associations. Therefore, the identification 
of interacting proteins by affinity purification should be expanded include 
interacting complexes as well. With that in mind, we assembled the data for each 
specific bait protein, control-subtracted it, and input the results into Osprey 
network visualization software [155]. As shown in Figures 4.2, 4.3, and 4.4 , each 
identified protein for a particular bait was represented as a node in the network 
diagram. Each represented node was then probed for its known interacting 
proteins as dictated by the human BioGRID database. Edges were drawn 
between known interacting proteins. Note: only those proteins that were identified 
by our MS analysis are represented in these diagrams. Also note that only the 
TRF2 interaction diagram contains two subsections: (i) a connected diagram that 
shows identified proteins that can be traced back to TRF2 by some degree of 
separation and (ii) an unconnected diagram that represents identified protein 
networks/complexes that do not connect back to the bait protein. Additionally, 
each representation is color coded to provide a quick view of how frequently the 
putative interacting proteins appeared in the MS results: green (high), yellow 
(med), red (low), blue (very low). Although these frequencies are helpful, they 
can also be deceiving. For example, intuitively, we may regard a “green” 
identification as being a positive, strong interacting partner while something 
“blue” is weak and/or possibly a false-positive due to lack of representation. 
However, a protein identified at a very low frequency could be indicative of a 
transient interaction. Conversely, a protein identified at a high frequency could be 
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indicative of a non-specific protein that co-purifies with the tagged bait protein all 
the time.  
 
These network diagrams are valuable indicators of (i) novel bait protein function, 
represented by co-purifying proteins functional groups, (ii) purification frequency 
and connectedness, lending evidence towards whether the interaction is direct or 
indirect, and (iii) novel interacting complexes / networks with indication as to 
which component may be the direct link. Additionally, proteins listed in the table 
(see Appendix A ) that do not appear in the network diagrams indicate novel 
interacting partners that may or may not be directly linked to the bait protein. 
Although there may be less evidence supporting hypotheses as to why these 
particular proteins interact, attention should be paid to those that make sense 
functionally and/or appear at decent frequencies.  
 
The protein network analysis for each bait protein yielded interesting results. For 
TRF2, many MS-identified, potential interacting partners fell into several 
functional classifications. The most prevalent categories included the shelterin / 
telosome complex, DNA damage response and repair, transcription / cell cycle 
regulation, signal transduction, RNA processing, protein transport, nuclear 
import, ubiquitin-based degradation, and DNA replication. Also, several other 
categories were represented that do not appear in the network connection 
diagrams but rather in Appendix A  including chromosome cohesion and 
chromatin modification / remodeling. Several of the above mentioned functional 
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groups have been previously identified to relate in some way to TRF2’s function. 
For example, TRF2’s interaction with members of the telosome is no surprise 
(see above) as well as its connection to the DNA damage response [64, 65, 152, 
153, 158]. In fact, there were a total of 22 proteins identified that relate, in some 
way to the damage response or to DNA repair including, but not limited to: Rad50 
(known [159], HR), BRCA1 (tumor suppressor / genome surveillance), Ku80 
(known, Ku70/80 heterodimer [160], NHEJ), MSH2, MSH3 (mismatch repair), 
and DDB1 (nucleotide excision repair) (Entrez Gene, NCBI). Another functional 
category, DNA replication (11 proteins identified), has been previously linked 
TRF2 as well [95, 161]. Other categories include: the ubiquitin-based protein 
degradation (30 proteins identified) (direct communication, Pieshu et al. as well 
as several published reports on TRF2’s homolog TRF1, [162, 163]), chromosome 
cohesion (6 proteins identified; telosome components linked to cohesion [164, 
165]), and chromatin remodeling / modification (21 proteins identified; linking 
telomeres and chromatin modification, [166]). Although there are no published 
links to the other functional categories mentioned above, this does not preclude 
their relevance to TRF2 function. 
 
In comparison to TRF2, the other telomere binding proteins did not co-purify as 
many potentially novel interacting proteins, though they each identified all or 
most of the components of the telosome complex (internal control; see Table 4.2, 
Figure 4.3 and 4.4). Interestingly, the connectivity of TRF1 and POT1 co-
purifying proteins (based on the human BioGRID database) was substantially 
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less than TRF2. This perhaps indicates that these proteins participate in less 
cellular pathways relative to TRF2 or that they have been studied less, at least in 
regards to their interacting partners. Nevertheless, the major TRF1 co-purifying 
complexes fell into the following function categories: the telosome, nuclear import 
machinery, DNA replication, ubiquitin-based protein degradation, signaling, cell 
cycle regulation, and chromosome condensation. Like TRF2, several of these co-
purifying complexes may perhaps be validated by previous research. For 
example, it has been shown that TRF1 is imported into the nuclease via classical 
nuclear import, regulated by both KPNB1 and KPNA2 [167]. As mentioned 
above, the telomere is thoroughly integrated with the cellular response to DNA 
damage. Additionally, a recent report has implicated TRF1 in DNA damage-
mediated cell cycle arrest [168]. TRF1 has also been previously linked to 
ubiquitin-based protein degradation [162, 163]. Members of the structural 
maintenance of chromosomes (SMC) family have also been linked to the 
telomere and TRF1 [169]. Finally, TRF1’s involvement in DNA replication, 
especially considering its role in telomerase regulation, has been previously 
documented [95, 104, 130, 170].  
 
In regards to POT1, the identification of potentially interacting complexes and 
proteins were even less than what was identified for TRF1, suggesting either the 
loss of interacting proteins with lower affinities, interference from nonspecific 
proteins (i.e. the leeching of immunoglobin components from the beads specific 
to ProA purification), or perhaps the notion that this protein may play less of a 
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role in processes outside the telomere. This suggestion is valid as the all of the 
telosome components were frequently identified, many of which at higher levels 
compared to the other two bait proteins. Whatever the case, POT1 co-purified 
several subcomplexes including the telosome, those involved in transcription, the 
cellular response to stress, and DNA repair.  
 
As mentioned above, the putative interacting proteins and complexes identified 
for both TRF1 and POT1 were not as extensive as TRF2, especially when control 
subtracted. Although TRF2 was sampled a greater number of times (8 vs. 5), the 
total number of non-redundant proteins identified per sample was significantly 
less in TRF1 and POT1 pull downs when comparing only samples treated the 
same way, i.e. whole cell lysis and tet-regulatable expression only (data not 
shown). This may reflect the degree of interaction each bait protein undergoes 
and is not necessarily a reflection on the analysis. For example, there is little 
dependence of the number of identified co-purifying partners on bait protein 
abundance. This is perhaps best exemplified by general increased 
capture/identification of POT1 relative to TRF2 coupled with the identification of 
less POT1 co-purifying proteins. However, it is difficult to make conclusions 
based on these trends as there are several factors that could impact the 
efficiency of interacting protein capture including expression and stability of the 
protein, solubility, affinity, or buffer compatibility. 
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Additional notes on the analysis: three TRF2 samples sets included in the 
analysis were treated somewhat differently than the other in that they were 
transfected with additional HtS-TRF2 to vastly increase the amount of bait protein 
in the analysis. This was primarily done to probe for sites of phosphorylation that 
occur in response to ionizing radiation exposure (see Chapter 5). Although 
treated slightly differently than the other sample sets, the interacting protein 
analysis is still valid and was thus retained in this current analysis.  
 
In order to probe some interesting interactions, either that were frequently 
identified and/or functionally relevant, we performed co-immunoprecipitation 
experiments to validate some of the interacting partners. Although one interaction 
was confirmed (see KPNA2 pull down, Chapter 6, Figure 6.5 ), not every protein 
that was frequently identified by our affinity purification-LC-MS/MS approach 
translated to a confirmed interaction via Co-IP and western analysis. However, 
the IP conditions as well as the efficacy of the purchased antibodies may provide 
questionable results. Thus, a non-confirmation by Co-IP does not preclude 
confirmation by another methodology. 
 
In this study, we have systematically probed the interaction network surrounding 
each telomere binding protein TRF1, TRF2, and POT1. The complete 
identification of all known telosome components as well as identification of 
several known interacting partners for each protein lends validity to our 
approach. Interestingly, the telosome co-purification data presented here both 
95
confirms previous assessments regarding the overall architecture of complex as 
well as suggests the notion that TRF1 may in fact be more loosely associated 
with the complex as was previously thought. The telosome analysis also 
demonstrates the non-direct nature of the affinity purification-LC-MS/MS 
approach and indicates the co-purification of proteins at various degrees of 
separation, i.e. secondary, tertiary, quaternary interactions and so on. This idea 
suggests that perhaps in addition to identifying novel interacting proteins, we 
should also pay attention to novel interacting complexes. Combined, these 
different viewpoints can provide more information about a particular bait protein 
such as its role in additional, perhaps novel cellular processes. The interaction 
analysis provided in this study has identified quite a few leads for future analysis. 
Although, several of the above identified functional processes have been 
previously linked to the telomere and/or the telomere binding proteins, analyses 













Probing Novel Sites of TRF2 




The genomes of cells are continuously being assaulted by a multitude of 
exogenous and endogenous factors including, but not limited to, ionizing 
radiation (IR), ultraviolet light, and reactive oxygen species (ROS); all of which 
interact with and damage DNA to various levels of severity. If not properly dealt 
with, these chromosomal lesions can lead to severe genome aberrations. This is 
especially true in actively dividing cells where unchecked DNA replication and 
cell cycle progression can amplify the damage, leading to point mutations, 
chromosomal breakage, fusion and/or rearrangement, and genomic instability, 
one of the hallmarks of cancer [171]. One of the most severe types of DNA lesion 
is the double strand break (DSB), which occurs when the sugar-phosphate 
backbone of a continuous stretch of DNA is broken on each complementary 
strand of the DNA double helix. Depending on the distance between the 
individual single-strand breaks from one another, the hydrogen bonds linking the 
nitrogenous bases of each strand may be unable to hold the DNA together, 
leading to a complete chromosomal breakage and liberation of each half from 
one another [120].  
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DSBs, perhaps one of the most difficult lesions to repair, are actually quite 
common during the replicative lifespan of a cell. Although they do result from 
exposure to various exogenous insults such as IR, these breaks are usually 
induced via normal metabolic pathways, for instance, the generation of ROS 
through the oxidation of foodstuffs, respiration, or even errors during DNA 
replication [120]. As they are such a common yet dastardly occurrence, cells 
have naturally developed intricate mechanisms to both sense and repair the 
damage while at the same time coordinating the repair with cell cycle arrest to 
effectively deal with the damage before it is amplified and propagated by DNA 
replication and subsequent cell division [172, 173]. 
 
There are two major DSB repair pathways that operate in eukaryotic cells: non-
homologous end-joining (NHEJ) and homologous recombination (HR). NHEJ 
involves the end-processing and joining of two broken DNA ends, regardless of 
their homology. As this nuclease-dependent end-processing essentially deletes 
genetic information flanking the DSB, NHEJ is considered a relatively error-prone 
repair process. Nevertheless, this pathway predominates in G1 cells and overall 
plays a more significant role in DSB repair relative to HR in higher eukaryotes 
[120]. HR, on the other hand, is a much more accurate repair pathway, utilizing 
undamaged, homologous DNA as a template for repair. This pathway is more 
prevalent in S and G2 cells where the genomic DNA has been duplicated, 
allowing the HR machinery to use the sister chromatid as the error-free template. 
In order to minimize the loss of heterozygosity, HR seems to be repressed in G1, 
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where it could conceivably use the homologous chromosome as a template 
[120]. Although each of the repair pathways described above utilize their own 
respective arsenal of repair proteins and mend DNA by vastly different 
mechanisms, both rely on a shared upstream signaling event that, when 
disrupted, negates their importance to genomic stability. 
 
In mammalian cells, DSBs are thought to be initially sensed by the 
Mre11/Rad50/NBS1 (MRN) complex, which subsequently accumulates (through 
NBS1) and activates (through Mre11) ATM kinase at the DSB for subsequent 
signal transduction [174-176]. ATM, Ataxia Telangiectasia Mutated, is the 
lynchpin of the DSB signaling pathway [175]. Following treatment with IR or DSB-
inducing drugs, ATM is rapidly activated and localized to damage foci in every 
phase of the cell cycle [177]. As a kinase, it functions to phosphorylate multiple 
substrates including Chk2 kinase (promoting S and G2 arrest), p53 (promoting 
cell cycle arrest and apoptosis), histone H2AX (central component of DSB 
signaling apparatus), and a multitude of other proteins directly involved in the 
signaling and repair of DNA damage [175, 177]. Patients with missing or 
deactivated ATM display a radiosensitive phenotype and predisposition to cancer 
while cells grown in culture show acute radiosensitivity, characterized by an 
increase in chromosomal aberrations, cell mortality, and radioresistant DNA 
synthesis (RDS) due to defects in cell cycle arrest [178-180]. This, ATM kinase is 
an integral part of the cellular response to DNA damage and thus better 
knowledge of its substrates would help identify additional components of the 
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damage response and perhaps shed more light on general mechanisms of 
malignant transformation and cancer progression. 
 
It is well known that the telomere, like the well-orchestrated cellular response to 
DNA damage, is an integral component of overall genomic stability. As detailed 
in Chapter 2, one of the main functions of the telomere is to protect the ends of 
linear chromosomes from being recognized as damaged DNA and subsequently 
processed by the DNA repair machinery. Thus, it only makes sense that some 
cross talk between the two pathways must exist. To that end, the telomere and 
the components of the telosome/shelterin complex, have be shown to associate 
with various DNA damage response factors including the MRN complex (see 
above, damage sensor, recombinatorial repair), ERCC1/XPF (nucleotide excision 
/ crosslink repair), WRN and BLM helicases (see Chapter 1), DNA-
PKcs/Ku70/Ku80 (DSB repair through NHEJ pathway), PARPs and Tankyrases 
(base excision repair, mitosis), and RAD51D (perhaps DSB repair through HR 
pathway) (as reviewed in [64]). As the telomere is essentially a persistent double 
strand break and thus it may be regarded so as far DNA damage response 
proteins are concerned, the telomere is not to be repaired, and thus other factors 
must play a role in preventing the erroneous activation of the DSB response. 
 
Upon closer inspection of the telosome, one component stands out as possibly 
playing an alternative role in the cellular response to DNA damage, telomere 
repeat binding factor 2 (TRF2). Many of the known DNA damage response and 
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telosome-associated factors mentioned above have actually been shown to 
interact mainly with TRF2, such as the MRN complex, DNA-PK/Ku70/Ku80, 
WRN, BLM, and PARP-2. Interestingly, TRF2 has also been shown to associate 
with ATM, the major transducer of the DNA damage signal described above 
([153, 181] and Chapter 3). Specifically, TRF2 binds to an area close to ATM’s 
S1981, the residue that is autophosphorylated in response to DNA damage and 
integral to is activation through disruption of the less active ATM dimer into its 
more active monomer [182]. Therefore, it has been suggested that TRF2 may 
have some inhibitory effect on ATM activation and it was shown that 
overexpression of TRF2 reduced the efficacy of the ATM-mediated DNA damage 
response [181]. These data coincide with the agreed upon function of the 
telosome complex, indicating a potential additional role for the protective 
complex: to prevent the localized activation of ATM and the ensuing response 
which is not welcome at the telomere [64].  
 
In addition to this data, several recent studies [65, 152, 158, 159, 181, 183, 184], 
even some that are yet to be published (Gilley et al. manuscript in preparation), 
indicate that TRF2 may play a pivotal role in the cellular response to DNA 
damage. Utilizing fluorescence microscopy, YFP-tagged TRF2, and the laser 
microbeam irradiation to induce DSB formation, Bradshaw and colleagues 
demonstrate that YFP-TRF2 accumulates at DSB tracts within seconds after 
irradiation, but remains for only a few minutes [152]. Although hotly debated, this 
makes sense. As TRF2 is required for telomere protection, it may be required for 
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genomic double strand break protection as well, or at least until the break has 
been resolved. Alternatively, perhaps it is involved in the recruitment of DNA 
damage response and repair factors to break point. No matter what the case, 
further study into the alternate functional roles of TRF2, if any, would provide 
supplementary insights into the mechanisms involved in maintaining overall 
genomic stability. 
 
As mentioned several times above, one of the key players in the cellular 
response to DNA damage that is also associated with the telomere and TRF2 is 
ATM kinase. ATM is a member of the phosphatidylinositol kinase-related kinases 
(PIKK), a group that also includes ATR (Ataxia Telangiectasia and Rad3-related) 
and DNA-PKcs (DNA-dependent Protein Kinase, catalytic subunit) protein kinases 
that are integral, upstream regulators of the DNA damage response and cell 
cycle damage checkpoint that occurs immediately after the discovery of a 
chromosomal lesion [185-187]. All three are members of the serine/threonine-
specific protein kinase (EC 2.7.11.1) class of enzymes and target these specific 
amino acid residues for the addition of a negatively charged phosphate group. 
The phosphorylation of proteins by kinases is an important cellular regulatory 
mechanism that leads to a physical alteration of the targeted protein after it has 
been fully translated, i.e. a post-translational modification (PTM). Like other 
PTMs, the addition of a phosphate group(s) on a protein leads to a change in its 
functional activity, localization, and/or association with other proteins. Therefore, 
it is an important “switch-like” regulatory mechanism that provides an additional 
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level of regulation on top of other cellular controls such as expression or 
proteolysis. As for the prevalence of phosphorylation, it is estimated that up to 
30% of proteins may be modified by one or more phosphorylation events [9, 
188]. Due to their importance in regulating cellular events through 
phosphorylation, kinases themselves are very highly regulated, often being 
themselves phosphorylated (cis or trans) and/or inhibited / activated by other 
interacting proteins and small molecules [9, 185].  
 
As phosphorylation is such an important PTM, knowledge of which proteins 
become phosphorylated and in response to what stimulus is an important goal of 
the systems biology era. Luckily, researchers have at their disposal a tool that 
seems built to probe the seemingly random addition of PTMs on proteins in an 
unbiased way and without need for much preliminary knowledge of the protein 
aside from its sequence. Mass spectrometry (MS) is able to provide intricate 
measures of protein and/or peptide mass, as well as garner sequence 
information through the predictable collision-induced fragmentation of a peptide 
at the bonds linking each residue to one another (see Chapter 1). The intact 
peptide mass information along with these fragmentation or tandem mass 
spectra allow one to identify potentially phosphorylated peptides (parent mass 
plus ~79.97 Da per phosphate group) as well as the exact locations of the 
additions, which manifest themselves as predictable and observable shifts in the 
fragment ions flanking the PTM(s) [189, 190]. 
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Our previous studies involving the development of a dual-tag affinity purification 
system (Chapter 3 and [153]) and the elucidation of the protein network 
surrounding the telomere binding protein utilizing this system (Chapter 4) 
generated vast amounts of mass spectrometry data. In addition to the 
identification of novel interacting partners of each bait protein, numerous 
collision-induced dissociation (CID) spectra (tandem MS or MS/MS) of each 
respective telomere binding protein used in the analysis were also obtained. As 
the bait proteins were the most abundantly identified proteins in each respective 
2D-LC-MS/MS analysis, an opportunity presented itself to study one of these 
proteins in greater detail, specifically the phosphorylation status of human TRF2. 
 
In this study, we identify several candidate phosphorylation sites along the TRF2 
protein sequence using a combined MS and bioinformatic approach. One 
candidate MS-identified site, serine 380, was found to be conserved through 
several species and predicted to be phosphorylated by the DNA damage kinase 
ATM or DNA-PKcs. Due to the most recent data linking TRF2 to the cellular 
response to DSBs, this site was further probed to identify phenotypes resulting 
from its disruption. Although no phenotype was identified in transient co-
localization studies, the mutation of this residue to alanine appears to have a 
negative affect on cell viability in a stable line expressing the mutated version 
over the course of 15 generations. Our study demonstrates the relative ease at 
which additional information regarding PTMs can be obtained from mass spectra 
utilized in other analyses, i.e. proteomic evaluations or protein complex 
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identification (see Chapter 4), and that such information can be useful in 
constructing targeted inquiries to uncover useful biological information. 
 
5.2: Materials and Methods 
Identification of TRF2 Phosphorylated Residues via Tandem MS 
Tandem MS datasets obtained from N-HtS-TRF2 dual-tag affinity 
purification (see Chapter 4) were researched with DBDigger to identify putative 
sites of phosphorylation on TRF2. DBDigger was instructed to search for 
modified serine and threonine residues (dynamic; phosphate group  +79.97 
Da) and modified cysteine residues (static; iodoacetamide  +57 Da) against a 
sub-database containing the FASTA sequences of only those proteins that were 
identified in the original search (see Chapter 4). Additional parameters were as 
follows: enzyme specificity was semi-tryptic, allowing for missed cleavages, a 
precursor mass error of 3.0 Da, a fragment mass error of 0.5 m/z, and a peptide 
mass range spanning 400 to 5100 Da. After researching the datasets, DTASelect 
was used to filter and organize the data with peptide acceptance contingent upon 
the following criteria: XCorr values were set at ≥23, ≥28, or ≥43, for singly-, 
doubly-, and triply-charged ions, respectively, allowing for an approximated 5% 
false discovery rate at the peptide level; DeltCN was required to be ≥0.08, and a 
minimum of 2 peptides per locus was required per protein identification (as 
described in Chapter 4). 
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To increase our confidence in the tandem MS identified phosphorylation sites, we 
combined manual verification of the spectra, evolutionary conservation analysis, 
and a bioinformatic / neural net phosphorylation site prediction analysis. For the 
evolutionary conservation analysis, ClustalW was used to align the TRF2 protein 
sequences of human (Homo sapiens), cow (Bos taurus), mouse (Mus musculus), 
rat (Rattus norvegicus), chicken (Gallus gallus), and yeast 
(Schizosaccharomyces pombe). Highly conserved residues were noted and 
compared to the tandem mass spectrometry results. In addition to this 
conservation analysis, NetPhos 2.0 [191] and NetPhosK [192] were utilized to 
identify sites, based on the sequence, that are likely to be phosphorylated and by 
what specific class of enzymes. 
 
Site-Directed Mutagenesis of Putative Residues 
Wild-type human TRF2 in the Gateway-compatible pDONR221 vector 
(Invitrogen, Carlsbad, CA) was used to generate TRF2 phospho-kill mutants (pK) 
for the putative phosphorylation sites identified by mass spectrometry, 
evolutionary conservation, and neural net prediction analyses described above. 
Primers specific to each mutation were created, notably the primer converting 
sites Ser379 and Ser380 in wild-type TRF2 to Ala379 and Ala380, to remove the 
substrate for the kinase that putatively phosphorylates one or both serine 
residue(s). Two overlapping mutagenesis primers were created following the 
guidelines set forth in the Stratagene QuikChange Site-Directed Mutagenesis 
protocol (pKill-Fwd: 5’ – GC GCA GGC CTC AAC GCC GCC CAG GAG GCC 
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GC – 3’ and pKill-Rev: 5’ – GC GGC CTC CTG GGC GGC GTT GAG GCC TGC 
GC – 3’ [synthesized by Invitrogen, Carlsbad, CA]). The most important aspect of 
these primers is that the nucleotide point mutations necessary to convert the 
serine residues to alanines needed to be flanked by sufficient complementary 
sequence in order to successfully introduce the desired mutations into the target 
plasmid (wt-TRF2 pDONR221). The primers, wt-TRF2 pDONR221, PfuTurbo 
DNA polymerase, dNTPs, and buffer (latter three components, Stratagene, La 
Jolla, CA) were combined and PCR was used to mutagenize the template and 
amplify the mutagenized form (cycling parameters as described by Stratagene). 
Following the PCR, the samples were treated with the DpnI restriction enzyme to 
remove all traces of the parental vector. This step capitalizes on the fact that the 
parental, in vivo generated, wild-typeTRF2 pDONR221 template is methylated 
shortly after DNA replication in the bacterium in contrast to the in vitro PCR 
generated, mutagenized vector, which is not methylated after synthesis. As DpnI 
cleaves only methylated DNA, the parental vector (wild-type TRF2) is the only 
DNA that is targeted by the enzyme, leaving behind an enriched population of 
mutagenized vector. This step significantly reduces the number of false-positives 
obtained in the subsequent transformation of chemically competent E. coli strain 
JM109. Before transformation, 20% of the PCR sample was separated on a 1% 
agarose DNA gel for 1 hr at 100V, stained with ethidium bromide (EtBr), and 
visualized by a UV transluminator / gel box station to assess both the successful 
amplification and size of the mutagenized plasmid relative to the controls. JM109 
clones harboring the mutagenized plasmid were then selected on Kanamycin (50 
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µg/ml) agar plates, picked, expanded in LB broth with Kan50, and subjected to 
plasmid DNA extraction via alkaline lysis mini-prep (Qiagen, Valencia, CA). 
Concentration and purity of the extracted plasmid DNA was then assessed by UV 
spectrometry and the TRF2 coding region was sequenced using a internal primer 
(5’ – TACCTCCTCACGATGGCC – 3’, Invitrogen, Carlsbad, CA) to verify the 
incorporation of the point mutation (S379S380AA). This TRF2379-380-pK 
pDONR221 vector was then used as a donor vector for the Gateway system 
(Invitrogen, Carlsbad, CA) as described below. 
 
Generation of GFP-TRF2 or GFP-TRF2 379-380-pK Fusion Protein by Gateway 
Cloning 
  
To assess whether TRF2wt and TRF2379-380-pK retained telomeric 
localization before and after treatment with ionizing radiation, both the wild-type 
and mutant TRF2 coding sequences were first swapped into a Gateway 
destination vector harboring an in frame, N-terminal GFP coding sequence. 
Briefly, pDONR221 vectors containing either wild-type or mutated TRF2 were 
incubated overnight with pcDNA-DEST53 and LR Clonase II at room 
temperature. The recombination reaction was then treated with Proteinase K for 
10 min at 37°C to stop the reaction. One microliter  of the reaction was then 
transformed into chemically competent E. coli strain JM109 by heatshock and 
positive transformants containing the TRF2 (or mutant TRF2) coding sequence in 
the GFP-containing destination vector were selected on Ampicillin (100 µg/ml) 
agar plates. Colonies were isolated, expanded in LB broth with Amp100, and 
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subjected to plasmid DNA extraction via alkaline lysis mini-prep (Qiagen, 
Valencia, CA). The DNA was then cleaved by restriction endonucleases and 
separated by gel electrophoresis as described above to assess the success of 
the recombination via observation of the expected pattern/ sizes of restriction 
fragments. Verified plasmid DNA was then transfected into 293T cells by 
Lipofectamine Plus (Invitrogen, Carlsbad, CA) as previously described (Chapter 
3) and visualized by fluorescence microscopy outfitted with an immersion lens 24 
hours post-transfection to observe GFP signal and localization pattern; 
essentially a means to assess proper expression of the fusion protein.  
 
Localization of TRF2 wt and TRF2 379-380-pk Before and After Ionizing Radiation 
 To assess whether wild-type TRF2 or the phosphorylation dead mutant 
respond to intrachromosomal double strand breaks as has been recently 
implicated (see Discussion), either GFP-TRF2wt or GFP-TRF2379-380-pk were 
transfected, via Fugene 6 (Roche, Nutley, NJ) at a 3:1 reagent to DNA ratio 
(v/w), into osteosarcoma U2OS cells seeded atop coverslips at 30% confluence. 
After 24 hours, the transfected cells were treated with various amounts of 
ionizing radiation and fixed with 2% paraformaldehyde and fixed 5 minutes after 
exposure as previously suggested [152]. The cells were then dehydrated by 
three successive 5 min washes with 70%, 90%, and 100% EtOH and air dried. 
Fluorescence In Situ Hybridization (FISH) was then performed using a telomere-
specific probe (Cy3-[CCCTAA]3 PNA). A total of 100 µl hybridization solution 
(70% ultra-pure formamide, pH 7-7.5, 0.25% blocking protein, 10mM Tris, 0.5 µg 
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PNA Telomere Cy3 probe, 5% MgCl2 buffer) was applied to the cells. DNA was 
denaturated at 80°C for 3 min and hybridized with t he telomeric probe in a 
humidified chamber for 2 hrs. Cells were then washed 2 x 20 min in wash 
solution I (70% formamide, 10 mM Tris, 0.1% BSA, pH 7-7.5) and 3 x 8 min in 
wash solution II (100 mM Tris, 150 mM NaCl, 0.08% Tween-20, pH 7-7.5). Cells 
were subsequently dehydrated by three successive 5 min washes with 70%, 
90%, and 100% EtOH, air dried, and then mounted in Vectashield (Vector 
Laboratories, Burlingame, CA) with DAPI. Slides were then visualized with a 
Zeiss Fluorescent microscope to assess both the telomeric and 
intrachromosomal localization of both the wild-type and phosphorylation dead 
TRF2.  
 
In addition to the telomeric localization of the wild-type and TRF2 mutant, cells 
were exposed IR as described above, fixed in 2% paraformaldehyde, and 
counterstained with mouse anti-gamma H2AX (Abcam) and Alexa-fluor 594 anti-
mouse HRP. Fixed and stained cells were then visualized to assess the 
colocalization of the GFP-TRF2 species and sites of double strand break via 
gamma H2AX staining using the fluorescence microscope as described above.  
 
TRF2 Phosphorylation-Dead Mutants’ Affect on Cell V iability 
 HT1080 fibrosarcoma cells by themselves or containing stably integrated, 
inducible (Tet-OFF System, ClonTech, Mountain View, CA) TRF2 constructs 
(wild-type TRF2, TRF2T188A, TRF2
S380A, and TRF2T188A-S380A) were generously 
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provided by Dr. David Gilley (Department of Medical & Molecular Genetics, 
Indiana University-Purdue University Indianapolis). All HT-1080 stable cell lines 
were cultured at 37°C in growth media comprised of Dulbecco’s Minimum 
Essential Medium (DMEM; Mediatech, Inc., Manassas, VA) supplemented with 
10% fetal bovine serum (FBS), penicillin/streptomycin, L-glutamine, and sodium 
pyruvate. Each cell line (described above) was passaged for 15 generations 
either with or without doxycycline (4 µg/ml) which suppressed the expression of 
the exogenous version of TRF2. Due to complications with the viability of the HT-
1080 cells after passaging with Trypsin-EDTA by the traditional protocol (as 
described in Chapters 3-5), the cell passage protocol was slightly altered to 
reduce the harshness of the procedure. Specifically, confluent cells in a 60 mm 
culture dish were washed with warm PBS and treated with 1 ml trypsin (0.05%) / 
EDTA (1 mM) for 1 min to minimally degrade cell-cell adhesion proteins. Three 
milliliters of growth media was added to the cells to inhibit tryptic activity and the 
media plus trypsin was removed to a 15 ml falcon tube. Cells were then 
incubated with 2 ml of warm PBS with 10 mM EDTA for 4 min at 37°C to 
sequester Ca++ and Mg++ ions required for surface adhesion. The no longer 
adherent cells were then moved to the same falcon tube and centrifuged to 
collect the cells. Cells were resuspended in growth media and re-plated at 
roughly 50% density for the next passage. The remaining cells were counted via 
hemocytometer (average of 5 squares) and live to dead cell ratio was determined 
by the addition of trypan blue. Cell counts, live:dead ratio, days to confluence, 
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and number of cells plated for each passage (P) were recorded from P=0 to 
P=15 to assess how each mutant affected cellular viability. 
 
5.3: Results 
As the telomere essentially resembles a genomic double strand break 
(DSB) as well as being known to associate with various DNA damage response 
and repair proteins, it seems likely that certain telomere-specific proteins may 
exhibit alternate functional roles in the cellular DNA damage response. Recent 
reports indicate that this assertion may not be so farfetched. Specifically, 
telomere repeat binding factor 2 (TRF2) has been shown to localize to 
intragenomic DSBs, perhaps as a damage sensor / first responder to the insult 
[152]. Additionally, the well known fact that the cellular DNA damage response is 
a complicated but coordinated series of events that ultimately leads to cell cycle 
arrest and repair, senescence or apoptosis [120], better understanding of TRF2’s 
role in the process would advance our understanding the mechanisms that 
protect living organism from genomic instability and cancer.  
 
The DNA damage response is coordinated by a series of kinases, most notably 
ATM, ATR, and DNA-PK, which phosphorylate key repair and response proteins 
to alter their function in some aspect. One of the most famous examples is the 
phosphorylation of p53 and its inhibitor MDM2, destroying their interaction, which 
thus relieves MDM2’s proteolysis-based inhibition of p53 and allows its cellular 
concentration to rise to functional levels [21-23]. As kinases modify proteins by 
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attaching negatively charged phosphate groups to serine, threonine, and tyrosine 
residues, identifying phosphorylated residues of key proteins involved in the 
damage response would allow for further study and understanding of the exact 
functional role of that particular protein. In this case, we turn our attention to 
TRF2 and use a combined mass spectrometry, bioinformatic, and molecular 
biology approach to identify residues that are modified in response to DNA 
damage. 
 
To identify phosphorylated TRF2 residues, DBDigger was utilized re-search 
TRF2 interacting protein datasets obtained previously (see datasets from 
Chapter 3 and 4). To accomplish this, DBDigger was instructed to search for 
dynamic mass additions of approximately 79.97 Da on serines, threonines, and 
tyrosines. In order to reduce search time, a FASTA human protein sequence 
sub-database was created containing only those protein sequences that were 
identified by the original DBDigger search for TRF2 interacting proteins. Multiple 
TRF2 datasets were reanalyzed and several residues were identified as possibly 
harboring a phosphate group addition. As many phosphorylated residues are 
transient in nature, one would expect to observe a distribution of peptides 
containing either a modified or unmodified residue.  
 
In order to better direct our follow up experiments, a combined evolutionary 
conservation along with bioinformatic analyses were performed. For the 
conservation analysis, TRF2 protein sequences from human and several other 
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species were obtained and aligned using ClustalW. The identification of 
conserved residues between homologous proteins of distantly related species is 
an excellent tool to highlight amino acid residues that are necessary for proper 
function. Combined with the MS-identified phosphorylated residues, residues that 
are also conserved are more likely to be functionally important and perhaps have 
a better chance to be truly modified. This is especially true if there are regions of 
conservation that correspond to predicted kinase-targeting consensus 
sequences. Therefore, NetPhos 2.0 and NetPhosK were utilized to predict both 
phosphorylated residues and the kinases responsible for the modification, based 
solely on the TRF2 protein sequence searched against a database of known 
phosphorylation sites / consensus sequences.  The results from these two neural 
network-based bioinformatic prediction tools, in conjunction with the MS-
identified phosphorylation sites and evolutionary conservation analysis were 
used together to identify the residues that most likely harbor a phosphate 
addition at some point in the life of the protein. Additionally, the kinase prediction 
tool, NetPhosK, helps narrow down the cellular process by which the modification 
most like occurs, or in response to a specific stimulus. These data are 
summarized in Figure 5.1 . 
 
One of the most intriguing and highly identified phosphorylation sites discovered 
by the mass spectrometry analysis was serine 380. The CID-induced peptide 
fragmentation data (Tandem MS) of multiple sample runs indicate the existence 

















Figure 5.1: Predicted phosphorylation sites of hTRF2. Partial sequence of hTRF2 showing sites 
of phosphorylation identified by mass spectrometry (MS). Orthologous TRF2 sequences (Hs: 
Homo sapiens, Bt: Bos taurus, Mm: Mus musculus, Rn: Rattus norvegicus, Gg: Gallus gallus, Sp: 
Schizosaccharomyces pombe), aligned by ClustalW, were included to assess the residue 
conservation of the proposed modification site. Residues containing a modification on the human 
version were labeled. Bolded sites contained 3+ identified peptides across all three datasets. 
Green indicates a phosphorylation site identified by our MS data, with interspecies highlighting to 
show conservation, and gold indicates a site both known (Gilley) and identified by mass 
spectrometry (Liu). NetPhos 2.0, a neural-network / in silico based approach for predicting sites of 
phosphorylation was used to support the MS identifications. NetPhos 2.0 predicted sites are 
labeled (P). Only those sites that scored > 0.500 are labeled as a NetPhos predicted site. 
NetPhosK, a similar utility, was used to predict specific kinase interaction sites. The colored 
triangles indicate specific site(s) of action of those kinases that were both predicted by NetPhosK 
and identified in our dual-tagged hTRF2 pull downs. Blue triangle, DNA-PKcs; red triangle, ATM; 















containing the Ser380 site but differing in length / terminal residues. Figure 5.2  
(stacked figure) summarizes the various permutations of parent ions that 
represent this modified amino acid. As shown in Figures 5.1 and 5.2 (zoomed in 
sequence), this amino acid is also highly conserved down to chicken, Gallus 
gallus, and even negative charge conservation down to yeast. Additionally, 
NetPhos 2.0 and NetPhosK predicted this site to be phosphorylated by ATM 
and/or DNA-PKcs kinase. As mentioned above, and discussed below, this is very 
interesting as ATM and DNA-PKcs kinases are two of the major upstream 
transducers of the DNA damage signal, phosphorylating numerous proteins in 
order to coordinated the appropriate cellular response to the damage. Since 
TRF2 has also been recently implicated in playing a role in the recognition of 
genomic DSBs, we focused our attention on both validating this site and 
understanding its functional role. 
 
To increase our confidence in identification of serine 380 as a bona fide 
phosphorylation site, the best MS/MS fragmentation spectrum was manually 
verified (Figure 5.3 ). The triply charged peptide: L V L E E D S Q S T E P S A G 
L N S S * Q E A A S A P P S K P T V L N Q P L P G E K containing the 
phosphorylation (asterisk) was of the expected average mass/charge (1429.18 
m/z predicted, 1429.26 m/z observed), containing 21 y-ions (51.2% of the 
expected ions) and 3 b-ions that were easily distinguished from the noise and 
that matched the predicted ions of the theoretical fragmentation spectra of the 













Figure 5.2: Peptides identified across all sets of TRF2 that identified S380 (asterisk) as being 
phosphorylated. Listed are each peptide, its charge state, and the number of spectra obtained for 
that peptide. The peptide highlighted in red was picked to be manually verified due to both its 
XCorr score and the nature of the peptide, i.e. the phosphorylation site was conveniently located 

































Figure 5.3: Manual verification of peptide: L V L E E D S Q S T E P S A G L N S pS Q E A A S A 
P P S K P T V L N Q P L P G E K, containing a phosphorylated serine residue at S380 (p). The 
measured and theoretical average masses differ by only 0.06 m/z units. 51.2% of the predicted 
ions are represented in the spectrum as well as several characteristics such as a proline effect at 































present that help increase our confidence in the identification of the 
phosphopeptide, such as (i) a decently abundant and expected neutral loss peak 
at the appropriate mass to charge ratio (1396.595 m/z) and (ii) a very abundant 
y16 ion at 851.80 m/z, corresponding to the preferential fragmentation of the 
parent at the amide bond N-terminal to a series of prolines; the proline effect. 
 
To further investigate the importance of this phosphorylated residue, especially in 
regards to the ATM / DNA-PKcs-related DNA damage response, site-directed 
mutagenesis was performed on amino acid residues 379 and 380 to convert the 
wild-type serines to either alanines or aspartic acids. These two mutations aim to 
abolish (SSAA) or mimic (SSDD) phosphorylation in this region of TRF2 so 
that observations regarding the functional importance of the phosphorylation 
event could be assessed. Following verification of the point mutations and 
cloning into an N-terminal GFP destination vector, the fusion proteins were 
transiently expressed in U2OS to gauge both their expression level and 
localization to the telomere. As shown in Figure 5.4 (left) , the fusion proteins 
GFP-TRF2wt, GFP-TRF2SSAA, and GFP-TRF2SSDD all localized to the telomere. 
This was expected as the N-terminal basic domain and C-terminal myb domain, 
both involved in TTAGGG repeat binding, were not altered.  
 
To assess whether TRF2 wild-type or mutant versions changed their localization 
pattern after exposure to ionizing radiation (IR), cells were exposed to 2 Gy of IR 




Figure 5.4: Telomere localization of all versions of GFP-TRF2: wild-type, SSAA (phosphor-kill), and SSDD (phospho-mimic). GFP signal 
represents the TRF2 molecule, TTAGGG represents the telomeric tract, stained by TEL-FISH, and Merge overlaps the previous two images to 





with a DNA probe specific to the 3’ G-rich overhang. As previous studies have 
implicated TRF2 as playing a role in the response to intragenomic DSBs, 
including its localization to these sites after as little as 5-10 seconds [152], it was 
expected that if TRF2 did in fact relocalize / also localize to DSBs, there would be 
an observable change in the degree of colocalization with the telomere. In other 
words, no damage leads to a complete telomeric localization while induction of 
DSB foci via IR would lead to the appearance of additional TRF2 foci that were 
not associated with the telomere. As shown in Figure 5.4 (right) , there appears 
to be no change in localization following exposure to IR with almost complete 
localization to the telomere across all versions of TRF2. 
 
With the lack of an observable phenotype in both wild-type TRF2 and the 
mutants, the localization of just wild-type TRF2 was assessed to see if time after 
exposure had any affect on its localization. As shown in Figure 5.5 , the wild-type, 
GFP-tagged TRF2 remained at the telomere at all times following exposure to 2 
Gy of IR. This is in contrast to these newest findings suggesting TRF2 localizes 
quickly to DSBs [152]. As an alternative, cells expressing GFP-TRF2 were 
exposed to 2 or 10 Gy of IR, fixed after 10 minutes, and probed with a traditional 
DSB marker, γH2AX. This protein is an ATM kinase-targeted histone that occurs 
at a low but repetitive frequency along the chromosome. Upon induction of 
DSBs, ATM phosphorylates H2AX, forming the γH2AX at the break points. The 

















Figure 5.5: Attempt at confirming the reported TRF2 localization to DSBs after exposure to IR. 
Using an IR exposure of 2 Gy and multiple fixation time points following treatment, GFP-TRF2 















shown in Figure 5.6. Interestingly, it appears that both γH2AX staining and GFP-
TRF2 signal was mutually exclusive. 
 
As the functional role of the S380A mutation has yet to be elucidated by the 
above-described experiments, it was hypothesize that perhaps the phenotype of 
the mutation would take longer to develop and be displayed. Therefore, HT1080 
cells stably expressing inducible versions of TRF2 (wt-HT1080 control, wt-TRF2, 
TRF2T188A, TRF2S380A, and TRF2T188A-S380A) were cultured for 15 generations with 
observations made on cell viability and telomere length either every passage or 
every three passages respectively. A western blot showing the inducible 
expression of TRF2 in each clone is shown in Figure 5.7. Cell viability for the 
passage series’ of each HT1080 clone was quantified in two different ways, 
doublings per day and percent dead. The former of which is calculated by taking 
the square root of the total number of lives cells per confluent plate (end of 
generation) divided by the number of plated live cells at the beginning of each 
generation and dividing this number by the length of time in days to reach 
confluence. The ratio of live to dead cells was also computed following each 
generation.  
 
As depicted in Figure 5.8 , the number of doublings / day within each clonal set of 
mutants (expressed versus unexpressed TRF2 species) is affected by the 
expression of the mutated TRF2. This is in contrast to the clonal set that either 

















Figure 5.6: The lack of colocalization between GFP-TRF2 and the DSB marker γH2AX, 10 
minutes post-exposure to IR. The number of DSB foci increase with higher IR dose, but TRF2 





































Figure 5.7: Regulatable expression of wild-type TRF2, T188A and S380A mutants in HT1080 
cells. Expression is based on the Tet-OFF system, utilizing doxycycline as the blocking agent. 
Whole cell lysate was obtained for western blot analysis. B, blocked (doxycycline added); E, 




























































Figure 5.8: The expression of various versions of TRF2 and their effect on the proliferative 
capacity of each clone, as measured by doublings per day. There is a significant decrease in the 
proliferative capacity of cells expressing both mutant forms of TRF2. This was not observed for 
cells expressing a wild-type version. WT, wild-type TRF2; 188, T188A mutant; 380, S380A 















difference in the doublings / day metric as was observed in the phosphorylation 
dead clonal sets. Interestingly, the double mutant (T188A plus S380A) was 
unable to be passage. Overall, the T188 and S380 phosphorylation sites may 
have some functional relationship to cell’s ability to grow properly that is 
independent from the over expression of TRF2 in general. Additionally, the 
expression of TRF2 in general, whether it be the wild-type or mutated versions, 
seems to increase the percentage of dead cells observed each passage (Figure 
5.9). Taken together, these results indicate that the MS-identified S380 
phosphorylation site is indeed a true site of modification and that it may play a 
role in cell viability, perhaps in stalling the cell cycle, leading towards senescence 
or impediment of growth in culture. 
 
5.4: Discussion 
Several interesting studies regarding the functional role of human TRF2 
outside its known role at the telomere have recently been reported. Although 
under intense debate within the telomere community, one study provided 
conclusive evidence that TRF2 acted as one of the most upstream sensors of 
genomic double strand breaks (DSBs) when cells were damaged using a laser 
knife [152]. In this study, YFP-TRF2 quickly accumulated at sites of double 
strand break (as visualized by both γH2AX and TUNEL analysis) shortly (5 
seconds) after irradiation with the laser knife, which itself creates user-targeted 
tracts and/or spots of DNA damage. Although the laser knife is a sort of artificial 























Figure 5.9: The expression of various versions of TRF2 and their effect on the cell death, as 
live:dead cell ratio during passage (trypan blue). There is a significant increase in cell death in 
both the WT and T188A clones, but not in the S380A clones. WT, wild-type TRF2; 188, T188A 
mutant; 380, S380A mutant; B, blocked; E, expressed.  
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evidence, such as the known fact that TRF2 and other telomere components 
interact with several members of the DNA damage response [65], suggest that 
findings in this study may not be so far-fetched.  
 
As mentioned above, the previously generated data provide a unique opportunity 
to garner additional information about each bait protein. One specific area that 
has gathered much attention recently is the identification of post-translational 
modifications using mass spectrometry. This area is especially pertinent to our 
study of TRF2 and its putative involvement in DSB recognition and perhaps even 
repair as the cellular response to DNA damage is largely coordinated by the PI3K 
family of kinases, ATM, ATR, and DNA-PK (see Introduction). These kinases act 
as transducers of the DNA damage signal, phosphorylating their targets to 
alter/direct their function in regards to the overall damage response (cell cycle 
arrest, repair, senescence or apoptosis) [193]. As phosphorylation is the means 
by which the damage signal is transduced, this post-translational modification is 
perhaps one of the best indicators that TRF2 may be involved in some aspect of 
the damage response, especially if this modification is applied in response to 
genomic insult.  
 
To gather information regarding the phosphorylation status of TRF2, DBDigger 
was instructed to search the previously generated tandem mass spectra for 
differentially/dynamically modified serine, threonine, and/or tyrosine residues. Of 
the twenty amino acids, these three are the only residues that can incorporate 
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the addition of a phosphate group. If modified, there would be an observable 
mass shift of 79.97 Daltons on the ion peak representing the amino acid and a 
predictable shift in all the ions (b’s and y’s) that contain the modified residue in 
the tandem mass spectra. There were several putative phosphorylation sites 
identified across the entire TRF2 sequence with several sites being more 
prevalent and confidently identified than others. However, it is important to 
realize that searching for dynamically modified amino acids increases the false-
positive rate. Therefore, several other analyses were performed in conjunction 
with the MS-based identification to increase our confidence and help focus the 
analysis to the most likely candidate sites. 
 
As described in the Results section, combined evolutionary conservation analysis 
and phosphorylation site prediction algorithms were utilized to provide additional 
information regarding the MS-identified phosphorylation sites. Theoretically, sites 
identified by MS that are (i) abundantly identified, (ii) highly conserved, (iii) 
predicted to be modified by phosphorylation site consensus sequence analysis 
(NetPhos 2.0), and (iv) associated with a particular kinase recognition sequence 
(NetPhosK) are those sites that present the greatest opportunity for successful 
follow up study. Figure 5.1  combines all the above describe metrics and helps to 
highlight the best candidates for focused study. As shown in this figure, several 
sites meet the above criteria. Most notable, however, is the region spanning 
amino acids 368-385 (7 of 18 being possible acceptor sites), specifically serine 
380, which also happens to identify the aforementioned DNA damage relevant 
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kinases, ATM and DNA-PKcs. Figure 5.2  emphasizes the prevalence of this 
identification by aggregating the MS-identified peptides across all datasets 
exhibiting evidence of the phosphoserine 380 (pS380). 
 
Although this site represents the best candidate linking TRF2 to the DNA 
damage response and was aptly identified by the aforementioned criteria, we 
wanted to rule out the possibility that this site was falsely identified by DBDigger’s 
pattern matching algorithm, especially since searching for modified amino acids 
can wreak havoc on false positive rates. Therefore, the tandem mass spectrum 
best representing the pS380 was manually verified. As shown in Figure 5.3  and 
explained above (see Results), manual analysis of this triply charged, rather 
large peptide indicates that this residue is indeed phosphorylated. Although triply 
charged peptides are less than ideal, especially in an algorithmic sense, the fully 
tryptic peptide representing this region must be triply charged in order to fall 
within the mass/charge range of the linear-ion trap mass analyzer. This is due to 
the predictable missed cleavage at the internal lysine residue immediately 
flanked by a proline. Therefore, assuming fully tryptic ends, there are three points 
of protonation on the peptide. As explained above, several metrics allow for the 
unambiguous identification of the phosphorylated peptide: (i) the correlation 
between the theoretical and observed parent mass of the singly phosphorylated 
peptide, (ii) 51.2% of the predicted y-ions were represented and practically all 
major peaks in the spectrum were assignable, (iii) a predicted high intensity y16 
ion was observed that correlates very well to the anticipated proline effect at that 
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site [194], (iv) an observable neutral loss peak at the correct mass, a 
phenomenon that occurs when the phosphate group, a good leaving group, is 
lost during CID with no net change in charge, (v) a concomitant loss of intensity 
of this neutral loss peak most likely explained by the competing proline effect, 
and (vi) the localization of the phosphorylation event to S380 by exclusion of the 
other possible candidate acceptor sites. Taken together, these observations, 
including the observed peptide without a phosphate group addition, allowed us to 
conclude that serine 380 on human TRF2 can be differentially phosphorylated. 
Corroborating our finding is a recent study published in Science that identified 
substrates of ATM and ATR kinases as well as the specific site of 
phosphorylation [195], of which our pS380 site was identified along with another 
of our MS-identified sites, pS368 (see Figure 5.1 ).  
 
After the establishing that serine 380 of TRF2 is a bona fide phosphate group-
accepting residue and that its phosphorylation was most likely due to a DNA 
damage response related kinase (ATM or DNA-PKcs), several N-terminal GFP 
tagged TRF2 mutants were constructed that either mimicked the charged nature 
of a phosphate group addition (S379-S380DD) or destroyed the possibility of 
the residues being modified (S379-S380AA). Once their proper expression and 
localization to the telomere were verified (Figure 5.4 left ), these mutants, in 
conjunction with a wild-type GFP-TRF2, were used to ascertain whether shortly 
after exposure to IR, (i) wt-TRF2 could localize to sites of genomic DSB and (ii) 
TRF2 mutant localization pattern differs from that of wild-type TRF2. The former 
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goal, although somewhat attempted before, employed the most recent data from 
Bradshaw et al. suggesting that TRF2 accumulates at intragenomic DSB foci in 
as little as 5 seconds after exposure to IR and persisted for only a few minutes. 
This idea is in contrast with previous studies [181] which did not detect an IR-
induced change in TRF2’s localization pattern. However, these observations 
were based on longer post-IR incubation periods and thus the discrepancy may 
lie within the experimental design rather than in actual fact. As shown in Figure 
5.4 right , both wild-type and mutant GFP-TRF2 fusion proteins were never found 
at sites other than the telomere. Further probing just the localization pattern of 
wild-type GFP-TRF2, we found that at all time points, TRF2 localized only to the 
telomere (Figure 5.5 ) and failed to colocalize with DSB foci, as visualized by 
γH2AX (Figure 5.6 ). The latter localization pattern did not even change in 
response to varying dosages, somewhat large dosages of IR (10 Gy). These 
results were disappointing as the experiments performed by Bradshaw et al. 
provided conclusive evidence of TRF2 localization to DSBs. One thing to note, 
however, is the difference in the tools used to generate the DSBs. In our study, 
we used X-Ray radiation in a field-accepted dosage range while the study 
performed by Bradshaw et al. used a laser knife to deliver a gargantuan amount 
of localized radiation (on the level of ~80 Gy). Additionally, the laser knife 
targeted radiation technique has lately come under some scrutiny as many in the 
field feel that this is a very unnatural way to induce DSB formation and perhaps 
this creates method creates artifactual data. In any case, although our results do 
not exclude the possibility that a miniscule, perhaps undetectable amount of 
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TRF2 does in fact localize to DSBs, our data does not support the hypothesis 
that TRF2 acts as a first responder / damage sensor following DSB formation.  
 
One interesting observation, however, is the mutual exclusivity of GFP-TRF2 and 
γH2AX signal / localization (Figure 5.6 ). With the dosage used, leading to an 
abundance of DSB foci and γH2AX formation, it would seem that, by chance, 
there should be at least some random co-localization of TRF2 and γH2AX. This 
observation does fit with the model proposed in Bradshaw et al. where TRF2 
localized to the laser-induced DSB even before γH2AX was formed. Additionally, 
it is well known that γH2AX formation at the telomere is contingent upon the 
TTAGGG tract length becoming critically short [65, 92]. As described in Chapter 
2, the shortening of the telomere would lead to less TTAGGG repeats and thus 
less binding sites for telomere bound proteins such as TRF2. The telomere then 
becomes deprotected through t-loop disruption and a DNA damage response 
ensues. Perhaps TRF2, in some way, prevents the formation of γH2AX foci, 
protecting against DSB reparation through a transient access block or 
restructuring of the DNA surrounding the break. At the telomere, this is beneficial. 
However, at genomic DSB foci, this may be the reactive initial protective 
mechanism that becomes quickly “overruled” by the cellular repair machinery, 




Up until this point, the mutation of the S380 residue has exhibited no observable 
disruption in the normal function of TRF2. It was thus hypothesized that 
analyzing the mutation in a transient rather than long term view might be the 
major hurdle in unveiling the importance of this phosphorylation event. With that 
in mind, several inducible stable lines were created that express various versions 
of TRF2 (wild-type, S380A mutant, T188A [another site identified by a 
collaborator], and combined T188A+S380A) to assess the viability of the cells 
expressing these proteins over a period of 15 generations. If the phenotype takes 
a while to manifest, this cell culture passage strategy should uncover differences 
in growth/health based solely upon the expression of the version of TRF2. The 
controls used in the study were wild-type, non-transfected HT1080 cells as well 
as internal controls via the regulatable expression of each version (i.e. induced 
versus non-induced). As described in the Materials and Methods and Results 
sections above, after each passage several metrics on cell viability were accrued 
including cell number per confluent plate, amount plated in the next passage, 
passage length in days, and live:dead cell ratio. Additionally, cell pellets were 
collected every three passages (0, 3, 6, 9, 12, 15) to measure the telomere 
length by TRFL analysis (data in preparation). After 15 generations, and 
comparing each clone set was compared to one another by plotting two statistics, 
doublings per day and percent dead cells. Interestingly, both the S380A and 
T188A stable clones showed a detectible and significant (assuming an alpha of 
95%, p-values of 0.050 and 0.019 respectively) growth deficiency in the cultures 
that expressed the mutant TRF2 (Figure 5.8 ). In comparison, the stable line that 
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expressed a wild-type version of TRF2 showed no difference in doublings per 
day (p-value = 0.739). This indicates that it is not the expression of TRF2 that 
causes the deficiency but rather the expression of the TRF2 mutant, which would 
compete with the endogenous version in some negative way.  
 
The other metric obtained from each set of clones was the percent dead cells 
counted per passage (Figure 5.9 ). As shown in the figure, it seems as though 
just expressing a version of TRF2, whether wild-type or mutant, leads to an 
increase in the number of dead cells observed per passage. Statistically, only the 
comparisons between the wt-TRF2 and T188A sets were significantly different 
(p-value = 0.004 and 0.001 respectively) while the difference amongst the S380A 
clones was not (p-value = 0.175). No matter what the case, the trend seems to 
suggest that the overexpression of TRF2 in any form has an impact of cell death, 
possibly related the previously reported telomere attrition phenotype [196]. 
However, this increase in cell death, as it was also observed in the control, wt-
TRF2 expressing cells, does not seem to impact the doublings per day metric 
shown in Figure 5.8 , especially since the doublings per day of the wt-TRF2 
expressing cells did not differ from one another.  
 
Taken together, these results indicate the importance of sites T188 and S380 in 
cell viability and growth. Interestingly, stable cells that expressed both mutant 
forms in the same cell line did not survive in culture very long, suggesting an 
additive effect on growth and/or survivability. Perhaps the disruption of these 
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DNA damage kinase target sites plays a role in decreasing the efficacy of the 
damage response, resulting in growth retardation perhaps through a prolonged 
DNA damage response (decreasing the doublings per day metric). Similarly, the 
perturbation in the damage response may also lead to a general increase in 
genomic instability, leading to a certain percentage of the cell population to enter 
cellular senescence prematurely (relative to cells not expressing the mutant 
versions of TRF2). This “early retirement” would also similarly affect the 
doublings per day metric similarly. 
 
In conclusion, several candidate phosphorylation sites were identified in samples 
that were initially used to identify novel interacting partners of TRF2 by mass 
spectrometry. This re-analysis of the data proved useful in identifying a key 
residue, serine 380, which is potentially phosphorylated in response to DSB 
induction most likely by a DNA damage response related kinase [195]. Although 
there was no immediate detectible phenotype in our colocalization studies, which 
could have enhanced the confidence in the data generated by Bradshaw et al., 
further analyses using MS and traditional cell biology showed that the 
phosphorylation at S380 is responsive to IR and that the disruption of this residue 







TRF2’s Interaction with KPNA2, a Member of 




The telomere is a tandem repeat tract of DNA that exists at the ends of 
linear chromosomes whose major function is to address the end replication 
problem inherent to semi-conservative DNA synthesis. During DNA replication, 
lagging strand synthesis fails to duplicate the very distal ends of the 
chromosome, leading to its progressive shortening upon each somatic cell 
division. In this context, the telomere is thought to act as a sort of genetic buffer, 
allowing for this inevitable loss of DNA without genetic consequence. Although 
certain cell types have the ability to replenish the lost DNA through the action of 
telomerase, including those that have undergone malignant transformation, most 
cell types do not have this ability. In general, telomeres bestow a replicative 
lifespan upon non-telomerase expressing cells and their progressive shortening 
ultimately leads to cellular senescence, apoptosis, or, in the worse case, 
chromosomal instability. Thus, the telomere and the processes surrounding its 
upkeep have been linked to aging disorders, cancer and genomic stability in 
general (see Chapter 2 for complete review). 
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Lining the tandem repeat tracts of the telomere is a group of proteins called the 
telosome / sheltering. This six-member complex is involved in several important 
functions regarding telomere maintenance including t-loop formation, regulation 
of telomerase activity / access to the region and the prevention of its erroneous 
recognition as damaged DNA [64]. In this regards, several telomere associated 
proteins, including some members of the telosome complex, are intimately 
involved in the cellular response to DNA damage, including the detection, repair, 
and cell cycle arrest associated with it [65]. One such protein, human repeat 
binding factor 2 (TRF2), has been shown to associate with various DNA damage 
response factors [64, 65, 152]. In addition to these associations, several recent 
reports have pit TRF2 right in the middle of the cellular response to DSBs, acting 
as first responder to the site of breakage [152] as well as data implicating TRF2 
as an ATM substrate, being phosphorylated at serine 380 shortly after exposure 
to ionizing radiations (Chapter 5 and [195]).  
 
With all this novel data suggesting alternate roles for TRF2, as well as a general 
interest in obtaining more information about the protein network surrounding the 
telomere, we utilized our recently developed dual-affinity purification system 
(Chapter 3 and [153]) to identify novel interacting partners of the telosome 
proteins TRF1, TRF2, and POT1 using MudPIT 2D LC-MS/MS (Chapter 4). 
Regarding novel TRF2-associated proteins, several hundred proteins were 
identified across eight biological replicates however, three proteins involved in 
the classical nuclear import apparatus piqued our interest, importin alpha 1 / 
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karyopherin alpha 2 (KPNA2; identified in 7 of 8 samples), importin beta 1 / 
karyopherin beta 1 (KPNB1; identified in 3 of 8), and nucleoporin 50 kDa (Nup50; 
identified in 1 of 8). The identification of these three related proteins suggests 
that TRF2’s nuclear localization may be contingent upon and/or regulated by the 
classical nuclear import pathway. 
 
In contrast to prokaryotes, eukaryotic cells are highly compartmentalized, with 
the most notable physical separation being that of the cytoplasm and the 
nucleus. These two compartments, although separated in their general functional 
classifications, are inextricably linked and thus require a deliberate, orchestrated 
mechanism to regulate the transport of substrates like RNA and proteins across 
the nuclear envelope. As the localization of substrates is one form of cellular 
regulation, especially in regards to the timely expression of genes for processes 
such as embryonic development, cell division, and the DNA damage response, 
the nuclear import/export mechanism is a vitally important system that warrants 
greater scrutiny. In fact, deregulation or disruption of the transport system and/or 
its usurpation by unsavory pathogens is linked to several deleterious conditions 
such as viral infection, autoimmune disease, and cancer (as reviewed in [197]).  
 
Nuclear import and export involves three main components, the nuclear pore 
complex (NPC), transport receptors, and cargo. The NPC is a greater than 60 
MDa protein complex that spans the nuclear envelop, forming a channel that 
allows for the passive diffusion of smaller molecules less than 40 kDa but a more 
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regulated transport of molecules greater than 40 kDa via a plethora of transport 
receptors (see below) [197-201]. The main constituents of the NPC are the 
nucleoporins (Nups), each of which falls into a structural or functional 
classification. The structural Nups and their associated pore membrane proteins 
are involved in overall configuration of the NPC and its anchoring to the nuclear 
envelop. The FG-Nups, named for their domains that are littered with repeat 
motif sequences comprised of phenylalanine (F) and glycine (G) residues, line 
the central channel of the pore complex and extend outwards into both the 
cytoplasmic and nuclear compartments [197, 202-205]. They are considered the 
functional components of the NPC, implicated in both (i) creating a permeability 
barrier within the channel to prevent the diffusion of larger molecules through the 
pore and (ii) providing interaction points for the transport receptor-cargo 
subcomplex during translocation through the channel by yet to be proven 
mechanism (as reviewed in [197]).  
 
Aside from the cargo to be transported, the other components involved in the 
translocation of protein and RNA molecules across the nuclear envelope are the 
transport receptors. These receptors, belonging to the karyopherin family of 
proteins, are involved in both the recognition and binding of the cargo to be 
transported as well as directing the cargo to the NPC to initiate the process. 
Karyopherins that are involved in nuclear import are designated as “importins” 
while those involved in export are called “exportins”. Whatever the directionality 
of transport, the specific karyopherins involved fall into either of two categories, 
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betas and alphas. Karyopherin betas (Kapβ), in most cases, bind directly to the 
cargo to be transported and direct it to the NPC for translocation. However 
certain Kapβs, like the importin beta 1 (KPNB1), utilize an adaptor protein that 
links it to the cargo to be transported [206]. These adaptor proteins can be one of 
several karoypherin alpha (Kapα) isoforms and each has its own specificity for a 
particular cargo. Thus the ultimate fate of a particular cargo depends on the 
composition of the associated karyopherin subcomplex, which itself is dictated by 
a specific, cargo-encoded receptor recognition sequence, classified as either a 
nuclear localization sequence (NLS) or nuclear export sequence (NES) [199, 
207].  
 
As described above, karyopherin alpha 2 (KPNA2) was shown to co-purify with 
TRF2 (along with KPNB1 but at a reduced frequency) in our MS-based 
investigation of the protein network surround telomere binding proteins. As 
KPNA2 is key player in the classical nuclear import system, acting as an adaptor 
protein linking cargo to importin beta (KPNB1), a brief description regarding the 
general mechanism of import is imperative. The first step in nuclear import 
involves the binding of the heterodimeric receptor complex KPNA2/KPNB1 to the 
nuclear bound cargo via KPNA2’s association with the cargo-encoded NLS. 
Once bound, the three-member complex is brought to the NPC by KPNB1 where 
the entire complex then translocates through the pore (by a yet unknown 
mechanism) and enters the nucleus. Although now in the nucleus, the cargo is 
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still partnered with the importins and must be dissociated before it can function 
properly. The first step in this dissociative process involves the binding of 
RanGTP with KPNB1, which causes a conformational change in the protein and 
release of the KPNA2-cargo subcomplex.  The release of KPNB1 exposes the N-
terminal importin beta binding (IBB) domain of KPNA2 that mimics the classical 
NLS (see Discussion section) the protein itself recognizes. This leads to an 
autoinhibitory reaction where the unbound IBB domain folds over and interacts 
with the NLS binding pocket of KPNA2, effectively displacing the NLS of the 
cargo and releasing it into the nucleoplasm. KPNA2 is then recycled back to the 
cytoplasm with the help of other nuclear factors like Nup50 and CAS/RanGTP to 
begin the cycle over again (reviewed in [157, 197]). 
 
One important regulatory factor mentioned in the above mechanism is Ran. As a 
GTPase, it is associated with either GDP or GTP and that association largely 
depends on other factors such as Ran guanine nucleotide exchange factor 
(RanGEF; RCC1 in Homo sapiens) and Ran GTPase-activating protein 
(RanGAP1) [208-211]. RanGAP1 induces the GTPase activity of Ran and 
causes hydrolysis of the bound GTP to GDP. It is a cytoplasmic only protein and 
in this context sustains cytoplasmic Ran in the GDP-bound form. As RanGDP 
does not bind KPNB1, the association of KPNB1 with KPNA2 in the cytoplasm is 
allowed to occur thus forming the active import heterodimer. RanGEF, on the 
other hand, is a nuclear-only protein that replenishes the KPNB1-binding version 
of Ran by exchanging the GDP with GTP. It is this GTP-bound version of Ran 
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that initiates the release of the nuclear destined cargo from the import apparatus. 
In contrast, nuclear export utilizes a complimentary mechanism, where the 
cytoplasmic destined exportin-cargo subcomplex requires the binding of RanGTP 
to the beta exportin and its release is contingent upon the dissociation of Ran via 
the hydrolysis of GTP to GDP [157]. Therefore, these two compartmentalized 
accessory factors generate a distribution of Ran within the cells, with RanGDP in 
the cytoplasm and RanGTP in the nucleus, creating a sort of regulatory switch 
that controls the binding and release of cargo in the nuclear import/export system 
[208, 212]. 
 
The involvement of the classical nuclear import apparatus in the nuclear 
localization of TRF2 may not be hard to fathom. A recent study probing the 
compartmentalization of telosome components found that telosome assembly at 
the telomere is, in part, contingent upon the nuclear localization of TPP1-POT1 
through the action of TIN2 [25]. This suggests that the spatial distribution or 
compartmentalization of telosome components plays a role in telomere length 
maintenance and, by association, overall genomic stability. More importantly, it 
does not exclude the possibility that nuclear import of other telosome 
components, like TRF2, can regulate telosome assembly. 
 
Additional and perhaps stronger evidence linking TRF2’s participation in the 
classical nuclear import mechanism can be construed from studies on telomere 
repeat binding factor 1 (TRF1). TRF1, one of TRF2’s most closely related 
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proteins and companion in the telosome complex, was shown to associate with 
and be imported by members of this system. Specifically, importin beta, KPNB1, 
was able to stimulate TRF1’s nuclear import unilaterally, without the need for the 
adaptor importin KPNA2. Although TRF1 was shown to bind KPNB1 alone as 
well as the KPNB1/KPNA2 heterodimer with similar affinities, the heterodimer-
based import unexpectedly demonstrated an inhibitory effect on TRF1 nuclear 
localization in vitro [167]. This unconventional view of the classical import 
mechanism may not be so far-fetched as similar reports on parathyroid hormone-
related protein (PTHrP) and the yeast transcription factor GAL4 also describe an 
importin alpha-based inhibitory effect on each respective protein’s nuclear import 
[213, 214]. In agreement with these observations is a recent modeling study 
suggesting that the nuclear import of a particular cargo via the classical adaptor-
based mechanism, i.e. KPNA2 linking the cargo to KPNB1, is more energy 
intensive and thus a less efficient process relative to the importin beta-only 
strategy. In this regard, the alpha adaptor proteins, in addition to providing broad-
based adaptor-type regulation might also be involved in modulating the efficiency 
of nuclear import [215]. This idea hints at an additional layer of regulation built 
into the nuclear import system that may be tied into other cellular processes, 
especially those that require fine-tuned control and/or a quick, coordinated 
response, for instance, cell cycle progression or the DNA damage response. 
 
Indeed, a 2004 study analyzing the cell cycle’s influence on nuclear import 
efficiency of a cargo protein containing a classic NLS (requiring the alpha/beta 
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heterodimer) revealed that import efficiency, but not capacity, was tied into the 
cell cycle. Specifically, import efficiency of an NLS-tagged GFP reporter was 
found to be lowest in early S, G2/M, and M/G1. Interestingly, the changes in 
import had nothing to do with cargo abundance or its interaction with importin 
alpha, but rather, a decrease in the affinity of importin alpha to bind/co-purify with 
importin beta [215]. It is important to point out that this study focused on a 
reporter protein utilizing classical, importin alpha recognizing NLSs (mono- and 
bipartite), which, theoretically, should utilize both the alpha adaptor and beta 
importins for efficient nuclear entry. On that note, it would be interesting to probe 
the reciprocal situation, i.e. utilizing beta-preferred cargos, such as TRF1, 
PTHrP, or GAL4, to see if their nuclear import efficiency followed a similar or 
opposite trend. Perhaps at cell cycle phases where cargo/alpha/beta complex 
formation is found to be low, beta-preferred cargos are more highly and efficiently 
transported across the nuclear envelope due to a relaxation in the apparent 
inhibition by importin alpha. Conversely, in cell cycle phases that allow for or 
upregulate the alpha/beta interaction, there may be a decrease in the overall 
import efficiency of beta-preferred cargos with a concomitant increase in import 
efficiency in those cargos that require both components.  
 
The cellular need for TRF2, as measured by its expression profile, seems to 
depend on the cell cycle as well. Specifically, an increase in the total cellular 
amount of TRF2, measured via western blot and immunofluorescence, was 
observed during S phases through mitosis to compensate for the increased DNA 
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content, i.e. more telomeres, and to, as suggested by the authors, protect the 
chromosomes during segregation [216]. Accordingly, mRNA expression levels of 
TRF2 followed this trend. As mRNA is translated in the cytoplasm, any protein 
product larger than 40 kDa would need to traverse the nuclear pore via a nuclear 
import mechanism. To not waste energy, this upregulation of TRF2 during S-
phase through mitosis should correspond to its efficient nuclear import. However, 
according to the classical mechanism, these phases of the cell cycle show the 
lowest import efficiency owing to a weak alpha/beta interaction. This could 
suggest that TRF2, like TRF1 (which also exhibits its highest mRNA expression 
at G2/M [217]), may follow the beta-preferred strategy described above.  
 
Regulation of cellular processes via nuclear import is not a novel idea. However, 
the suggestion made by Riddick and Macara that importin alpha / KPNA2 may 
act as an import modulator and the data presented regarding TRF1 [167] raise 
questions as to how many processes may be regulated in this fashion and to 
what end nuclear import regulates TRF2’s nuclear entry. Current research has 
implicated TRF2 as a major player in the DNA damage response, specifically 
DSB repair. Not only are TRF2 mRNA levels upregulated after exposure to IR 
[217], TRF2 protein has been shown to transiently localize to DSB foci within 
seconds of exposure [152]. This rapid response, from the ramping up of TRF2 
mRNA expression to the protein’s localization to sites of damage implies the 
quick and efficient, and perhaps regulated import of TRF2. 
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Coincidently, several recent reports have linked nuclear import to the regulation 
of components involved in the DNA damage response as well. For example, it is 
well known that p53 compartmentalization is essential to its function. One study 
demonstrated that importin alpha binds the NLS of p53 to facilitate its nuclear 
import. As predicted, importin alpha over expression increased p53’s nuclear 
localization and led to an increase in the mRNA levels in one of p53’s 
downstream targets, p21waf1/cip1, as well as an increase in apoptosis. This was 
in contrast to the expression of a truncated form of importin alpha that maintained 
p53 in the cytoplasm and therefore did not elicit the same response [218].  
 
The nuclear import mechanism has also been shown to regulate general 
components of the DSB response. It was shown that that knocking down KPNA2 
mRNA led to a decrease in the efficacy of DSB repair when compared to normal 
cells [219]. Further study into the topic revealed that DSB repair proteins involved 
in the ATM-mediated response to DNA damage, such as NBS1 and Chk2, are 
regulated by KPNA2 [219-221]. These proteins are targets of ATM kinase. 
Coincidently, so is TRF2. As described in Chapter 5, serine 380 on TRF2 
appears to be differentially phosphorylated by ATM in response to the formation 
of DSBs. Taken together, these data indicate an important regulatory role for 
KPNA2 and links the protein to the cellular response to DSBs. 
 
Whatever the case, dual-tag affinity purification of TRF2 followed by the MS-
based elucidation of co-purifying proteins identified KPNA2 and other members 
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of the classical nuclear import machinery. As this association has not been 
described before, it would be interesting to probe both the fidelity of this putative 
interaction as well as the functional relationship between TRF2 and nuclear 
import, i.e. does it follow the conventional classic nuclear import pathway or is 
the relationship more similar to its telosome companion TRF1 where by KPNA2 
acts as an impediment towards import. In this study, we provide evidence 
demonstrating the physiological interaction of TRF2 with KPNA2 as well as 
linking the functional relationship to that of TRF1 and other proteins that seem to 
be inhibited by this interaction.  
 
6.2: Materials and Methods 
Cell Lines and Culture Conditions   
For all experiments, Human Embryonic Kidney 293T cells (ATCC, 
Manassas, VA) stably expressing both a tetracycline repressor protein (T-REx 
system compatible, [Invitrogen, Carlsbad, CA]) and a tetracycline-regulatable, 
dual-tagged fusion protein His-tev-Strep-CCPGCC-hTRF2 (N-HtS-TRF2 [153]) 
were utilized. To establish this stable cell line, HEK293T cells were first 
transfected with pcDNA™6/TR (Invitrogen, Carlsbad, CA), which expresses a 
tetracycline-repressor, followed by clonal selection with 5 µg/ml of the antibiotic 
Blasticidin-S HCl (Invitrogen, Carlsbad, CA). Antibiotic-resistant clones, conferred 
by stable incorporation of the pcDNA™/TR vector, were then co-transfected with 
the dual-tag construct (N-HtS-TRF2) and pBabe-puro (a kind gift from Dr. Gerard 
Evans), and stable clones were established by further selection with 3 µg/ml 
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puromycin (a quick acting antibiotic), 800 µg/ml G418 (selection for the N-HtS-
TRF2 construct) and 5 µg/ml Blasticidin-S (selection for the tet-repressor 
element). The most tetracycline responsive clones were selected and used for 
further experiments. These 293T-REx N-HtS-TRF2 stable cells were cultured at 
37°C in Dulbecco’s Minimum Essential Medium (DMEM; Mediatech, Inc., 
Manassas, VA) supplemented with 10% fetal bovine serum (FBS), 
penicillin/streptomycin, and L-glutamine. Cells were passaged with trypsin 
(0.05%) / EDTA (1 mM) according to accepted cell culture practices.  
 
TRF2 / KPNA2 Co-immunoprecipitation  
293T-REx N-HtS-TRF2 stable cells were cultured to around 70% 
confluence and transfected with an N-terminal Flag-tagged Karyopherin Alpha 2 
(Flag-KPNA2; a kind gift from Drs. Peter Palese and Megan Shaw, Mount Sinai 
School of Medicine, New York, NY) expression vector using Lipofectamine 
(Invitrogen, Carlsbad, CA) according to the manufacturer’s protocol. After a 3 hr 
incubation with the vector-liposome complexes in Opti-MEM (Invitrogen, 
Carlsbad, CA), the transfection media was replaced with normal growth media 
(as described above) with the addition of 5 µg/ml of tetracycline to induce the 
expression of the HtS-TRF2 fusion protein. Cells were incubated for 24 hr post-
transfection, harvested, and whole cell lysis was prepared by three freeze/thaw 
cycles (liquid nitrogen freeze, 4°C thaw) with  mil d lysis buffer BF3-FT (1 ml per 
10cm confluent plate; 50 mM Tris-HCl, 150 mM NaCl, 50 mM NaH2PO4, 0.1% 
NP-40, 10% glycerol, adjusted to pH 8.0 with freshly added β-mercaptoethanol 
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[10 mM], Complete Mini [EDTA-free] protease inhibitor cocktail [Roche, 
Switzerland], 1 mM phenylmethylsulphonyl fluoride [PMSF]) as previously 
described (Chapter 4) to retain protein-protein interactions. Lysate was 
precleared by centrifugation at 21000 g (two 30 min spins at 4°C), and incubated 
with 50 µl of solid protein A conjugated sepharose beads for 1 hr at 4°C with 
nutation to deplete the sample of debris, aggregated proteins, and proteins that 
non-specifically bind to the beads. Lysate was then split in half with one sample 
receiving 40 µg of ANTI-FLAG® M2 monoclonal antibody (Sigma-Aldrich, St. 
Louis, MO) and the other receiving none (negative control). Samples were 
incubated overnight at 4°C with nutation. Following  the formation of antibody-
antigen (Flag-KPNA2) complexes, 20 µl of solid protein A beads were applied to 
each sample and incubated at 4°C for 3 hr with nuta tion. Protein A-immobilized 
Flag-KPNA2 and associated proteins were then washed five times with BF3-FT 
and purified complexes were eluted, reduced, and denatured with 30 µl Laemmli 
buffer and incubation at 100°C for 5 min. Sample we re then separated by SDS-
PAGE on a 10% gel and blotted to nitrocellulose (Bio-Rad, Hercules, CA)  for 
western blot analysis using rabbit anti-hTRF2 (Novus Biologicals, Inc., Littleton, 
CO) or ANTI-FLAG® M2 primary antibodies, HRP-conjugated donkey anti-rabbit 
IgG or sheep anti-mouse IgG (GE Healthcare, Piscataway, NJ) secondary 





Inhibition of TRF2 Nuclear Localization by KPNA2 Ov erexpression   
N-HtS-TRF2 293T-REx cells were grown to 50% confluence and 
transfected (or not) with Flag-KPNA2 using Lipofectamine (Invitrogen, Carlsbad, 
CA) as per the manufacturer’s protocol. Transfected and non-transfected 
(control) cells were incubated for 24 hr and then induced with 15 ng/ml of 
tetracycline to achieve a close to endogenous expression of N-HtS-TRF2. Cells 
were incubated for an additional 24 hr and then harvested. Cells were then lysed 
with Nuclei EZ Lysis Buffer (Sigma-Aldrich, St. Louis, MO) to obtain both 
cytoplasmic and nuclear protein fractions. Fractions were loaded onto a 10% 
SDS-PAGE gel and blotted to a nitrocellulose membrane for western blot 
analysis. The blot was probed with the following primary and secondary 
antibodies: mouse anti-Strep tag (Qiagen, Valencia, CA), mouse ANTI-FLAG® 
M2, mouse anti-B23/nucleophosmin (Sigma-Aldrich, St. Louis, MO), mouse anti-
beta-Actin (Cytoskeleton, Inc., Denver, CO), and HRP-conjugated sheep anti-
mouse IgG (GE Healthcare, Piscataway, NJ). Antibody-antigen complexes were 
detected using ECL and ECL+ reagents (GE Healthcare, Piscataway, NJ). 
Densitometry analysis was performed using ImageJ (NIH, Bethesda, MD) with 
the density of each N-HtS-TRF2 band normalized against the loading control for 
each fraction (B23, nuclear; beta-actin, cytoplasmic). Transfected versus non-
transfected nuclear to cytoplasmic N-HtS-TRF2 ratios were compared to 





Indirect Immunofluorescence of KPNA2 and TRF2  
Due to the low adherence of 293T cells in general, cover slips placed in 35 
mm culture dishes were treated with poly-L-lysine before seeding. Briefly, 250 µl 
of 0.25 mg/ml poly-L-lysine was applied to each cover slip and incubated for 30 
min at room temperature. Cover slips were then washed three times with PBS 
and allowed to dry before plating cells. Freshly trypsinized N-HtS-TRF2 293T-
REx cells were seeded onto the poly-L-lysine coated cover slips to an estimated 
50% density and immediately transfected with Flag-KPNA2 (1 µg) using FuGENE 
6 transfection reagent (Roche, Switzerland) at a 6:1 ratio (FuGENE 
6:micrograms of DNA). Transfected cells were incubated at 37°C for 24 hr 
followed by a low level induction of N-HtS-TRF2 with 15 ng/ml tetracycline for an 
additional 24 hr. Cells were and immunostained as previously described (Chapter 
3 and [153]). Briefly, cells were fixed with ice-cold methanol overnight at -20°C, 
permeablized with 0.1% NP-40 in PBS for 10 min at RT, blocked with 1% BSA in 
PBS for 30 min at RT, and stained with the following antibodies: monoclonal 
mouse ANTI-FLAG® M2, polyclonal rabbit anti-FLAG® (Sigma-Aldrich, St. Louis, 
MO), monoclonal mouse anti-Strep tag (Qiagen, Valencia, CA), and/or polyclonal 
goat anti-hTRF2 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) primary 
antibodies with fluorescent dye-conjugated secondary antibodies specific to each 
primary antibody’s IgG specificity, Alexa Fluor Dye series (Molecular Probes / 
Invitrogen, Carlsbad, CA) 488 and 594 anti-mouse, 594 anti-rabbit, and/or 488 
anti-goat, each probe chosen carefully to avoid species cross-reactivity. Each 
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staining step was performed in the dark with 1 hr incubation at 37°C per 
antibody. Following staining, the chromatin was stained with DAPI for 10 min at 
RT and mounted on a microscope slide with PermaFluor™ (Thermo Fisher 
Scientific, Waltham, MA).  
 
Mean Nuclear Intensity Analysis   
Images of the mounted immunostained cells described above were 
acquired with a fluorescent microscope (Carl Zeiss MicroImaging, Thornwood, 
NY, USA) outfitted with a charged-coupled device camera and Openlab imaging 
software (Improvision, Waltham, MA). For each sample, images at 100X 
magnification were acquired from five random locations around the cover slip to 
garner intensity data from a large population of HtS-TRF2 / Flag-KPNA2 
expressing and non-expressing cells (5569 cells in total). Three TIFF (lossless 
compression) images per location were acquired, one for each fluorescent filter / 
color channel, at 1024 x 768 resolution with exposure settings per channel 
consistent across all images: DAPI filter, 1 second exposure, 1x gain; Texas Red 
filter, 1 second exposure, 1x gain; FITC filter, 1 second exposure, 32x gain. 
Image sets for each location were then analyzed with ImageJ (NIH, Bethesda, 
MD) software to determine the mean nuclear intensities of both HtS-TRF2 and 
Flag-KPNA2 on a cell-by-cell basis.  
 
To accomplish this, each image was processed by the following series of steps. 
First, each image was split into its representative RGB channels (Image > color > 
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RGB Split) and only those channels that were specific to the intensities being 
measured were kept. For example, for the FITC stained HtS-TRF2, only the 
green channel was retained while the other two channels (red and blue) were 
discarded. Once obtained, the blue DAPI channel representing cell nuclei was 
converted to a binary mask (Process > Binary > Convert to Mask), despeckled 
(Process > Noise > Despeckle), dilated (Process > Binary > Dilate), and 
processed by a watershed (Process > Binary > Watershed) command to 
individualize and separate each nucleus. The nuclear mask was then used to 
parse out just the nuclear intensity information from each of the other two 
channels. This was accomplished by processing both the red and green 
channels with the image calculator (Process > Image Calculator) and then 
inputting the following values for each dropdown box: “Image1:” the Red or 
Green channel, “Operation:” AND, “Image2:” the blue channel, making sure the 
“Create New Window” box is checked. The resultant images have had all 
intensity information outside the nuclei discarded. The channel representing 
Flag-KPNA2 (red) was then utilized to create a selection of each individual 
nucleus so that each member of the population could be analyzed independently: 
Image > Adjust > Threshold, select “Over/Under” from the dropdown box, and 
then “Set” the value of “Lower Threshold Level:” to 1 and “Upper Threshold 
Level:” to 255. At this point, the pencil tool could be used to manually separate 
(i.e. draw a line through the center of) nuclei that the software could not 
distinguish as individuals (clumped nuclei). Then create a selection of the 
masked out nuclei (Edit > Selection > Create Selection) and analyze the mean 
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nuclear intensity (MNI) of each nucleus with the “Analyze Particles” function built 
into ImageJ (Analyze > Analyze Particles, setting the size to 300,000 to Infinity 
and making sure “Display Results” is checked). The resultant table outputs the 
intensity information for each nucleus, which is copy and pasted into excel. The 
same method was applied to the HtS-TRF2 channel (green) but instead of 
creating a selection after thresholding the image, the selection used for the red 
channel is restored (Edit > Selection > Restore Selection) to make sure the 
nuclear intensity information for each nucleus is exactly matched to the 
information obtained from the previous channel (red; Flag-KPNA2). An ImageJ-
specific macro/script was written to help automate the process across all image 
sets (see Figure 6.1 ). 
 
To normalize the data, the intensity information per channel for every analyze cell 
was pooled and the population MNI was calculated. This value was then used to 
normalize the intensities for each individual panel by first obtaining the average 
MNI for that specific panel and then applying a bonus/penalty factor depending 
on the difference from the population mean. This bonus/penalty was then applied 
to every measured MNI in that specific panel to make sure that all panels were 
equivalent. Normalized intensity data for each separate experiment were then 
plotted by green MNI (HtS-TRF2, x-axis) and red MNI (Flag-KPNA2, y-axis) in a 
scatter plot so that each individual point represented the MNI values of one 
independent nucleus. Scatter plots were then created to visualize trends in Flag-





Figure 6.1: General flow of the image processing script written for ImageJ analysis of cells. 
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were combined to get the average TRF2 MNI at different Flag-KPNA2 cutoff 
values (20, 50 75, and 100). 
 
6.3: Results 
Our previous work utilizing our dual-tag affinity purification system and 
MudPIT MS/MS to study the interacting protein network that encompasses the 
human telomere binding proteins TRF1, TRF2, and POT1 (Chapter 3 and [153]) 
identified numerous candidate interacting partners for each bait protein. One 
putatively identified interacting partner of TRF2 was importin alpha 1, otherwise 
known as karyopherin alpha 2 (KPNA2). KPNA2 is one of the major components 
of the nuclear import pathway in mammalian cells that is specifically involved in 
binding to nuclear destined cargo as an adaptor protein via a NLS encoded on 
the protein to be imported. In the classical nuclear import mechanism, the cargo-
KPNA2-KPNB1 subcomplex translocates through the nuclear pore complex in 
order to deliver the cargo to the nucleoplasm [157].  
 
In our previous study, we identified KPNA2 in seven out of eight biological 
replicates with a total of 7 unique peptides and 21.4% sequence coverage over 
all TRF2 affinity purification-LC-MS/MS sample runs (Figure 6.2 ). One of the 
most confidently identified tryptic peptides, K.GINSSNVENQLQATQAAR.K, is 
specific to KPNA2 as evident by a protein-protein BLAST (blastp) search against 
all coding sequences in the Homo sapiens non-redundant protein database (data 


















Figure 6.2: KPNA2 peptide identification metrics from the HtS-TRF2 affinity purification-MudPIT-
MS/MS runs performed in Chapter 4. The top row shows identification frequency over all TRF2 
purifications (7 out of 8) with unique peptide and spectral count data indicated in the parentheses. 
The 7 unique peptides found across all 8 runs are listed in the box. The peptide in red was 
















provided for its unambiguous identification based on its very clear y- and b-ion 
series (y3  y14; b7b9, b11b17) and expected mass of the doubly charged 
parent ion of 951.28 m/z (Figure 6.3 ). This peptide was chosen as an example 
and representative of the other KPNA2-specific peptides listed in Figure 6.2 . 
Although we are confident KPNA2 was indeed present in seven of eight HtS-
TRF2 dual-tag purifications and absent from our control sets, we cannot rule out 
the possibility that this protein co-purified with TRF2 in a non-specific manner.  
 
To rule out the possibility that KPNA2 was co-purifying non-specifically with HtS-
TRF2, N-HtS-TRF2 293T-REx stable cells were transiently transfected with N-
terminally FLAG-tagged KPNA2 and induced with tetracycline to express N-HtS-
TRF2. Following 24-hour incubation, cells were harvested and lysed to perform a 
co-immunopurification using FLAG-KPNA2 as the bait. FLAG-KPNA2 was used 
as the bait (purification: anti-FLAG antibody and protein A conjugated beads) in 
this particular experiment to complement the results obtained from our previous 
MS study (see above) where HtS-TRF2 was used as bait (purification: Strep-
Tactin beads). Doing the reciprocal experiment helps increase the confidence of 
the potential interaction as each experiment is more independent of one another 
as opposed to just duplicating / propagating false positive identifications that 
could result if the co-purification were performed the same way each and every 
time. As shown in Figure 6.4 , HtS-TRF2 co-purified with FLAG-KPNA2 but only 
when anti-FLAG antibody was incubated with the lysate. Input lanes were 





Figure 6.3: Manual verification of the KPNA2-specific peptide: G I N S S N V E N Q L Q A T Q A A R. A complete y-ion series (y3 to y14; blue) 





















Figure 6.4: Co-immunoprecipitation of TRF2 with KPNA2. HtS-TRF2 293T-REx cells were 
transfected with Flag-KPNA2 and lysed. Flag pull down successfully purified both Flag-KPNA2 
and HtS-TRF2 indicating a positive interaction. Control lane (IP –) was devoid of flag antibody 
and thus did not purify KPNA2 or TRF2. HtS, His-tev-Strep; IP, immunoprecipitation; W, western; 





















identification of KPNA2 in the dual-tag MS study is not a false positive and thus 
the co-purification of TRF2 with KPNA2 or vice versa depends on their 
interaction. Additionally, there are several putative NLSs within TRF2’s protein 
coding sequence, all of which are conserved through mammals and one, 
327KNKRPRK333, conserved through mammals and avians (Figure 6.5 ). These 
data, including previous work suggesting TRF1 (a closely related Shelterin 
component) is inhibited by KPNA2 [167] prompted us to explore the possible 
functional relationship, if any, between TRF2 and KPNA2. 
 
As a follow up to the study performed by Forwood and Jans showing that KPNA2 
is not required for but actually represses TRF1 nuclear import, we explored 
whether TRF2’s nuclear localization is similarly repressed by KPNA2. To 
accomplish this task, N-HtS-TRF2 293T-REx cells were transiently transfected 
with FLAG-KPNA2 and allowed 24 hours to express the fusion protein, effectively 
setting up a KPNA2 overexpression block in positively transfected cells. After 24 
hours of FLAG-KPNA2 expression, HtS-TRF2 expression was induced at close 
to endogenous levels. As KPNA2 expression was already fully engaged, we 
wanted to measure the partitioning of HtS-TRF2 in transfected versus non-
transfected cells. To accomplish this, the cells were harvested and lysed as 
described in the Materials and Methods, and both the cytoplasmic and nuclear 
fractions were obtained. The fractions of both the FLAG-KPNA2 transfected and 
control cells were analyzed by western blot and densitometry using ImageJ. As 














Figure 6.5: Putative nuclear localization signals on TRF2 homologs from human (Hs), cow (Bt), 
mouse (Mm), rat (Rn), and chicken (Gg), aligned by ClustalW. Two types of NLSs were found, 
monopartite and bipartite. Green shading indicates conservation of the residue and/or positive 
charge as the charge distribution plays a large role in recognition. Numbers below each site are 


























Figure 6.6: KPNA2 causes a decrease in TRF2 nuclear localization and a concomitant increase 
in cytoplasmic localization. KPNA2 was transfected into HtS-TRF2 293T-REx cells and allowed to 
express for 24 hours prior to HtS-TRF2 induction. Cells overexpressing KPNA2 appear to 
decrease TRF2 nuclear accumulation even though B23 (constitutively nuclear) and beta-actin 














be a partitioning of HtS-TRF2 out of the nucleus and into the cytoplasm in 
KPNA2-positive cells. To obtain a more tangible measurement, ImageJ was used 
to both obtain the density of HtS-TRF2 in each fraction and to calibrate the 
densities according to the nuclear (B23 / nucleophosmin) and cytoplasmic (beta-
Actin) loading controls. We found that in the cells transfected with KPNA2, there 
was a 2.39 fold increase in cytoplasmic HtS-TRF2 compared to the control. This 
corresponded to a 2.19 fold decrease in nuclear HtS-TRF2 in FLAG-KPNA2 
positive cells. Another way to represent the data is to report the HtS-TRF2 
nuclear to cytoplasmic (N/C) density ratios in the control and FLAG-KPNA2 
positive cells, which were 1.94 and 0.37 respectively.  
 
Also provided in Figure 6.6  is a panel demonstrating both the positive 
transfection of KPNA2 and its proper localization predominantly to the cytoplasm. 
Additionally, the FLAG-KPNA2, B23, and beta-Actin panels also demonstrate the 
success of the fractionation as each component was identified only in the fraction 
where they are expected to localize (B23, nuclear; FLAG-KPNA2 and beta-Actin, 
cytoplasmic). These data suggest that over expression of FLAG-KPNA2 is able 
to suppress the nuclear localization of mildly expressed HtS-TRF2 after a KPNA2 
block has been established (via a 24 hour head start in expression). However, 
this analysis is more of a “brute force” measurement and analyzing the functional 




To get a broad picture as to what might be occurring, cells were immunostained 
and analyzed by ImageJ (NIH, Bethesda, MD). Using the DAPI stain, the 
software was able to distinguish each cell from its neighbor and accurately 
measure the mean nuclear intensities for both HtS-TRF2 (green) and Flag-
KPNA2 (red). Generally speaking, there seems to be an observable mutual 
exclusivity displayed between cells that are positive for both TRF2 and KPNA2 
(Figure 6.7 ). Interestingly, KPNA2 seemed locate to the nucleus, but this 
contradicts both our data in Figure 6.6  as well as the accepted localization of the 
importin molecule. Whatever the case, its “nuclear localization” allowed us to 
process the cells with ImageJ with relative ease. To analyze the data on a cell-
by-cell basis, a scatter plot was created (Figure 6.8 ). Every point represents the 
mean nuclear intensity (MNI) of both TRF2 and KPNA2 for each individual cell in 
the analysis. A total of 5569 cells were analyzed by this method. As shown, the 
data seems to cluster around each axis, suggesting the “mutual exclusivity” is 
valid observation. Most of the cells with high KPNA2 MNI fall within the low end 
of TRF2 MNI. Looking at the population of cells on a whole rather than cell-by-
cell, come to a similar conclusion; when KPNA2 MNI is high, TRF2 MNI intensity 
is reduced (Figure 6.9 ). Although several thresholds are represented, the upper 
thresholds begin to show significant decreases in TRF2 MNI (KPNA2 MNI 


















Figure 6.7: Sample images used in the multicellular analysis to assess decreases in HtS-TRF2 
nuclear intensity in Flag-KPNA2 positive cells (10x objective). The high intensity staining for both 
TRF2 and KPNA2 seem to be mutually exclusive, suggesting a possible import block on TRF2 in 
KPNA2 positive cells. Also note the odd, seemingly nuclear-only staining pattern of KPNA2 
positive cells which contradicts the western blot in Figure 6.6 as well as the known localization 












































Figure 6.8: Scatter plot of TRF2 and KPNA2 mean nuclear intensities (MNI). Each point 
represents the measurements from an individual cell. Notice that cells expressing KPNA2 tend to 

































































































Figure 6.9: Bar graph depicting the decrease in TRF2 MNI in cells that are highly expressing 
KPNA2 (represented by high KPNA2 MNI). Several KPNA2 MNI cutoffs are listed, from 20 
(slightly above background) to 100 (substantially above background) with the progression 
showing the progressive decrease in TRF2 MNI. This suggests that cells highly expressing 
KPNA2 decrease TRF2 nuclear accumulation. 
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6.4: Discussion  
 In our previous study looking for novel interacting proteins of the three 
major telomere binding proteins (Chapter 4), members of the classical nuclear 
import mechanism were identified, namely, KPNA2 (importin alpha), KPNB1 
(importin beta), and Nup50. Although KPNA2 and KPNB1 were represented in 
the affinity purifications of both TRF1 and TRF2, the largest enrichment of each, 
especially KPNA2, was found in the datasets generated when TRF2 was used as 
bait. Regarding TRF2, KPNA2 was identified in 7 out of 8 sets (Figure 6.2 ) while 
KPNB1 was identified in only 3 sets. Interestingly, the only set that did not 
demonstrate the TRF2-KPNA2 co-purification was the nuclear lysate sample. 
This is to be expected as this interaction should cease to exist once the 
TRF2/importin subcomplex enters the nucleoplasm (see Introduction). Although 
amply identified by multiple peptide hits, search algorithm-based false-positives 
are a possibility. To remove any doubt, the MS-identified KPNA2 peptide 
exhibiting the best Xcorr value, G I N S S N V E N Q L Q A T Q A A R, was 
manually verified (Figure 6.3 ). This peptide is unique to KPNA2 as evident by 
protein-protein BLAST (data not shown). We are confident that DBDigger 
correctly identified KPNA2 as being present in the sample; however, this does 
not exclude the possibility that the interaction, rather than the identification, is a 
false positive. Although proper controls were utilized (see Chapter 4), a more 
direct biochemical approach would help alleviate any doubts regarding the 
validity of this interaction. As shown in Figure 6.4 , the immunoprecipitation of 
FLAG-tagged KPNA2 was able to co-purify HtS-TRF2 from a whole cell lysis. 
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This reciprocal purification, relative to the HtS-TRF2-based affinity purification 
used to initially identify the interaction, lends credence to the physiological 
association of TRF2 with KPNA2. Although the overexpression of a tagged 
version of KPNA2 could, theoretically, lead to artifactual data, our initial 
identification of the endogenous form of the importin by mass spectrometry 
(Chapter 4) suggests this is not the case. 
 
Although never described before this study, the interaction between TRF2 and 
KPNA2 (and other members of the nuclear import apparatus, see above) is 
particularly exciting as another telosome component, TRF1, was previously 
shown to interact with both KPNA2 and KPNB1 ([167] and Chapter 4 / Appendix 
A). Interestingly, TRF1’s association with KPNA2 circumvents the conventional 
understanding of classical nuclear import and pits KPNA2 as a negative regulator 
of import rather than an accessory factor [167]. Although the observed KPNA2-
dependent decrease in nuclear import efficiency has been corroborated by other 
studies [213-215], this regulatory mechanism is still poorly understood. As TRF2 
is very closely related to TRF1, both structurally and functionally, perhaps it too 
follows a similar mechanism. To this end, the functional relation between TRF2 
and KPNA2 was probed.  
 
The suggestion that KPNA2 negatively impacts TRF2’s nuclear import was 
assessed using two approaches, cell fractionation / western blot on a population 
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of cells versus immunofluorescence on a cell-by-cell basis. Both experiments 
were designed to first set up an “import block” by allowing time for FLAG-KPNA2 
to accumulate in transfected cells before inducing the expression of HtS-TRF2. 
As shown in Figure 6.6  and explained above (see Results), the nuclear 
accumulation of HtS-TRF2 in KPNA2 transfected cells was over 2-fold less 
relative to the non-transfected control. This decrease in nuclear accumulation 
was accompanied by a greater than 2-fold increase in the cytoplasmic 
accumulation, again relative to the control. This data suggests that the 
overexpression of KPNA2 does impart a negatively impact TRF2 nuclear 
accumulation and fits nicely with the observations observed with TRF1 and other 
proteins. 
 
Strengthening this conclusion is the cell-by-cell data obtained from our 
immunofluorescence / mean nuclear intensity study (Figures 6.8 and 6.9). The 
scatter plots, where each point represents the intensity data for an individual cell, 
indicate that those cells that have significant KPNA2 expression (measured by 
intensity on the y-axis) cluster towards the lower end of TRF2 mean nuclear 
intensity (x-axis). Essentially, cells expressing high levels of KPNA2 show 
reduced levels of nuclear TRF2. Taking a more population-based approach, the 
results are even clearer. The bar graph indicates that at different KPNA2 nuclear 
intensity thresholds, TRF2’s mean nuclear intensity decreases as the KPNA2 
threshold is increased. It should be noted, however, that the over expression of 
KPNA2 in this experiment could affect the natural regulation of nuclear import in 
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general, which may perturb other metabolic pathway and lead to an indirect 
decrease of TRF2 nuclear accumulation. Similarly, KPNA2 has an affinity for 
cytoskeletal components [222-224]. Perhaps the over-expression of KPNA2 and 
its apparent affect of TRF2 nuclear localization by western blot is more so due to 
the creation of a cytoskeletal trap, holding TRF2 in the cytoplasm and leading to 
a shift in the nuclear to cytoplasmic ratio. Though plausible, we have no evidence 
to support these claims nor can we ignore the apparently synonymous situation 
occurring with TRF2’s telosome companion TRF1. Taken together, the data 
provided in this study strengthen the notion that, like TRF1, TRF2’s nuclear 
import through the classical mechanism is inhibited and/or modulated by KPNA2. 
 
This notion of regulation is not novel. As described above, the modeling study 
performed by Riddick and Macara concluded that the use of KPNA2 as an 
adaptor protein is actually more energy intensive than if import was 
accomplished through KPNB1 alone. Although this notion is against the 
conventional understanding of classical nuclear import, there are numerous 
examples whereby major cellular processes are governed, in part, by nuclear 
import. Perhaps the KPNA2 adaptor protein also acts as a modulator as 
previously suggested [215]. 
 
As described above (see Introduction) there is a measurable decrease in nuclear 
import efficiency of substrates that require both KPNA2 and KPNB1 (classic 
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import) during early S, G2/M, and M/G1 due to a decrease in the association 
between both importins [225]. In regards to both TRF1 and TRF2 following the 
classic mechanism, this decrease in efficiency is at odds with the cells increased 
need for these proteins, as evident by increased mRNA expression for both at 
exactly these times [216, 217]. However, the finding that several proteins are 
able to be imported through KPNB1 alone, as well as the observed KPNA2-
mediated inhibition of nuclear import for these same proteins indicate that 
perhaps the observed decrease in import efficiency described in one study [225] 
only pertains to those proteins that utilize KPNA2 as an adaptor required for 
import. Conversely, those proteins that seem to be importin beta-preferred and 
inhibited by KPNA2 might be regulated in the exact opposite manner. For 
example, in cell cycle phases where the importin alpha/beta association is the 
weakest, proteins that can bind KPNB1 directly would capitalize on both the 
increase in the amount of free importin beta as well as the decrease in nuclear 
pore traffic, both of which could translate to an increase in transport efficiency for 
these beta-preferred cargos. Theoretically, this would address the apparent 
timing discrepancy for TRF1 and, perhaps TRF2, described above. However, this 
does not preclude other explanations such as an increased mRNA expression of 
TRF1 and TRF2 to compensate for the decrease in import efficiency at these 
phases. Whatever the case, the data provided here do strengthen previous 
observations pitting KPNA2 as an inhibitor/modular as well as indirectly 
suggesting the plausibility of the proposed, switch-like timing mechanism, i.e. 
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beta-preferred import during early S, G2/M, and M/G1 versus alpha/beta-
preferred import during the reciprocal stages of the cell cycle.  
 
Seemingly, TRF2 is inhibited by KPNA2. However, there are several 
discrepancies that should be addressed. One is the frequency of MS-based 
identification of KPNA2 as opposed to KPNB1, 7/8 versus 3/8 respectively (TRF2 
as bait, Chapter 4). If TRF2 were imported through its interaction with KPNB1 
alone then why would the KPNA2 interaction be identified more frequently? One 
possibility is that as the majority of unsynchronized cells in culture are at 
interphase (especially fully confluent cells), a high point for the importin 
alpha/beta association, TRF2 would be most frequently associated with the 
KPNA2/KPNB1 heterodimer, binding through KPNA2 rather than KPNB1. In this 
way, the purification and identification of KPNB1 would be through KPNA2, a 
secondary interaction that could manifest as a decrease in the capture efficiency 
of KPNB1 during the purification. On the other hand, if cells were synchronized to 
one of the stages where the importin alpha/beta interaction was weakest, i.e. 
early S, G2/M, or M/G1, there may be an observable enrichment of the 
TRF2/KPNB1 direct interaction and a concomitant decrease in TRF2’s direct 
association with KPNA2, especially as KPNA2 does not bind its substrates well in 
the absence of KPNB1 binding (see Introduction). It should noted, however, that 
the data was collected using cells that over express a tagged version of TRF2, so 
we cannot exclude the possibility that we are observing and rationalizing a data 
artifact. Along these lines, it has been shown that endogenous TRF2 expression 
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is low in non-proliferating cells, such as those that have reached 95-100% 
confluence in culture [216]. As mentioned above, non-proliferating cells are 
predominantly at cell cycle stages where the importin alpha/beta interaction is 
substantial. Therefore, we may be forcing an interaction that rarely occurs in 
nature through the exogenous expression of TRF2 in cells at these stages. This 
could also explain the increased frequency of KPNA2 capture over the KPNB1-
preferred mechanism, if the latter is in fact the true mechanism of import.  
 
Another discrepancy is the localization of FLAG-KPNA2 in the 
immunofluorescence experiment (Figure 6.7 ). There were several examples of 
cells that appeared to have a ring-like accumulation at the nuclear envelope, 
although these cells were few and far between. Interestingly, almost all of the 
positively transfected cells showed an intense nuclear-only staining of KPNA2, 
which is in stark contrast to the conventional understanding of KPNA2 as well as 
the compartmentalization data presented in Figure 6.6 . Here, the transfected 
FLAG-KPNA2 was only detected in the cytoplasmic fraction while none was 
found in the nuclear fraction. One explanation is that what we were visualizing in 
the fixed, immunostained cells was localization to the nuclear membrane rather 
than true nuclear staining. Alternatively, perhaps the fixation conditions altered 
the distribution of the protein or contracted the cytoplasmic compartment to a 
degree where it was virtually no longer distinguishable from the nucleus. The 
latter is a possibility due to the use of a dehydration-based fixative (methanol) 
and 293T cells, which are known to have notoriously small cytoplasmic 
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compartments. To this end, live cell imaging and/or confocal microscopy could 
address this discrepancy. 
 
Despite these inconsistencies, the data provided here indicate that TRF2 does in 
fact interact with KPNA2 and this association seems to parallel that of TRF1, 
GAL4, and PTHrP with regards to the inhibition of import via KPNA2. Further 
evidence of this interaction and the capacity by which TRF2 is imported into the 
nucleus could be obtained from a study aimed at determining the existence of a 
NLS in TRF2’s protein sequence; after all, if the protein is to be imported, it must 
contain the signal. In general, there are two token NLS signals each of which 
must first be recognized by an import receptor (importin) before translocation can 
occur. The monopartite sequence, demonstrated by the SV40 large T antigen, is 
126PKKKRRVA132 [226] (consensus K-K/R-X-K [227]) and the bipartite sequence, 
demonstrated by nucleoplasmin, is 155KRPAATKKAGQAKKKK170 [228]. As 
exemplified by both types, NLSs are basic by nature and it is this charge 
distribution that is most important for importin recognition [157, 226, 229, 230]. In 
regards to TRF2, Figure 6.5  identifies several locations in the protein sequence 
of TRF2 that could be NLSs: 17RR … RRGRH31, 154RK … KKHM182, 
327KNKRPRK333, and 446KKQK449. All of the sites are conserved though mammals 
with one site, KNKRPRK, conserved through mammals and avian species. This 
sequence also bears remarkable resemblance to the monopartite consensus 
described above (K-K/R-X-K/R), while also containing several other flanking, 
positively charged amino acids. This site also resembles the NLS of GAL4, 
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another imported protein that has been shown to be inhibited by KPNA2 [214]. 
Interestingly, this site is just upstream from a recently identified phosphorylation 
site, S323 [231], perhaps indicating an import switch that either allows or 
disallows NLS recognition. In addition, this region of TRF2 is generally regarded 
as unstructured, lying between the homodimerization domain and the myb-DNA 
binding domain, so it is generally available for switch-like modifications and the 
binding of transient factors such as the importins. Although these putative NLSs 
seem to strengthen the proposed association of TRF2 with members of the 
nuclear import system, they have not yet been confirmed experimentally. 
Perhaps several of these sites are involved, each directing the TRF2’s import, or 
lack thereof, at certain times and situations [157]. This notion again suggests the 
intricate regulation that the nuclear import apparatus imposes on cellular 
pathways. 
 
Although it seems like common sense that a constitutively nuclear protein such 
as TRF2 is imported to the nucleoplasm by some rendition of the nuclear import 
system, the factors associated with this import have yet to be described. In this 
study, we identified and confirmed that TRF2 interacts with importin alpha 1 / 
KPNA2 of the classical nuclear import pathway. Taking notes from its telomere-
based companion TRF1, it was shown that KPNA2 is able to inhibit the nuclear 
import of TRF2 by some yet to be determined mechanism. Implications for this 
are far reaching as TRF2 is one of the major determinants of overall genomic 
stability, both through its protective role at the telomere (see Chapter 2) as well 
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its recently proposed role in the cellular response to double strand breaks (see 
Chapter 5). Regarding the latter, perhaps the upregulation of TRF2 after 
exposure to ionizing radiation is partly dependent on nuclear import, whereby the 
increase in mRNA expression must be met by an increase in the import efficiency 
of the translated protein, possibly through changes in its association with KPNA2. 
 
The modulation of import by KPNA2 has been suggested previously [215] and 
has been demonstrated in other proteins such as TRF1, GAL4, and PTHrP [167, 
213, 214], however, the specific details regarding this regulatory mechanism 
have not been described. Perhaps the import of proteins that are characterized 
by being importin beta-preferred and inhibited by importin alpha are at odds with 
those that are imported through the classic definition of the mechanism, i.e. via 
the importin alpha/beta heterodimer. In this situation, the cell has at its disposal a 
broad-spectrum molecular switch that directs the import of large groups of 
proteins at specific times during the cell cycles or in certain situations that require 
a swift, orchestrated response. Although only hinted at in this report, a greater 
understanding of such regulation would both further emphasize the importance of 
the nuclear import system as a whole as well as provide new insights into the 
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Table A.1:  Combined list of co-purifying proteins identified by dual-tag affinity purification and 
MudPIT-MS/MS, organized by bait protein (first row of table). Highlighted in yellow are the 
peptide(spectra) counts for the bait protein specific to its own purification, i.e. capture efficiency. 
Highlighted in blue are members of the telosome complex. “Count” describes the frequency of 
identification out of a total of 18 sample runs. Rows with the same “group” number identify those 
proteins that have not been totally narrowed down and usually represent an unambiguous group 
of isomeric species. Represented in this table are only those co-purifying proteins that were 






















TRF1-1 TRF1-2 TRF1-3 TRF1-4 TRF1-NL TRF2-1 TRF2-2 TRF2-3 TRF2-4 TRF2-NL TRF2-irC TRF2-ir1 TRF2-ir2 POT1-1 POT1-2 POT1-3 POT1-4 POT1-NL Count Gene Group
9(10) 6(6) 4(5) 2(2) 2(2) 3(3) 10(11) 4(5) 4(5) 5(8) 9(20) 9(13) 10(20) 13 TIN2 296
4(5) 61(413) 57(192) 79(262) 52(182) 66(723) 89(1220) 86(1239) 98(1244) 10(30) 5(7) 9(24) 12 TRF2 253
36(175) 34(124) 47(128) 39(114) 60(335) 37(124) 31(117) 39(179) 2(2) 4(4) 2(2) 3(10) 12 RAP1 448
5(6) 3(3) 7(7) 3(4) 13(20) 8(9) 12(18) 5(6) 6(9) 5(5) 7(12) 11 NUDT21 40
7(8) 3(4) 3(3) 3(7) 3(3) 4(5) 3(3) 8(19) 10(41) 12(16) 11(30) 11 TPP1 297
4(4) 2(2) 3(3) 3(3) 8(18) 15(24) 14(31) 4(5) 6(9) 3(5) 10 ZC3HAV1L 66
5(5) 7(9) 2(2) 5(5) 14(15) 10(11) 4(4) 3(4) 4(5) 3(4) 10 RBM15B 115
14(21) 3(3) 3(11) 8(9) 3(3) 49(459) 57(444) 37(171) 43(255) 8(15) 10 POT1 293
2(2) 2(2) 2(2) 2(3) 2(3) 5(6) 3(4) 2(3) 3(6) 9 PLAT 664
2(2) 2(2) 2(2) 2(3) 2(3) 5(6) 3(4) 2(3) 3(6) 9 PLAT 664




2(2) 2(2) 2(2) 3(3) 2(2) 5(6) 3(4) 4(4) 8 130
2(2) 2(2) 2(2) 3(3) 2(2) 5(6) 3(4) 4(4) 8 KPNA2 130
2(2) 2(2) 2(2) 3(3) 2(2) 5(6) 3(4) 4(4) 8 KPNA2 130
2(2) 2(2) 2(2) 3(3) 2(2) 5(6) 3(4) 4(4) 8 130
33(47) 33(48) 32(93) 80(328) 33(88) 6(7) 2(3) 7 TRF1 7
2(2) 2(3) 4(5) 15(31) 8(12) 2(2) 2(2) 7 STUB1 118
2(2) 2(4) 4(4) 2(3) 3(3) 5(7) 2(2) 7 YY1 126
4(4) 5(7) 5(6) 2(6) 8(10) 9(13) 3(3) 7 PRR8 251
2(4) 2(2) 4(5) 4(5) 2(2) 2(4) 3(5) 7 PABPC4 350
2(4) 2(2) 4(5) 4(5) 2(2) 2(4) 3(5) 7 350
2(4) 2(2) 4(5) 4(5) 2(2) 2(4) 3(5) 7 PABPC4 350
2(4) 2(2) 4(5) 4(5) 2(2) 2(4) 3(5) 7 PABPC4 350
23(52) 10(14) 17(29) 15(20) 6(8) 2(2) 4(4) 7 MCCC2 449
3(3) 7(9) 4(4) 7(10) 2(2) 3(3) 6 303
3(3) 4(6) 5(5) 5(8) 2(2) 2(2) 6 CSNK2B 312
3(3) 4(6) 5(5) 5(8) 2(2) 2(2) 6 CSNK2B 312
3(3) 4(6) 5(5) 5(8) 2(2) 2(2) 6 CSNK2B 312
3(3) 4(6) 5(5) 5(8) 2(2) 2(2) 6 312
3(3) 4(6) 5(5) 5(8) 2(2) 2(2) 6 CSNK2B 312
3(3) 4(6) 5(5) 5(8) 2(2) 2(2) 6 CSNK2B 312
2(2) 2(2) 10(13) 4(5) 9(14) 2(2) 6 BMP2K 368
2(2) 9(14) 7(8) 13(13) 10(12) 2(2) 6 CYFIP1 381
22(81) 24(96) 23(187) 37(762) 5(22) 3(4) 6 TERF2 450
2(2) 2(2) 4(4) 4(4) 3(4) 2(2) 6 518
7(10) 5(7) 4(4) 2(2) 3(3) 3(3) 6 DDX3X 579
3(5) 4(5) 3(6) 3(3) 2(3) 2(2) 6 SF3B4 594
3(3) 2(2) 2(2) 2(2) 2(2) 5 S100A8 21
204
6(6) 2(2) 2(2) 2(2) 3(3) 5 HSPA4 91
6(8) 3(3) 4(5) 9(10) 2(2) 5 ACTN1 110
6(8) 3(3) 4(5) 9(10) 2(2) 5 ACTN1 110
3(3) 3(3) 5(5) 3(3) 7(7) 5 MCM7 140
2(2) 2(2) 3(4) 2(2) 4(6) 5 DDB1 148
2(2) 2(2) 3(4) 2(2) 4(6) 5 DDB1 148
3(3) 3(5) 12(30) 3(3) 11(30) 5 PRDX4 209
1(13) 2(11) 1(11) 1(21) 1(39) 5 RASGEF1C 224
7(8) 3(3) 2(2) 2(2) 5(6) 5 CDK9 247
7(8) 3(3) 2(2) 2(2) 5(6) 5 CDK9 247
9(15) 16(29) 4(6) 7(10) 5(6) 5 FBXO21 249
9(15) 16(29) 4(6) 7(10) 5(6) 5 FBXO21 249
9(15) 16(29) 4(6) 7(10) 5(6) 5 FBXO21 249
2(2) 2(2) 2(4) 4(4) 3(4) 5 254
2(2) 5(10) 7(12) 9(17) 2(3) 5 BAIAP2L1 269
6(6) 6(6) 2(2) 4(4) 9(9) 5 CHD8 273
6(6) 6(6) 2(2) 4(4) 9(9) 5 CHD8 273
2(2) 3(4) 2(2) 7(8) 4(6) 5 TOX4 276
2(2) 3(6) 5(9) 5(7) 2(2) 5 341
2(2) 3(6) 5(9) 5(7) 2(2) 5 CLK3 341
2(2) 8(8) 5(5) 8(9) 2(2) 5 SEC16A 382
2(2) 2(2) 2(2) 2(3) 2(4) 5 DNAJB11 490
2(2) 4(5) 5(5) 4(6) 2(2) 5 TLN1 540
2(2) 4(5) 5(5) 4(6) 2(2) 5 TLN1 540
3(9) 3(3) 4(7) 3(6) 4(7) 5 MYO10 554
2(9) 1(10) 1(36) 1(26) 1(26) 5 ABCD1 716
9(15) 6(10) 4(7) 6(7) 6(12) 5 1141
8(8) 6(6) 2(2) 2(2) 4 derp12 51
2(2) 3(3) 2(2) 3(3) 4 55
2(2) 3(3) 2(2) 3(3) 4 55
2(2) 2(2) 2(2) 4(11) 4 S100A7 86
3(3) 3(3) 2(12) 2(11) 4 HSP90Bb 96
5(7) 2(2) 3(3) 5(6) 4 KPNB1 119
2(2) 3(3) 2(2) 2(2) 4 133
3(3) 7(8) 9(11) 2(2) 4 USP9X 175
3(3) 7(8) 9(11) 2(2) 4 USP9X 175
3(3) 2(2) 2(2) 2(2) 4 RPS2 245
8(10) 4(4) 6(7) 2(2) 4 CSNK2A2 291
20(27) 2(2) 3(3) 2(2) 4 PLOD2 292
3(4) 2(2) 3(3) 2(2) 4 RING1 318
3(4) 2(2) 3(3) 2(2) 4 RING1 318
205
4(5) 2(2) 2(3) 6(7) 4 ZNF281 334
4(5) 2(2) 2(3) 6(7) 4 ZNF281 334
3(3) 4(4) 3(3) 7(7) 4 FOXJ3 335
4(4) 2(2) 2(2) 4(4) 4 LARP7 336
3(4) 6(9) 2(2) 2(2) 4 344
2(2) 2(5) 4(7) 3(5) 4 BCDIN3 346
2(2) 6(6) 4(4) 10(11) 4 IRS4 378
2(2) 4(4) 3(3) 3(3) 4 SAP30BP 394
2(2) 4(4) 3(3) 3(3) 4 SAP30BP 394
2(2) 2(8) 3(3) 2(6) 4 CHD5 430
2(2) 2(2) 2(2) 2(2) 4 DST 443
2(2) 2(2) 2(2) 2(2) 4 DST 443
2(2) 2(2) 2(2) 2(2) 4 DST 443
2(8) 3(6) 3(8) 4(5) 4 SNRPD1 453
4(4) 2(3) 10(21) 3(3) 4 458
4(4) 2(2) 2(2) 4(5) 4 UGDH 471
2(3) 2(6) 4(6) 2(4) 4 ERH 474
8(8) 10(11) 11(11) 8(8) 4 PC 476
5(5) 2(3) 3(3) 2(3) 4 MYO1C 495
3(3) 5(8) 12(15) 5(7) 4 PITRM1 504
3(3) 5(8) 12(15) 5(7) 4 PITRM1 504
6(8) 3(4) 17(24) 9(10) 4 MYH10 515
6(8) 3(4) 17(24) 9(10) 4 MYH10 515
6(8) 3(4) 17(24) 9(10) 4 MYH10 515
1(43) 1(15) 1(27) 1(26) 4 ATP2B1 538
1(43) 1(15) 1(27) 1(26) 4 ATP2B1 538
1(43) 1(15) 1(27) 1(26) 4 ATP2B1 538
1(43) 1(15) 1(27) 1(26) 4 ATP2B1 538
1(43) 1(15) 1(27) 1(26) 4 ATP2B3 538
1(43) 1(15) 1(27) 1(26) 4 ATP2B1 538
1(43) 1(15) 1(27) 1(26) 4 ATP2B1 538
1(43) 1(15) 1(27) 1(26) 4 ATP2B2 538
1(43) 1(15) 1(27) 1(26) 4 ATP2B2 538
1(43) 1(15) 1(27) 1(26) 4 ATP2B2 538
1(43) 1(15) 1(27) 1(26) 4 ATP2B2 538
1(43) 1(15) 1(27) 1(26) 4 ATP2B2 538
1(43) 1(15) 1(27) 1(26) 4 ATP2B2 538
1(43) 1(15) 1(27) 1(26) 4 ATP2B3 538
1(43) 1(15) 1(27) 1(26) 4 ATP2B3 538
1(43) 1(15) 1(27) 1(26) 4 ATP2B3 538
1(43) 1(15) 1(27) 1(26) 4 ATP2B3 538
206
1(43) 1(15) 1(27) 1(26) 4 ATP2B3 538
1(43) 1(15) 1(27) 1(26) 4 ATP2B3 538
1(43) 1(15) 1(27) 1(26) 4 ATP2B3 538
5(8) 3(6) 3(4) 2(5) 4 564
5(8) 3(6) 3(4) 2(5) 4 564
5(8) 3(6) 3(4) 2(5) 4 564
3(4) 4(4) 5(7) 2(2) 4 CARM1 611
3(4) 4(4) 5(7) 2(2) 4 CARM1 611
4(4) 4(5) 2(2) 4(5) 4 SLTM 632
4(4) 4(5) 2(2) 4(5) 4 632
2(4) 5(7) 2(2) 2(2) 4 NT5DC2 652
2(2) 2(2) 4(4) 2(2) 4 THRAP3 707
2(7) 2(6) 2(8) 2(5) 4 746
2(2) 2(2) 2(2) 2(2) 4 CALD1 1026
2(17) 3(5) 2(40) 2(80) 4 TMPRSS13 1196
2(17) 3(5) 2(40) 2(80) 4 TMPRSS13 1196
2(17) 3(5) 2(40) 2(80) 4 TMPRSS13 1196
3(4) 2(3) 2(4) 2(2) 4 V 1260
10(12) 4(4) 2(2) 3 XRCC5 47
10(10) 4(4) 2(2) 3 HSP90B1 62
7(7) 2(2) 2(2) 3 ACLY 104
2(2) 2(2) 2(2) 3 PRPS1 120
2(2) 2(2) 2(2) 3 120
2(2) 2(3) 4(6) 3 IDH3A 128
2(2) 2(3) 4(6) 3 IDH3A 128
2(2) 2(3) 4(6) 3 128
2(2) 2(3) 4(6) 3 IDH3A 128
2(2) 2(3) 4(6) 3 128
2(3) 5(5) 3(3) 3 HSPH1 156
2(3) 5(5) 3(3) 3 156
2(3) 5(5) 3(3) 3 HSPH1 156
2(3) 5(5) 3(3) 3 HSPH1 156
2(2) 2(2) 2(2) 3 SPTAN1 179
2(2) 2(2) 2(2) 3 SPTAN1 179
2(2) 2(2) 2(2) 3 179
4(9) 3(4) 2(2) 3 MACROD2 204
2(2) 2(2) 2(3) 3 207
2(2) 2(2) 2(3) 3 207
2(2) 4(5) 5(5) 3 BAG3 219
10(11) 9(9) 2(2) 3 TNKS 257
4(5) 4(4) 2(2) 3 CCNT1 265
207
3(3) 7(10) 2(3) 3 MYH9 283
2(3) 2(2) 7(11) 3 TBPL1 308
2(2) 2(2) 2(2) 3 RPS8 313
4(4) 3(6) 2(2) 3 SF1 320
2(3) 2(3) 2(4) 3 KCTD15 330
2(2) 2(3) 2(3) 3 PLOD1 353
3(3) 3(3) 2(3) 3 TBX1 354
2(2) 6(6) 2(2) 3 RSBN1L 372
2(2) 2(2) 2(2) 3 RAD50 375
2(2) 2(2) 2(2) 3 RAD50 375
2(2) 2(2) 2(2) 3 RAD50 375
2(2) 2(3) 2(4) 3 TRPC5 421
3(3) 2(2) 2(3) 3 C10orf80 424
3(6) 5(18) 3(3) 3 GTF2A2 452
3(6) 5(18) 3(3) 3 452
3(5) 3(3) 2(5) 3 531
3(5) 3(3) 2(5) 3 POLD1 531
3(5) 3(3) 2(5) 3 531
2(2) 2(2) 2(2) 3 MLL2 546
2(2) 2(2) 2(2) 3 MLL2 546
2(2) 2(2) 2(2) 3 MLL2 546
2(2) 2(3) 2(3) 3 553
2(2) 2(2) 3(4) 3 556
2(2) 2(2) 3(4) 3 SYNE1 556
2(2) 2(2) 3(4) 3 SYNE1 556
2(2) 2(2) 3(4) 3 SYNE1 556
2(2) 2(2) 3(4) 3 SYNE1 556
6(7) 9(14) 6(12) 3 566
4(5) 3(3) 3(3) 3 POLDIP3 569




2(2) 2(3) 2(2) 3 RPS6 577
4(4) 3(3) 3(3) 3 585
5(5) 2(2) 2(2) 3 CCNL1 598
5(5) 2(2) 2(2) 3 CCNL1 598
7(7) 8(9) 2(2) 3 600
7(7) 8(9) 2(2) 3 OPA1 600
7(7) 8(9) 2(2) 3 OPA1 600
7(7) 8(9) 2(2) 3 OPA1 600
7(7) 8(9) 2(2) 3 OPA1 600
4(5) 2(2) 2(2) 3 AP2A2 602
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6(6) 2(2) 3(3) 3 606
4(4) 4(4) 2(2) 3 ZNF703 607
5(5) 2(2) 2(2) 3 CTNND1 616
5(5) 2(2) 2(2) 3 CTNND1 616
5(5) 2(2) 2(2) 3 CTNND1 616
5(5) 2(2) 2(2) 3 616
5(5) 2(2) 2(2) 3 CTNND1 616
5(5) 2(2) 2(2) 3 CTNND1 616
5(5) 2(2) 2(2) 3 CTNND1 616
5(5) 2(2) 2(2) 3 CTNND1 616
5(5) 2(2) 2(2) 3 CTNND1 616
5(5) 2(2) 2(2) 3 CTNND1 616
5(5) 2(2) 2(2) 3 CTNND1 616
5(5) 2(2) 2(2) 3 CTNND1 616
5(5) 2(2) 2(2) 3 CTNND1 616
5(5) 2(2) 2(2) 3 CTNND1 616
5(5) 2(2) 2(2) 3 CTNND1 616
5(5) 2(2) 2(2) 3 CTNND1 616
2(2) 2(2) 2(2) 3 623
3(4) 4(6) 2(2) 3 G3BP2 624
3(4) 4(6) 2(2) 3 G3BP2 624
3(4) 6(6) 2(2) 3 SEC24B 669
3(4) 6(6) 2(2) 3 SEC24B 669
2(2) 6(7) 4(4) 3 CCNT2 671
2(2) 6(7) 4(4) 3 CCNT2 671
2(2) 3(3) 3(4) 3 OSBPL11 675
2(2) 2(2) 2(2) 3 SKIV2L2 676
2(2) 3(3) 2(2) 3 ZGPAT 683
2(2) 3(3) 2(2) 3 ZGPAT 683
2(2) 3(3) 2(2) 3 ZGPAT 683
3(3) 3(3) 2(2) 3 CHD7 708
2(2) 6(7) 3(3) 3 KIAA1429 718
2(3) 3(4) 2(2) 3 728
2(2) 2(2) 2(3) 3 MACF1 730
2(2) 2(2) 2(3) 3 730
2(2) 2(2) 2(3) 3 MACF1 730
4(9) 4(6) 3(4) 3 732
2(2) 2(2) 2(2) 3 DDX3Y 744
3(3) 2(3) 2(2) 3 SMC3 751
2(2) 2(4) 3(4) 3 DHX57 765
2(2) 2(4) 3(4) 3 DHX57 765
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2(3) 2(7) 2(2) 3 KIAA1033 771
2(2) 2(2) 3(4) 3 MYH13 774
5(5) 2(2) 2(2) 3 C20orf27 823
5(5) 2(2) 2(2) 3 C20orf27 823
11(27) 8(13) 9(24) 3 HSPA1A 1111
8(29) 5(9) 4(12) 3 1112
25(92) 4(4) 4(6) 3 SFPQ 1121
2(2) 2(2) 3(5) 3 1136
3(8) 4(5) 4(9) 3 1163
2(5) 2(3) 2(5) 3 TUBB1 1191
4(6) 3(6) 3(4) 3 1256
4(6) 3(6) 3(4) 3 1256
3(4) 2(3) 2(2) 3 1272
2(2) 4(5) 4(5) 3 RPS19 1301
2(2) 6(7) 4(6) 3 PCMT1 1306
2(2) 6(7) 4(6) 3 PCMT1 1306
3(7) 2(2) 2(6) 3 1330
2(2) 2(2) 2(2) 3 RPS7 1336





6(7) 3(3) 2 PSMB5 30
5(6) 7(7) 2 GRPEL1 32
4(4) 3(3) 2 PSMA7 44





3(3) 2(2) 2 PRMT1 88
3(3) 2(2) 2 PRMT1 88
3(3) 2(2) 2 PRMT1 88
2(2) 2(2) 2 PPP2CA 124
2(2) 2(2) 2 124
2(2) 2(2) 2 PPP2CB 124
2(2) 2(2) 2 PPP2CA 124
4(5) 2(2) 2 TOP1MT 132
3(3) 3(3) 2 GANAB 146
3(3) 3(3) 2 GANAB 146
3(3) 3(3) 2 GANAB 146
3(3) 3(3) 2 GANAB 146
3(3) 2(2) 2 LIG3 149
3(3) 2(2) 2 LIG3 149
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3(3) 2(2) 2 LIG3 149
3(3) 2(2) 2 LIG3 149
2(2) 2(3) 2 151
2(2) 2(3) 2 PRMT5 151
2(3) 2(2) 2 160
2(2) 2(2) 2 KIAA2022 170
2(2) 2(2) 2 TDRD6 181
2(2) 2(2) 2 DOCK2 182
2(2) 3(4) 2 SYNE2 189
2(2) 3(4) 2 SYNE2 189
2(2) 2(2) 2 CENPF 239
2(2) 3(3) 2 RPS16 252
3(3) 2(2) 2 TAF2 278
3(3) 2(2) 2 TAF2 278
2(4) 2(2) 2 RYR2 287
18(78) 10(24) 2 290
2(2) 2(3) 2 294
2(2) 2(3) 2 RPS10 294
3(4) 2(3) 2 331
3(4) 2(3) 2 RNF2 331
3(3) 2(3) 2 ATN1 352
3(3) 2(3) 2 352
3(3) 2(3) 2 ATN1 352
2(2) 3(3) 2 CDC37 358
2(2) 2(2) 2 ARHGEF18 369
2(2) 2(2) 2 369
2(2) 2(2) 2 369
3(3) 3(3) 2 377
2(2) 3(3) 2 CDC2L5 385
2(2) 3(3) 2 CDC2L5 385
2(4) 3(5) 2 P140 386
2(4) 3(5) 2 P140 386
2(2) 2(2) 2 388
3(3) 2(2) 2 408
2(2) 2(2) 2 RNF40 415
3(3) 2(3) 2 UTRN 426
2(2) 2(2) 2 HK1 436
2(2) 2(2) 2 HK1 436
2(2) 2(2) 2 HK1 436
2(2) 2(2) 2 HK1 436
3(4) 2(2) 2 DMD 440
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2(2) 2(2) 2 GARNL1 445
2(2) 2(2) 2 GARNL1 445
2(2) 2(2) 2 GARNL1 445
2(2) 2(2) 2 GARNL1 445
2(2) 3(4) 2 DNAJA2 472
2(2) 2(2) 2 SNW1 488
2(3) 5(12) 2 GTF2A1 492
2(3) 2(3) 2 499
2(2) 2(2) 2 500
2(2) 2(2) 2 DHX33 530
2(2) 3(3) 2 KIF13B 534
2(3) 2(4) 2 ARHGAP20 539
2(3) 2(4) 2 MCM3AP 552
2(3) 2(4) 2 552
3(4) 3(3) 2 558
2(3) 3(36) 2 560
8(9) 6(7) 2 RAVER1 563
6(6) 7(9) 2 EDC3 568
4(4) 6(6) 2 U2AF1L4 570
4(4) 6(6) 2 U2AF1L4 570
8(17) 10(16) 2 U2AF2 571
8(17) 10(16) 2 U2AF2 571
2(5) 3(5) 2 mer5 576
2(5) 3(5) 2 PRDX3 576
4(5) 6(7) 2 IVD 593
4(5) 6(7) 2 IVD 593
3(3) 3(3) 2 FHL1 596
3(3) 3(3) 2 596
3(3) 3(3) 2 FHL1 596
1(11) 1(14) 2 LDOC1L 601





2(2) 2(2) 2 SFRS11 618
2(2) 2(2) 2 SFRS11 618
2(2) 2(2) 2 SFRS11 618
2(2) 2(2) 2 SNRP70 627
2(2) 2(2) 2 SNRP70 627
3(3) 3(4) 2 MARK3 629
3(3) 3(4) 2 MARK3 629
3(3) 3(4) 2 MARK3 629
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3(3) 4(4) 2 630
3(3) 4(4) 2 630
3(3) 4(4) 2 PFKL 630
2(3) 2(3) 2 633
3(3) 3(3) 2 SFRS16 635
2(2) 3(3) 2 DKC1 643
2(2) 3(3) 2 FXR2 645
3(3) 2(2) 2 DARS2 646
2(2) 2(2) 2 SDF2L1 647
2(2) 3(3) 2 TBC1D15 650
2(2) 3(3) 2 CLPB 651
2(2) 3(3) 2 CLPB 651
2(2) 3(3) 2 USP15 656
2(2) 3(3) 2 USP15 656
2(2) 3(3) 2 USP15 656
2(2) 2(2) 2 GCFC 657
2(2) 2(2) 2 GCFC 657
2(2) 2(2) 2 GCFC 657
2(2) 2(2) 2 GCFC 657
3(4) 3(3) 2 HSPA4L 660
2(3) 2(5) 2 MMS19L 673
2(2) 4(4) 2 REPIN1 679
2(2) 4(4) 2 REPIN1 679
2(2) 2(2) 2 685
2(2) 2(2) 2 DHX40 685
2(2) 2(2) 2 DHX40 685
2(2) 2(2) 2 DHX40 685
2(2) 3(3) 2 LLGL1 691
2(2) 3(3) 2 LLGL1 691
2(2) 2(2) 2 696
2(2) 2(2) 2 MYOM2 696
2(2) 3(3) 2 BRD2 698
2(2) 3(3) 2 BRD2 698
2(2) 3(3) 2 BRD2 698
2(2) 3(3) 2 BRD2 698
2(2) 2(2) 2 LKAP 699
2(2) 2(2) 2 699
2(2) 2(3) 2 701
2(2) 4(5) 2 ZC3H13 705
2(2) 2(2) 2 NFRKB 720
2(2) 2(2) 2 NFRKB 720
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2(2) 2(2) 2 NFRKB 720
2(3) 2(3) 2 721
2(3) 2(3) 2 DHX37 721
2(3) 2(4) 2 REV3L 723
2(3) 2(4) 2 REV3L 723
2(2) 2(2) 2 SRRM2 725
2(2) 2(2) 2 SRRM2 725
2(2) 2(2) 2 SRRM2 725
2(2) 2(2) 2 CDK5R2 735
2(7) 2(2) 2 CAPS 742
2(7) 2(2) 2 FLJ00390 742
2(4) 2(4) 2 STXBP4 754
2(4) 2(4) 2 STXBP4 754
2(5) 2(5) 2 755
2(2) 2(2) 2 KIF7 756
2(2) 2(2) 2 773
2(2) 2(3) 2 775
2(2) 2(3) 2 775
2(3) 3(4) 2 HD 785
2(3) 3(4) 2 HD 785
2(2) 2(2) 2 MECP2 798
2(2) 2(2) 2 MECP2 798
2(2) 2(2) 2 KCTD1 802
2(2) 2(2) 2 802
2(2) 2(2) 2 802
2(2) 2(2) 2 TCOF1 810
2(2) 2(2) 2 TCOF1 810
2(2) 2(2) 2 TCOF1 810
2(2) 2(2) 2 TCOF1 810
2(3) 3(3) 2 PYCR2 820
3(6) 2(2) 2 NME4 824
3(6) 2(2) 2 NME4 824
4(4) 3(3) 2 DUSP11 826
5(6) 2(2) 2 BCKDK 829
5(6) 2(2) 2 829
5(6) 2(2) 2 BCKDK 829
4(5) 2(2) 2 TRIM47 849
2(3) 2(3) 2 851
2(3) 2(3) 2 851
2(3) 2(3) 2 SNX22 851
2(3) 2(2) 2 WDR5 852
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2(2) 2(2) 2 EEFSEC 856
4(4) 5(6) 2 AASS 866
4(6) 6(6) 2 GPATCH8 881
2(2) 2(2) 2 OSBPL9 884
2(2) 2(2) 2 OSBPL9 884
2(2) 2(2) 2 OSBPL9 884
2(2) 2(2) 2 ZKSCAN4 888
5(5) 2(2) 2 HELZ 891
2(2) 3(3) 2 TFIP11 905
19(29) 12(18) 2 TUBB2B 939
18(28) 11(17) 2 TUBB2A 940
3(4) 2(3) 2 WDR61 949
2(2) 2(2) 2 CYLC2 959
2(2) 2(2) 2 PCBP1 971
2(3) 2(2) 2 RIF1 1086
2(3) 2(2) 2 RIF1 1086
2(3) 2(2) 2 RIF1 1086
2(2) 2(3) 2 KIAA1109 1092
4(4) 2(3) 2 1100
4(4) 2(3) 2 1100
17(84) 3(4) 2 1102
2(3) 2(3) 2 1126
6(12) 4(5) 2 TUBB6 1149
4(4) 5(6) 2 RBM17 1153
4(4) 5(6) 2 RBM17 1153
2(2) 2(4) 2 UBAP2L 1165
2(3) 2(3) 2 LMNA 1177
2(3) 2(3) 2 LMNA 1177
2(2) 2(3) 2 MTBP 1178
2(3) 3(3) 2 MSH3 1197
2(3) 3(3) 2 MSH3 1197
2(2) 2(2) 2 EP300 1219
3(5) 3(3) 2 1229
4(5) 3(5) 2 1247
5(12) 3(3) 2 1251
5(12) 3(3) 2 1251
3(7) 2(3) 2 1257
4(5) 3(5) 2 1268
2(2) 2(3) 2 1270
4(9) 4(10) 2 1273
3(4) 3(6) 2 1275
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2(4) 2(6) 2 1280
3(9) 2(5) 2 1283
2(3) 3(5) 2 1297
2(2) 2(3) 2 1299
2(2) 2(3) 2 1299
2(2) 2(3) 2 1299
2(2) 2(3) 2 1299
2(2) 2(3) 2 1299
2(2) 2(3) 2 1299
3(3) 3(6) 2 F5 1303
1(19) 1(14) 2 GRINL1B 1311
2(13) 1(11) 2 AZI1 1314
2(13) 1(11) 2 1314
2(13) 1(11) 2 AZI1 1314
2(13) 1(11) 2 AZI1 1314
2(4) 2(2) 2 IGHA1 1345
33(153) 34(218) 2 1355
12(45) 18(89) 2 1369
11(15) 10(28) 2 ACD 1372
2(2) 2(2) 2 TXN 1379
2(2) 2(2) 2 TXN 1379
2(2) 2(2) 2 1379
7(11) 9(17) 2 TINF2 1383
2(3) 3(7) 2 TINF2 1386
3(4) 2(2) 2 1393
3(3) 2(2) 2 YTHDF1 1395
6(6) 4(5) 2 RBM14 1404
2(2) 2(6) 2 VH3 1412
3(3) 5(5) 2 YTHDF3 1414
3(3) 2(2) 2 1415
2(2) 2(2) 2 POLDIP3 1417
2(15) 2(6) 2 DNAJB1 1425
2(3) 3(7) 2 YTHDF2 1426
2(2) 3(3) 2 TF 1431
2(2) 3(3) 2 1431
3(4) 4(4) 2 CREBBP 1436
3(4) 4(4) 2 CREBBP 1436
3(7) 2(8) 2 DAZAP1 1459
3(7) 2(8) 2 DAZAP1 1459
2(2) 7(7) 2 IGHA1 1468
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